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Spectroscopy is increasingly used to investigate and monitor the solid state forms of 
pharmaceutical materials and products. Spectroscopy's speed, nondestructive 
sampling, compatibility with fibre optics and safety also make it attractive for in-line 
monitoring. 
In this thesis, the spectroscopic techniques Fourier transform Raman spectroscopy, 
terahertz pulsed spectroscopy and second harmonic generation were used to 
characterise and quantify polymorphism and crystallinity of pharmaceutical 
compounds. Where possible, the multivariate analysis technique partial least squares 
was used for quantitative analysis. Fourier transform Raman spectroscopy detects 
polarisability changes mainly associated with molecular vibrations. Terahertz pulsed 
spectroscopy is a new spectroscopic technique that operates between the infrared and 
microwave regions of the electromagnetic spectrum and detects dipole moment 
changes mainly associated with crystalline phonon vibrations in the solid state. 
Second harmonic generation is a nonlinear optical phenomenon that depends on the 
dipole moment in crystals and crystal symmetry. 
Several materials capable of existing in different solid state forms were used. FT-
Raman spectroscopy was able to differentiate carbamazepine forms I and III, enalapril 
maleate forms I and II and y-crystalline and amorphous indomethacin. Combined 
with partial least squares the technique could quantify binary mixtures of CBZ forms I 
and III with a limit of detection as low as 1 %, and mixtures of enalapril maleate with 
a limit of detection of as low as 2%. 
Terahertz pulsed spectroscopy obtained very different spectra for carbamazepine 
forms I and III, enalapril maleate forms I and II, y-crystalline and amorphous 
indomethacin, crystalline and supercooled thermotropic liquid crystalline fenoprofen 
calcium, three forms of lactose, and five forms of sulphathiazole. At present the 
modes in the spectra cannot be attributed to specific phonon modes. Quantitation of 
binary mixtures of different forms of a compound using partial least squares analysis 
usually resulted in a limit of detection of about 1 %. 
ii 
Second harmonic generation was used to quantify binary mixtures of different forms 
of enalapril maleate and lactose, as well as binary mixtures of enalapril maleate form 
II and polyvinylpyrrolidone. A quantitative relationship was present for each of the 
mixtures, however the limits of detection were usually above 10%. The high value is 
probably due to the machine being a prototype and univariate analysis associated with 
a single output variable. Future improvements to the apparatus and measurement 
parameters are likely to reduce the limits of detection. Ranitidine hydrochloride 
polymorphs could also be differentiated using second harmonic generation, however 
y-crystalline and amorphous indomethacin and forms I and III of carbamazepine could 
not. 
The methods used in this thesis were successfully used for qualitative and quantitative 
analysis of polymorphism and crystallinity of pharmaceutical compounds. TPS and 
SHG are useful additions to the range of experimental techniques that can be used to 
investigate and monitor properties of pharmaceutical solids. 
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Chapter 1 
Characterisation and quantitation of polymorphism 
and crystallinity of pharmaceutical compounds 
I 
1.1 The solid state 
Molecular solids can be divided into three broad categories according to their degree 
of molecular long-range orientational and positional order. Crystal structures possess 
orientational and positional long-range order in all three dimensions in space. Liquid 
crystalline forms are less ordered and contain long-range orientational and positional 
order in one or two dimensions, but not all three dimensions. A third form possible in 
the solid state is the amorphous form. Amorphous materials may contain short-range 
orientational and positional order, for example due to the formation of molecular 
dimers, but not long-range order 1-3. 
Within each category, variation m supramolecular structure 1s possible. 
Polymorphism (Greek: poly= many, morph = form) is the existence of materials with 
the same chemical composition but different lattice structures and/or different 
molecular conformations in the solid state 2,4. Crystalline and liquid crystalline 
materials may exhibit polymorphism. The amorphous phase may have varying 
degrees of short-range order 1-4. 
Different solid state forms of a material have different intermolecular bonding 
networks. Possible noncovalent interactions include hydrogen bonding, electrostatic 
and van der Waals interactions and n - n stacking. In addition there may be changes 
in the conformation of the molecules 4• 
Solids can often incorporate solvates. When the solvate present is water, the resulting 
form is known as a hydrate. Usually, but not always, the incorporation of a solvate 
leads to a new solid state structure. The ability to form solvates has been called 
pseudopolymorphism; however this term is no longer favoured because it has been 
used to describe many other processes associated with the solid state, such as 
desolvation, dynamic isomerism, grain growth, recrystallisation in the solid state, 








1.1.1 Crystal structure classification 
Crystalline solids consist of units that repeat themselves in three dimensions. The 
smallest unit that can be repeated is the unit cell, which is a parallel sided figure. A 
unit cell is described by three lattice constants, representing the length of the axes in 
three dimensions, and three angles between the three axes 6. A unit cell may consist 
of many atoms or molecules. 
Since crystal structures consist of repeating unit cells, they have varying degrees of 
symmetry. Symmetry operations describe manipulations after which the structure 
appears unchanged and may involve rotation, reflection, inversion ( collectively 
known as point symmetry) and/or translation. 
Unit cells may be divided into seven classes according to the rotational symmetry that 
they possess (Tablel.1). 
Table 1.1 The seven crystal systems defined by unit cell axis lengths, unit cell axis 
angles and their rotational symmetry (adapted from Atkins (1994) 7 and Massa 
(2000) 6). 
Crystal system Unit cell axis lengths Unit cell axis angles Essential rotational 
symmetries* 
Triclinic aj bj C at Pt r None 
Monoclinic aj bj C a=y = 90 ° One C2 axis 
Orthorhombic aj bj C a= p = y = 90 ° 
Three perpendicular C2 
axes 
Tetragonal a=b a= p = y = 90 ° One C3 axis 
Trigonal a=b a=P=90°,y=120° One C3 axis 
Hexagonal a=b a=P=90°,y=120° One C6 axis 
Cubic a=b=c a= p = y = 90 ° 
Four C3 axes in a 
tetrahedral arrangement 
*The unit cell rotational symmetries are defined by how many times the unit cell repeats itself while 
rotating 360 ° about an axis e.g., C2 means the unit cell repeats itself twice while rotating 360 °. For a 




Incorporation of inversion symmetry into the unit cell classification leads to fourteen 
types of unit cell, which are known as the Bravais lattices. 
If all possible symmetry operations are considered, including translation, there are 
230 possible operations. These are known as the 230 space groups. All crystal 
structures can be classified according to a space group. The space groups are usually 
described according to the internationally adopted Hermann-Mauguin notation 6,7. 
The symmetry ( space group) of a crystal affects fundamental properties of the crystal, 
such as optical and electric properties, as well as macroscopic appearance. Optical 
properties of the crystals are extremely important in the spectroscopy of solids. 
L 1.2 Thermodynamics of the solid state 
The solid state form of a material with the lowest free energy is the 
thermodynamically stable form, while all other forms are unstable. Temperature and 
pressure affect the thermodynamic stability of different solid state forms. Therefore 
at different temperatures and pressures different forms may be thermodynamically 
stable. At a constant pressure and temperature, the difference in Gibbs free energy of 
two solid state forms is defined as 
L1G = L1H -TL1S (1.1) 
where L1G is the difference in Gibbs free energy, L1H is the difference in enthalpy, 
reflecting structural differences between the two forms, Tis temperature (Kelvin) and 
L1S is the difference in entropy, which is related to disorder and lattice vibrations of 
the two forms. Conversion between two solid state forms only occurs in the direction 
in which L1G is negative. If L1G = 0, then the two solid state forms are in equilibrium. 
If L1G is positive then transformation is not possible at the specified temperature and 
pressure 2,4. 
The thermodynamic relationship between different forms of a material ( at constant 







1.1) 4'8. The material characterised in Figure 1.1 can exist in the solid state as three 
polymorphs, as well as glassy, rubbery and liquid amorphous phases. The 
thermodynamically stable form at a given temperature can be easily observed, by 
noting which form has the lowest Gibbs free energy. In Figure 1.1, crystal form C is 
the stable solid state form at all temperatures shown (below its melting temperature). 
Line intersections represent points where LIG = 0, and therefore the two phases exist 
in equilibrium. Intersection of the lines representing crystal forms A, B and C with 
the liquid state line are the melting points of each crystal form. The intersection point 
of crystal forms A and B represents the transition point where at higher temperatures 
form B becomes more stable than form A. 
Phase transitions associated with the intersection points can be thermodynamically 
characterised as first or second order transitions according to the Ehrenfest 
classification system 7. In a first order transition, the slope of the Gibbs free energy 
curve is different immediately below and above the transition temperature. This leads 
to a discontinuity in the first derivative of the Gibbs free energy with respect to 
temperature and S, H and the volume of the system are also discontinuous. The heat 
capacity is infinite at the transition temperature. In a second order phase transition the 
first derivative of the Gibbs free energy curve, S, Hand the volume of the system are 
continuous at the transition temperature. The heat capacity is discontinuous at the 
same temperature 2,7. Polymorphic transitions and melting are first order transitions 
as can be seen in Figure 1.1 by the change in slope of Gibbs free energy of the two 
phases below and above the transition temperature. 
Polymorphs may be defined as monotropic or enantiotropic 8• Two polymorphs are 
monotropic if there is no transition point where LIG = 0 below the melting point of the 
lower melting form (at constant pressure). In Figure 1.1, crystal form pairs A and C 
and also B and C are monotropic, since the Gibbs free energy of form C is lower at all 
temperatures below the melting points of forms A and B. Conversion from forms A 
to C and B to C are therefore irreversible. Enantiotropic polymorphs contain an 
equilibrium point where LIG = 0 below the melting point of the lower form. The 
Gibbs free energy curves of crystal forms A and B contain a temperature below the 





and B are therefore reversible, and the two crystal forms are considered 
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Figure 1.1 Schematic illustration of the thermodynamic relationships between three 
crystalline polymorphs and the amorphous form. Conversion between crystalline 
forms A and B is enantiotropic and occurs at the transition temperature, T1, while 
conversion from forms A and B to crystalline form C is monotropic. Melting points 
for crystalline forms A, Band Care shown as Tm,A, Tm,B and Tm,c respectively. The 
transition from the amorphous rubbery form to the supercooled amorphous glassy 
form occurs at the glass transition temperature, Tg (adapted from Rodriguez-Spong et 
al (2004) 9). 
Amorphous solids can exist as a rubbery state and, at lower temperatures, as a glassy 
state. The temperature at which transition between the rubbery and glassy states 
occurs is known as the glass transition temperature (Tg). The molecular mobility in 
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the rubbery state is higher than in the glassy state, and the Tg represents the 
temperature at which the material cannot kinetically obtain equilibrium as thermal 
energy is removed from the system io,ll. The Tg is a second order transition according 
to the Ehrenfest classification system and it is characterised by a continuous change in 
H (no immediate change in the slope of Gibbs free energy at the Tg in Figure 1.1) and 
a discontinuous change in the heat capacity of the system. Depending on the method 
of preparation the temperature of the Tg can change and kinetic states, relaxation times 
and glass properties may also be altered 10. Therefore, unlike crystalline materials, the 
properties of an amorphous material cannot simply be defined by temperature and 
pressure. 
The properties of glassy and rubbery materials are currently the subject of intensive 
research. There have been some suggestions of 'polyamorphism', or discrete 
amorphous forms, which have first order phase transitions. If such a phenomenon 
exists it is likely to be rare in pharmaceutical materials 12 . 
1.1.3 Kinetics of the solid state 
Although thermodynamic relationships dictate possible transformations, a 
thermodynamically possible transformation may not occur in a measurable time 
frame. This is because kinetic factors dictate the rate of a solid state transformation. 
Formation of a crystalline form is characterised first by molecular assembly and 
nucleation, and then crystal growth. For nucleation to occur molecules must break 
intermolecular bonds and rearrange themselves into a different arrangement and/or 
conformations with new intermolecular bonds. Energy barriers to nucleation are 
associated with molecular diffusion, molecular assembly and the creation of an 
interface between the two phases 4• Nucleation may be homogeneous or more 
commonly heterogeneous. In heterogeneous nucleation, the process is catalysed by a 
contaminant or by a surface that decreases the interfacial energy. The energy changes 
associated with the nucleation for two crystal forms are shown in Figure 1.2. The 
energy barrier associated with transformation of an initial form to form A is lower 
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than for the formation of form B. Because form A has a lower energy barrier than 
form B, form A nucleation will occur more rapidly than form B. Once nucleation has 
occurred, crystal growth follows. Crystal growth is dictated by a number of factors, 
including thermodynamic energy differences between the two forms, intermolecular 
bond interactions between the crystal surface and the other phase, temperature, degree 
of supersaturation, and the presence of impurities 9. Thus crystal formation is a 
balance between kinetic and thermodynamic factors 2• 
Nucleation energy barriers are often lower for transition to a metastable form, and 
therefore metastable forms are often created before the stable form, for example upon 
cooling of a melt. This observation is embodied in Ostwald's Rule of Stages 2A. 
The rate of attachment of molecules to different faces of the crystal determines the 
shape or habit of the crystal. Thus, if slightly different kinetic conditions prevail, 
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Figure 1.2 Diagram representing energy changes occurring during transformation 
from an initial form at G0 to forms A and B. The positive transition energy changes 
from G0 to G* A and Go to G*B are the energy barriers to the transformation to forms A 
and B respectively (adapted from Bernstein (2002) 2). 
1.1.4 Methods to create different solid state forms 
Although convers10n does not occur when LIG is positive, metastable forms (in 
normal conditions) may be created by altering the pressure and/or temperature of the 
system. In addition, crystal forms may be produced from solution 2• 
Amorphous forms may be obtained using conditions far from equilibrium. For 
example, a melt can be quench cooled to create first the rubbery state and then the 
glassy state. Freeze-drying and spray-drying are two other techniques used to obtain 
the amorphous phase ll. Conversion from one crystalline form to another polymorph 





Solid state form conversions may be intentional, but are more frequently 
unintentional, and important material characteristics ( described in Section 1.2) may be 
changed as a result of formation of a new solid state phase. 
1.2 Importance of polymorphism and crystallinity in 
pharmaceutics 
In 1979, Burger and Ramberger documented the polymorphism of many 
pharmaceutical compounds 13, and, since then, the incidence of pharmaceutical 
polymorphism and crystallinity has been increasingly ivestigated. In 2001, eight out 
of the ten most commonly prescribed drugs in the United States were known to 
exhibit polymorphism or hydrate formation 14• With the advent of combinatorial 
chemistry, drugs will contain more functional groups, allowing them to crystallise in 
many different polymorphic forms. Crystallinity variations in a pharmaceutical 
substance may exhibit physicochemical differences that impact at therapeutic, 
manufacturing, commercial and legal levels 2,3,5,14_ Therefore polymorphism is 
widespread and important in the pharmaceutical industry. 
1.2.1 Therapeutic implications 
Due to thermodynamic differences, polymorphic forms have different dissolution 
rates and solubilities, and the stable polymorph at a given temperature exhibits the 
lowest dissolution rate. If a drug has low solubility and high permeability it is 
classified in the Biopharmaceutical Classification System (BCS), a system used by the 
Food and Drug Administration, as Class Two 15' 16. These drugs exhibit dissolution 
rate-limited absorption, and therefore their polymorphs are likely to exhibit different 
absorption profiles and bioavailabilities. 
Drugs that have been found to exhibit significant changes in absorption rate or 
bioavailability as a result of polymorphism are chloramphenicol 17,18 
sulphamethoxydiazine 19, pentobarbital 20 and mercaptopurine 21 With a higher 
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solubility, amorphous drugs have exhibited higher bioavailability and efficacy 
compared with some crystalline counterparts 22 . 
While unpredictable variation m absorption and bioavailability are not desired, 
approaches of increasing the bioavailability of drugs with dissolution rate-limited 
absorption include the use of amorphous or metastable crystalline forms 23,24. 
However these forms tend to crystallise into more stable forms, and methods have 
been developed to stabilise such systems, for example the use of solid dispersions 25 . 
1.2.2 Other implications of polymorphism and crystallinity 
If a drug does not exhibit dissolution rate-limited absorption, polymorph or 
crystallinity changes are unlikely to affect absorption. However, polymorphism and 
crystallinity can affect properties important in tablet manufacture. Particle shape and 
powder density are influenced by the solid state form and they affect powder flow and 
compressibility, which are important in tablet and capsule manufacture 3,5,26. Other 
properties that may be affected are hygroscopicity ( especially if an amorphous phase 
is present), chemical stability, and filterability 3,27,28 . 
Regulatory bodies in the European Union, the United States and Japan require 
polymorphs, hydrates and amorphous forms of new drug substances to be 
characterised and their impact on bioavailability to be investigated. A decision tree to 
aid drug developers with investigations into polymorphism and amorphous content 
has been established (Figure 1.3) 29,30 . 
Solid state forms of drugs are frequently patented, and therefore polymorphism and 
crystallinity are not only of therapeutic and manufacturing concern, but also of 
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Figure 1.3 Decision tree to assess the need for acceptance criteria for polymorphism 
and amorphous content in drug substances and products ( adapted from an 





1.3 Polymorphism and crystallinity of pharmaceutical materials 
used in this thesis 
The following section introduces four pharmaceutical compounds that are capable of 
existing in more than one solid state form, and experiments with these compounds are 
presented in at least two chapters of the thesis. The different solid state forms for 
each are outlined, along with known pharmaceutical implications. Other compounds 
have also been used during this project, and they will be introduced in later sections. 
1.3 .1 Carbamazepine 
Carbamazepine (CBZ) is a dibenzazepine derivative (5H-dibenz[b,.f]azepine-5-
carboxamide, Figure 1.4). It has antiepileptic and psychotropic properties, and is used 
to control secondarily generalized tonic-clonic seizures and partial seizures. It is also 
used in the treatment of trigeminal neuralgia, other neurological syndromes associated 
with severe pain, and as a mood stabilizer in the treatment of bipolar disorder 31 . 
Figure 1.4 Molecular structure of CBZ. 
CBZ is known to exist in four anhydrous polymorphic forms and also as a dihydrate 
among other solvates. A primitive monoclinic polymorph was the first to be 
structurally defined by x-ray analysis 32'33 . A triclinic polymorph has also been 
investigated (Ceolin et al., 1997) and later its crystal structure was elucidated 34'35. 
Nomenclature for these polymorphs has varied between papers, generating some 
confusion. Designation of the characterised primitive monoclinic polymorph, form 
III, and the triclinic polymorph, form I, appears to be the most common system, 
however 35-39 , Forms I and III both exist as dimers with cyclic hydrogen bonding 






. Form III is the stable form at room temperature, 
while form I is stable at high temperatures. 
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CBZ is a poorly water-soluble drug and is classified as a BCS Class Two drug 15,16 . 
Thus its absorption from the gastrointestinal tract is dissolution rate-limited. The 
hydrate of CBZ, and to a lesser extent the polymorphs, have been associated with 
different intrinsic dissolution rates and bioavailabilities 40'41 , and different commercial 
brands of CBZ tablets have a history of bioinequivalence and clinical failure 42. In 
addition, tableting difficulties have been attributed to polymorphic changes 38. 
Therefore CBZ is one example that illustrates the necessity to identify, monitor, and 
understand pharmaceutical polymorphs as fully as possible. In this thesis, forms I and 
III are used as polymorphic examples. 
1.3 .2 Enalapril maleate 
Enalapril maleate (EM) (1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-L-proline l '-
ethyl ester maleate, Figure 1.5) is a rapidly absorbed orally active prodrug used to 
treat hypertension and heart failure. In the blood the ethyl ester is hydrolysed to form 
the active enalaprilate, an angiotensin converting enzyme inhibitor 31•43 . 
• (COOH 
COOH 
Figure 1.5 Molecular structure of EM. 
EM is known to exist in two polymorphic forms. The crystal structure of a 
monoclinic polymorph, space group P21, was solved in 1986 by Precigoux et al 
44
, 




, however its crystal structure was not solved until almost twenty years later. 
Form II has been identified as an orthorhombic crystal, space group P212121 
47
. 
Forms I and II have very similar molecular packing. However form II is marginally 
denser and has a slightly higher lattice energy than form I at room temperature, 
suggesting that form II is marginally more stable in ambient conditions 47 . Both 
14 
polymorphs exhibit similar aqueous solubility and dissolution, with almost all the 
drug dissolving in water from tablet and capsule formulations within thirty minutes 46 . 
1.3 .3 Indomethacin 
Indomethacin (IM) ([1-( 4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid) 
is an indole acetic acid derivative (Figure 1.6). It is classified therapeutically as a 
nonsteroidal anti-inflammatory drug, and thus is used in the symptomatic 
management of painful and inflammatory conditions, especially musculoskeletal and 
joint disorders 31 . 
Figure 1.6 Molecular structure of IM. 
IM is practically insoluble in water and can be classified as a BCS Class Two drug. It 
is known to exist in two polymorphic forms, a y-form and an a-form. The y-form, 
which is the stable form at room temperature, was determined to be triclinic with 
space group P 1 48•49. The a-form crystal, a metastable modification, did not have its 
crystal structure elucidated until recently. It was determined to be monoclinic with 
space group P21 
28
. 
Unlike many other drugs, amorphous IM is easily produced without significant 
degradation by melting and subsequent cooling 50. The physical properties of 
amorphous IM have been extensively investigated 51 -56, and IM has been used as a 






. In this thesis they-form and amorphous forms ofIM are used. 
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1.3 .4 Lactose 
Lactose is the most commonly used diluent in tablet and capsule formulations. It is 
also used as a carrier for drugs in powder inhalers 31 . Lactose is a disaccharide 
composed of glucose and galactose moieties (Figure 1.7). It exists as two anomeric 
forms, a-lactose and ~-lactose, which differ in their configuration of the terminal 
hydroxyl group of the glucose unit, with OH axial in the a-form and equatorial in the 
~-form 66. 
OH OH 
"~ ,oL A. o, ~
Figure 1. 7 Molecular structures of a-lactose (left) and ~-lactose (right). 
Lactose is known to exist in a hydrated form and four polymorphic forms, which are 
known as: a-lactose monohydrate (aLMH), hygroscopic anhydrous a-lactose, stable 
anhydrous a-lactose (aL8), anhydrous ~-lactose (~L), and mixed compounds, a/~, 
with different stoichiometries 67-69 . The names of the crystal forms of lactose are 
slightly misleading because they imply each crystal form contains only one anomeric 
form. This is not quite true. It is known for example that in the pure crystal form 
named aLMH about 4% of the aL moieties are converted to the ~L anomeric form 70. 
The crystal structure of aLMH was found to be monoclinic, with space group P21 
71
. 
In 1974 the crystal structure of ~L was published and also found to be monoclinic, 
with space group P21, though all cell constants differ where possible 
72
• This was 
confirmed in another study in 2002 66 . To the author's knowledge, the crystal 
structure of aLs has not yet been published. Lactose can also exist in the amorphous 
form. 
The different solid state forms of lactose exhibit differing physical characteristics 
such as flow and binding properties, and solubility. Crystalline aLMH is the most 
commonly used form because it is stable, inexpensive and readily available. However 
its flow and binding properties are not sufficient to allow tablets to be made without 









exhibit much improved flow properties and direct compression can be used to make 
tablets. The BL form exhibits a much higher solubility compared with the anhydrous 
a-lactoses 73 . In this study aLMH, BL and aLs are the polymorphic forms used. 
1.4 Characterisation of polymorphism and crystallinity 
Brittain (1995) 74 has divided physical characterisation techniques into three 
categories depending on the level probed: molecular, particulate or bulk (Table 1.2). 
All techniques obtain different information, and all suffer disadvantages. It is their 
diversity that allows comprehensive polymorphism and crystallinity characterisation. 
Table 1.2 Techniques used to investigate polymorphism and crystallinity at the 
molecular, particulate and bulk levels (adapted from Brittain (1995) 74). 
Characterisation at the molecular level 
Vibrational spectroscopy 
Magnetic resonance spectroscopy 
Characterisation at the particulate level 
X-ray diffraction 
Optical and electron microscopy 
Thermal methods of analysis 





Specific techniques or measurements 
Fourier transform infrared spectroscopy (FTIR) 
including diffuse reflectance Fourier transform 
spectroscopy (DRIFTS) and attenuated total 
reflectance spectroscopy (ATR), near-infrared 
(near-IR) spectroscopy, Raman spectroscopy 
Nuclear magnetic resonance (NMR) 
Single crystal x-ray diffraction, x-ray powder 
diffraction (XRPD) 
Polarising light microscopy (PLM), hot stage 
microscopy, scanning electron microscopy (SEM) 
Differential scanning calorimetry (DSC) 
including modulated temperature DSC (MTDSC), 
thermogravimetric analysis (TGA) 
Specific surface area, porosity and powder and 
true density measurements 
Flowability and compaction measurements 
Dissolution rate and solubility measurements 
using isothermal calorimetry 
Karl-Fischer titration, dynamic vapour sorption 
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1.4.1 Vibrational spectroscopy 
1.4.1.1 Infrared spectroscopy 
Infrared (IR) spectroscopy probes the absorbance of materials in the region 400 and 
4000 cm-1, known as the mid-IR region. When an electric field irradiates a sample, it 
induces a change in the electron cloud, which forms a counteracting and oscillating 
dipole moment within the molecule. If this dipole moment oscillation is at a natural 
vibrational frequency of the molecule, then the nuclei in the molecule will vibrate at 
this natural frequency in response to the dipole moment. A schematic of IR 
absorption is shown in Figure 1.9. The vibration represents the excitation of the 
molecule from a ground state vibrational energy level (v = 0) to an excited state 
energy level (v = 1). To move from v = 0 to v = I, a quantised amount of energy, L1E, 
is absorbed, defined by 
L1E = hcv (1.2) 
where his Planck's constant, c is the speed of light in vacuum and v is the frequency 
in wavenumbers (cm-1) of the photons (or light) absorbed. Since hand care constant, 
v must be solely determined by the energy absorbed during the vibration, and 
therefore only light of one frequency is absorbed. This gives rise to an absorption 
band in an IR spectrum 75 . There are 3n - 6 (where n is the number of atoms) allowed 
vibrations in nonlinear molecules, each with a defined L1E. 
The intensity of the absorption is dictated by how much the molecular vibration 
interacts with the dipole moment induced by the electromagnetic radiation. The 
interaction is larger for vibrations where there is a large dipole moment change 
associated with the nuclear vibration. Vibrations involving polar bonds generally 
absorb strongly, while vibrations involving nonpolar bonds with little change in the 
dipole moment associated with the nuclear vibration absorb IR radiation weakly. If 
there is no dipole moment change associated with the molecular motion, then no 
absorption will occur. Therefore the selection rules for IR spectroscopy state that a 
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molecular vibration must cause a change in the dipole moment of the molecule for 
absorption to occur. Modes in the IR region can be divided into the vibration types: 
stretching, wagging, bending, rocking and twisting 75,76 . 
IR spectra are usually collected using Fourier transform (FT) IR spectroscopy (FTIR). 
A typical setup of an FTIR spectrometer is shown in Figure 1.8. In FTIR, the source 
emits radiation at all mid-IR frequencies simultaneously. The beam is split into two 
and one beam travels a fixed length while the other travels a variable length using a 
movable mirror. The two beams recombine, and pass through the sample before 
being detected. The detector records an interferogram in the time domain based on 
the path differences of the two light beams. Through Fourier transformation, the 
interferogram is converted into the frequency domain to produce a spectrum. Fourier 
transformation improves the signal-to-noise ratio (SNR) and/or reduces acquisition 







Figure 1.8 Typical setup for a FTIR spectrometer ( adapted from Kealey and Haines 
(2002) 77). 
Since changes in the solid state form of a compound involve changes in the molecular 
environment or molecular conformation, IR active modes are often affected by 





FTIR spectroscopy have led to its extensive use to investigate polymorphism and 
crystallinity in pharmaceutical materials. Several reviews 71 •78-80 and books 2•74 have 
covered the use of FTIR spectroscopy to investigate solid state forms of 
pharmaceutical materials. Diffuse reflectance FTIR spectroscopy (DRIFTS) and 
attenuated total reflectance spectroscopy (ATR) do not involve high pressure or high 
mechanical energy input for sample preparation. Therefore there is a lower risk of 
solid state transformation, making them the preferred methods of sample preparation 
for IR spectroscopy studies of polymorphism and crystallinity. 
1.4.1.2 Near-infrared spectroscopy 
Near-IR spectroscopy involves radiation between 4 000 and 13 000 cm-1, and probing 
combinations and overtones of fundamental vibrations observed in the mid-IR region. 
These combination and overtone modes are the result of anharmonicity of the 
fundamental vibrations. Many bands observed in the near-IR region are overtones 
and combinations for bonds involving hydrogen 81 . These bands are difficult to 
interpret and frequently overlap, and therefore this region has not been used as much 
as the mid-IR for structural analysis. However near-IR measurements can be made in 
reflectance mode with undiluted samples, lending the technique to inline monitoring. 
In combination with multivariate analysis (covered in Section 1.5.2) the technique is 
becoming popular for quantitation of polymorphism and crystallinity during 
processing. Aaltonen et al (2003) used near-IR spectroscopy to screen for 
sulphathiazole polymorphs and solid state changes induced by milling and 
compression 82. Using near-IR spectroscopy, quantitative analysis of polymorphs in 
binary and multicomponent mixtures and pharmaceutical products has been 
performed 33-35 . 
1.4.1.3 Raman spectroscopy 
Raman spectroscopy is a vibrational spectroscopy technique complementary to IR 
spectroscopy. However, unlike in IR spectroscopy where a change in dipole moment 
is a prerequisite for absorption or IR activity, in Raman spectroscopy a change in 





Raman spectroscopy makes use of Raman scattering, and is a nonlinear optical 
technique. If a sample is irradiated by monochromatic radiation, most of the light, but 
not all, is scattered at the same frequency as the incident radiation. This scattering at 
the same frequency is known as Rayleigh scattering. If the light irradiating the 
sample is sufficiently intense, a small proportion of the light scattered has frequencies 
slightly above and below that of the incident radiation. This is known as Raman 
scattering, and is the response that is detected in Raman spectroscopy 75 . Raman 
scattering can be explained and compared to IR absorption and Rayleigh scattering by 
the use of vibrational energy levels (Figure 1.9). 
---- -- ----
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Figure 1.9 Schematic illustration ofIR absorption, Rayleigh scattering and Raman 
Stokes and anti-Stokes responses where v = 0 and v = 1 are vibrational energy levels, 
and the dotted line is a much higher virtual energy level ( adapted from Colthup et al 
(1990) 75). 
In Figure 1.9, it can be seen that IR absorption involves the transition of the molecule 
from a ground vibrational energy level (v = 0) to an excited vibrational energy level (v 
= 1 ). During this transition, the energy of the photon that excited the transition is 
completely absorbed. In Rayleigh scattering, a photon of higher energy (and therefore 





energy state (dotted line). However, the molecule immediately returns to the ground 
state, and releases a photon of exactly the same energy, and hence frequency, of the 
absorbed photon. Depending on the intensity of the radiation, in a very small 
proportion of cases the molecule does not return to the ground energy state, but 
instead returns to the v = 1 energy level. In this case, the energy of the photon (and 
hence frequency) is lower than that of the incident photon. This gives rise to a Stokes 
line in a Raman spectrum. The position of the Stokes line in a Raman spectrum (the 
Raman shift) corresponds to the energy and wavenumber difference between v = 0 
and v = 1. In a still smaller amount of cases, the molecule may already be at a higher 
vibrational energy level (v = 1). Upon excitation, the molecule absorbs the incident 
photon and is excited into a virtual high energy state, however the molecule returns 
not to the v = 1 level, but instead reverts to v = 0. Thus, more energy is released than 
was absorbed, and a photon with a higher frequency than the incident photon is 
released. This gives rise to an anti-Stokes line in a Raman spectrum 75 • In normal 
Raman spectroscopy, Stokes lines are more intense than anti-Stokes lines, because the 
number of molecules in the ground state vibrational energy level is always greater 
than those in the excited state 75 • 
At constant irradiation intensity, the amount of Raman scattering, both Stokes and 
anti-Stokes, depends on the polarisability change of the molecule during the vibration. 
If there is no polarisability change, then no Raman scattering occurs. Polarisability 
can be defined as the ease with which electrons flow in response to the electric field 
of the electromagnetic radiation. The greater the polarisability change during 
irradiation vibration, the greater the Raman scattering. Large polarisability changes 
are associated with molecules that have largely delocalised electron systems for 
example aromatic and nonpolar systems. This is in contrast to IR spectroscopy, 
where polar molecules are associated with strong IR absorption. Thus IR and Raman 
spectroscopy are complementary. 
Raman spectroscopy can be conducted by using an excitation wavelength ranging 
from the ultraviolet to near-infrared regions. The wavelength is normally chosen to 




degradation. The Raman signal may be collected usmg Fourier transformation 
( analogous to FTIR set up) or dispersion. Advantages of Raman spectroscopy include 
a very small sample size requirement, no sample preparation and a weak water signal. 
Raman spectroscopy is gaining popularity as a spectroscopic technique to investigate 
polymorphism and crystallinity. Tudor et al (1993) used near-IR FT-Raman 
spectroscopy to investigate and quantify the polymorphic mixtures of chlorpropamide 
polymorphs 86, and amorphous and crystalline forms of fructose and glucose were 
investigated by Soderholm et al (1999) using the same technique 87 • Taylor and 
Zografi (1998) quantified the crystallinity ofIM using FT-Raman spectroscopy 88 , and 
other examples of crystallinity and polymorphism investigations using Raman 
spectroscopy have been covered elsewhere 2'74'79 . Raman spectroscopy setups have 
been developed to investigate polymorphism in microlitre volume fluids 89 and 
pharmaceutical dosage forms 90'91 . In addition, Raman microscopy, also known as 
Raman mapping, has been used to map ibuprofen in two dimensions in solid 
dispersions with polyvinylpyrrolidone and to determine that the drug was in an 
amorphous, not crystalline, form 92. 
1.4.2 Nuclear magnetic resonance spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy measures the interaction of an 
applied magnetic field with atomic nuclei. If atomic nuclei spin and possess a dipole 
moment, an applied magnetic field induces the nuclei to align themselves with the 
magnetic field. In the case of C 13 and H 1 nuclei there are only two possible alignment 
options. The two alignments are separated by a quantised amount of energy, and the 
proportion of nuclei in each orientation is determined by the Boltzman distribution. If 
a radio frequency signal is applied to the system with a frequency corresponding to 
the energy difference between the two orientations, known as the resonance 
frequency, then overall some of the nuclei in the lower energy alignment will be 






The resonance frequency depends on the magnetic field experienced by the nucleus. 
The magnetic field is altered by shielding and deshielding resulting from the 
interaction of surrounding nuclei and electrons with the applied magnetic field. These 
effects result principally from chemical shift interactions, dipole-dipole coupling and 
spin-spin coupling. Chemical shift interactions come from magnetic field shielding 
by surrounding electrons. The shift depends on the strength of the magnetic field and 
the orientation of the molecule to the magnetic field. Dipole-dipole coupling involves 
the coupling of two nuclear dipoles of neighbouring nuclei with a dipole moment. 
The interaction depends on the orientation of the molecule. In most pharmaceutical 
materials only H1 and C13 coupling is important. Spin-spin coupling to other nuclei 
also occurs. In solution isotropic movement of the molecules removes orientation 
dependent responses and chemical shift interactions. Dipole-dipole coupling is 
averaged and spin-spin coupling is cancelled out. Thus, in solution the frequency of 
the absorbed radiation is effectively independent of molecular orientation 74. 
With the absorption frequency of the nuclei largely dictated by the environment of 
nuclei, NMR spectroscopy is ideally suited to investigations of polymorphism and 
crystallinity. However, because the molecules are not free to move isotropically, the 
orientation dependent effects of chemical shift interactions, dipole-dipole coupling 
and spin-spin coupling lead to broadening of the signals and uninterpretable spectra. 
Adjustments to the recording parameters are required in solid state NMR to obtain 
interpretable spectra 74 . 
The NMR spectra obtained from solids are improved by three methods - dipolar 
decoupling, magic-angle spinning and cross-polarisation. In dipolar decoupling the 
dipole-dipole coupling is eliminated by irradiation of the sample at the resonant 
frequency of the nucleus to be decoupled. Magic-angle spinning reduces the 
anisotropy induced broadening of the signal by spinning the sample at 54.7 ° to the 
applied magnetic field sufficiently fast (the angle is a result of the cosine squared 
function of the angle between the shielding and the magnetic field). Cross-
polarisation is used in solid state NMR to enhance the signal by increasing the 







magnetisation from neighbouring H1 nuclei. Cross polarisation also reduces the 
relaxation time of the C13 nuclei, shortening the required delay between successive 
scans. When these extra conditions are applied, the resolution and SNR of solid state 
NMR spectra become comparable to solution NMR spectra 74 . 
Solid state NMR is capable of extracting detailed structural information and can be 
used for crystal structure elucidation. The technique suffers the drawbacks of being 
expensive and often slow; however it is insensitive to particle size. The technique has 
been used in several investigations of pharmaceutical polymorphism and some 
reviews 73) 9,93,94 and books 2'74 have covered this area. In a study by Saindon et al 
(1993) solid state NMR was able to discriminate between two prednisolone 
polymorphs in tablets where the prednisolone constituted 5% of the dosage form 95 . 
Less investigated is the use of solid state NMR to study amorphous systems. Tromp 
et al (1999) investigated the relaxation of amorphous maltose alone and combined 
with plasticizers above and below the T g 96 • Forster et al (2003) investigated the 
stability of amorphous IM alone and co-melted with polyvinylpyrrolidone using solid 
state NMR 97 . In a quantitative study Gustafsson et al (1998) used NMR to detect 
amorphous lactose in crystalline lactose and obtained limits of detection as low as 
0.5% 98. 
1.4.3 X-ray diffraction 
In x-ray diffraction the lattice structure of the material is directly probed. When x-
rays impinge upon a sample, they are scattered by lattice planes within a crystal. 
These planes are defined by the positions of electron clouds of atoms within the 
sample. The scattered light is subject to constructive or destructive interference to 
create a scattering pattern. The interference is explained by the Bragg equation 





where n is an integer value, 2 is the wavelength of the radiation, d is the distance 
between the planes in the crystal, and () is the angle of the x-rays incident on the 
sample. For constructive interference to occur, it is necessary for the scattered x-rays 
to be in phase, and from the Bragg equation it is evident that to be in phase the x-rays 
scattered from one plane must travel an integer value (n) of the wavelength further 
than x-rays scattered from a nearer plane. Thus, only for certain angles will 
constructive interference occur (Figure 1.10) 6'99 . In the case of amorphous materials 
no lattice structure exists and therefore no interference pattern will be obtained. 
There are two mam methods of x-ray diffraction, namely single crystal x-ray 
diffraction and x-ray powder diffraction (XRPD). In single crystal diffraction a single 
crystal is used, and the x-ray scatter pattern is collected from the crystal by rotating 
the crystal in all three dimensions. A scatter pattern is obtained and the precise three-




Figure 1.10 Schematic illustration of x-ray scattering from lattice planes in a crystal 
(from Alexander (1969) 100). 
Single crystal x-ray diffraction is the gold standard technique for eliciting structural 
information about a crystal, and most crystal structures are solved using this 
technique 6. Disadvantages include the requirement for a perfect crystal of sufficient 





XRPD has traditionally been used for the qualitative identification of the solid state 
form of powders. The sample is not probed in three dimensions, and therefore the 
technique relies on random orientation of particles ( and lattice planes) in the 
powdered sample. Since x-ray diffraction probes the crystal structure of a solid, 
diffractograms obtained using XRPD are almost always unique to the system studied. 
XRPD is the most commonly used technique for polymorph identification 2• The 
absence of peaks in the diffractogram indicates an amorphous form. 
1.4.4 Optical microscopy 
Hot stage microscopy and polarising light microscopy are useful for obtaining 
qualitative information about polymorphism and crystallinity. Hot stage microscopy 
allows visualisation of thermally induced crystal form transitions, crystallisation and 
melting. In polarising light microscopy a linear polariser is placed below the 
condenser, and thus only polarised light reaches the sample. A second polariser, 
above the eyepiece, is rotated 90 ° to the lower polariser, and thus all light passing 
unaltered from the first polariser will be absorbed. Light passing through birefringent 
samples will alter the direction of the polarisation, and a component of this light will 
be transmitted through the second polariser. Amorphous (solid and melted) and 
optically isotropic (cubic) crystals will not rotate the light, preventing light 
transmission through the second polariser 74• Changes in the birefringence of the 
sample associated with phase transitions are easily observed using polarising light 
microscopy, when coupled with a hot stage. Hot stage and polarising light 
microscopy are comparatively simple techniques, and have been used in the study of 
pharmaceutical polymorphism and crystallinity for over forty years 5. 
1.4.5 Scanning electron microscopy 
Scanning electron microscopy (SEM) is used to obtain topographical information 




and therefore SEM is frequently used as a complementary technique for solid state 
investigations 2'74. 
1.4.6 Thermal methods of analysis 
1.4.6.1 Differential scanning calorimetry 
The most commonly used technique to investigate pharmaceutical polymorphism and 
crystallinity is differential scanning calorimetry (DSC). DSC is based on the fact that 
heat flows either into or out of the sample and changes in heat capacity occur upon 
phase transitions. In the pharmaceutical setting DSC has been extensively used to 
characterise polymorphism and crystallinity, including the relative stabilities of 
polymorphic and amorphous forms, energy changes involved with transitions between 
the forms, and whether the transitions are monotropic or enantiotropic 2,74,101 . There 
are two main types of DSC. In heat-flux DSC an inert reference material and a 
sample material are heated on one heating element and the temperature difference 
between the samples is measured. This temperature difference is converted into heat 
flow, and an enthalpy change for thermal events such as polymorphic changes, 
crystallisation and melting may be measured. The phase change may be endothermic, 
for example melting, or exothermic, such as crystallisation. Power compensated DSC 
yields the same data. However, the sample and reference are placed on separate 
heating elements and the amount of heat required to keep the two samples at the same 
temperature is controlled 74. DSC is not only able to measure events qualitatively, but 
also quantitatively, and therefore quantitation of polymorphism and crystallinity is 
possible 102. There are several variations of conventional DSC. Modulated 
temperature DSC (MTDSC) has improved resolution and can separate out reversible, 
irreversible and overlapping thermal events. Furthermore the heat capacity can be 
measured in a single run 103 . DSC and MTDSC have been widely used to investigate 
amorphous systems, including identifying and characterising glassy and rubbery states 
and the Tg of materials and mixtures 65,104. 
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Combination techniques such as DSC-thermogravimetry and DSC-x-ray diffraction 
are being increasingly used to investigate polymorphism and crystallinity 105, in 
addition to other thermal methods such as microthermal analysis 106. 
1.4.6.2 Isothermal microcalorimetry 
Isothermal microcalorimetry measures heat conduction into or out of a measuring cell 
into a heat sink as a function of time. A reference cell is used to correct for variations 
in heat sink temperature. Most often, a constant humidity is created in the sample 
chamber, and changes induced by water sorption are measured. Isothermal 
microcalorimetry is very sensitive to heat flow changes but is non-specific to 
chemical or physical processes 107 . 
Isothermal microcalorimetry has been used in pharmaceutics to quantify small 
amounts of amorphousness in otherwise crystalline material. Briggner et al (l 994) 
showed that I% amorphous lactose could be detected in crystalline lactose 108. Other 
studies have suggested that isothermal microcalorimetry is superior to other 
techniques, such as XRPD, for detecting low levels of amorphousness 109,uo. To the 
author's knowledge, the technique has not been used to quantify polymorphism. 
1.4.6.3 Solution calorimetry 
Solution calorimetry measures the heat of solution during dissolution in a solvent, and 
differences in solid state forms can be detected 101 . Like isothermal 
microcalorimetry, solution calorimetry has been used to detect small amounts of 
amorphous material in an otherwise crystalline substance 111 . Solution calorimetry 
can also be used to study heat of transition associated with polymorphism 101 • 
However, there are very few examples of quantification of polymorphism by solution 
microcalorimetry. 
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1.5 Quantitation of polymorphism and crystallinity 
Pharmaceutical polymorphism or crystallinity can be quantified usmg all of the 
techniques mentioned in Section 1.4, except for microscopy. Depending on the 
format of the data gathered, quantitative analysis can be performed and presented in 
many ways. This thesis focuses on spectroscopic techniques to quantify 
polymorphism and crystallinity, including an introduction to quantitative analysis 
using spectroscopy. However, most of the methods discussed can be applied to any 
analytical technique. 
The data processing used in quantitative analysis of spectra ranges from very simple 
calculations to complex mathematical and statistical techniques. Quantitative analysis 
methods may be divided into univariate and more complex multivariate analysis 
techniques. 
1.5 .1 Univariate analysis 
Univariate analysis, as its name implies, uses one variable to extract one set of 
information from a system, for example peak area, peak height, or the ratio of two 
peak heights. Univariate analysis has been used extensively in the pharmaceutical 
setting for its intuitive sense and ease of calculation. For example, two CBZ 
polymorphs and the dihydrate were quantified, using XRPD, by measuring intensities 
of diffractogram peaks unique to each form 112'113 . In a study by Vitez (2004) the heat 
of fusion data obtained by DSC was used to quantify the concentrations of anhydrate 
and hydrate forms of an unidentified drug in binary mixtures. However, quantitation 
of different crystal forms was not possible using heat of fusion data in two other cases 
where degradation occurred upon melting and the melting endotherms were 
overlapping 102. Using solid state NMR, two polymorphs ofroxifiban were quantified 
using peak areas unique to the two forms 114. There are many other examples of 
quantitative analysis using univariate analysis summarised in reviews of different 





As shown in the study by Vitez (2004), if peaks unique to the forms of interest are not 
available, univariate quantitative analysis of the data may not be possible. In this 
situation, multivariate analysis may be used. 
1.5.2 Multivariate analysis 
Multivariate analysis differs from univariate analysis in that it uses many (up to 
thousands) of variables to obtain quantitative data. It offers several advantages over 
univariate analysis. There is no requirement for a peak unique to one component, and 
several components in a sample can be analysed simultaneously. Improved precision 
is obtained through multiple correlated measurements, and interferents can be 
detected during component quantitation in new samples. In addition, if interferents 
have been incorporated into a model, prediction of components is possible even in the 
presence interferents 115 . The main disadvantage of multivariate analysis is that it is 
complex and not intuitive for those new to the subject, and therefore inappropriate 
data analysis is more likely. 
Several multivariate analysis methods can be used. They can broadly be divided into 
two categories: classical least squares analysis (CLS) and inverse least squares 
analysis (ILS). Beebe et al (1998) 115 provided a decision tree to assist with choosing 
the most appropriate method and an adapted form of the tree is shown in Figure 1.11. 
As specified in Figure 1.11, CLS can be subdivided into direct and indirect CLS. 
There are many methods based on ILS, the most common being multiple linear 
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Figure 1.11 Decision tree to assist choice of appropriate multivariate analysis method 
adapted from Beebe et al (1998) 115 . 
1.5.2.1 Classical least squares analysis 
A spectrum of an analyte can defined as a vector (x) which describes intensity values 
at each wavenumber i 
(1.4) 
where x is the response of analyte at frequencies 1, 2, 3 ... etc. 
i In equations associated with multivariate analysis, scalar quantities are denoted in lower case italics, 
e.g., x, vectors are denoted in lowercase bold, e.g., x, and matrices are denoted in uppercase bold, e.g., 
X. 
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Since the concentration, y, of the analyte is known, the response can be explained as 
x= ys (1.5) 
where y is the concentration of the analyte, and s is a vector describing the 
spectroscopic sensitivity at each frequency. Thus the responses at each frequency, or 
the spectrum, is a linear combination of the analyte concentration, times the 
spectroscopic sensitivity at each frequency. Once s is known, the concentration of the 
analyte can be predicted after the spectrum, x, is recorded. The sensitivities of many 
analytes can be calculated, and using matrix algebra, the concentrations of multiple 
analytes in a sample can be calculated simultaneously. In this situation, Equation 1.5 
becomes 
X =y S (1.6) 
where X is the matrix of responses (spectra) for the samples, y is a vector of the 
analyte concentrations, and S is a matrix of the sensitivities for each analyte at the 
different frequencies. The above approach is specifically called direct CLS, and 
requires each analyte to be available in pure form. If only mixtures are available, but 
all analyte concentrations are known, then a method called indirect CLS can be used, 
where prior to the analysis described above S is predicted using the mixtures 115 . 
The CLS method is analogous to the Beer-Lambert law, where X corresponds to 
absorption, and S relates to the absorption coefficient (and the path length) of the 
material at one particular frequency 115 . The advantages of CLS are that 
mathematically it is simple and comparatively few samples are required to create a 
quantitative model. However for a CLS model to be reliable all the analytes and their 
concentrations must be known and there must be no interferents in both the 
calibration and test samples. 
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1.5.2.2 Inverse least squares analysis 
ILS uses weighted amounts of each variable to calculate the analyte concentration 
y=Xb (1.7) 
where bis a vector denoting the regression coefficients (multiple regression). For one 
sample, 
(1.8) 
where y1, the concentration of sample 1, is equal to the sum of the coefficients, b1, b2, 
etc., multiplied by the value of each corresponding variable, x11 , x12, etc. The 
coefficients render some variables more important than others in determining the 
analyte concentration. 
To set up a calibration model, samples with known concentrations, y, are measured 
using spectroscopy to obtain X. To correlate the spectral measurements to the analyte 
concentration, the model coefficients, b, are estimated giving b. To calculate b, 
Equation 1. 7 is rearranged to obtain 
(1.9) 
where xt is the pseudoinverse of X. Once b has been calculated, y , which is an 
estimate of the concentration of the analytes in unknown samples, can be calculated 




The three most common ILS methods used to calculate b are MLR, PCR and PLS. 
The three methods differ in how xt is obtained. MLR uses spectral intensities at 
selected frequencies to calculate xt. This approach is intuitive. However, a limiting 
factor is that xt cannot be calculated unless the number of frequencies chosen is less 
than the number of samples measured, thus restricting the ability to gain useful 
spectral information to predict analyte concentrations. In addition, if the 
wavenurnbers chosen are correlated (i.e., they represent some of the same 
information) then xt is unstable, and prediction of unknown sample concentrations 
becomes unreliable. 
PCR and PLS decompose X in an attempt to retain more useful spectral information 
and exclude correlated and irrelevant data. When X is decomposed the 
dimensionality of the spectra is reduced by excluding redundant data. This allows xt 
to be calculated whilst still incorporating most of the useful information in the spectra 
and the quantitative model is more stable. PLS and PCR differ in the way X is 
calculated, and their theory is introduced in Chapter 3. 
An advantage of usmg ILS over CLS is that not all components and their 
concentrations must be known to build a quantitative model. As long as the variation 
due to redundant variables has been present during model construction, then variation 
in these redundant components will not interfere in the prediction of the components 
of interest in future samples. This is especially useful for complex mixtures, such as 
those in drug formulations. Also, other interference, for example by atmospheric 
carbon dioxide and water, is removed if it varies sufficiently during model 
construction. Disadvantages of ILS include the more complex calculations and the 
requirement for more samples to make a reliable model. 
There are many useful introductory texts such as Chemometrics: a practical guide by 
Beebe et al (1998) available for those interested to learn more about multivariate 
analysis, and chemometrics in general 115 . 
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Recently multivariate analysis has become especially popular for extracting 
information from near-IR spectra to quantify pharmaceutical polymorphism and 
crystallinity. Multivariate analysis is appropriate in near-IR spectroscopy because 
there is almost always peak overlap and the baseline is usually unclear 116' 117. 
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1.6 Project aims 
As discussed previously, polymorphism and crystallinity are important issues in the 
pharmaceutical setting, and therefore physical characterisation of the solid state is 
necessary. A variety of techniques is used, and spectroscopic techniques play an 
integral part in such investigations. Spectroscopy can be used not only for qualitative, 
but also quantitative analysis. Multivariate analysis is an approach that can overcome 
traditional problems in the use of spectra for quantitative analysis of polymorphism 
and crystallinity. In addition, there is scope for the development and assessment of 
new spectroscopic techniques to probe and quantify polymorphism and crystallinity. 
This project had two broad aims: 
• To develop and investigate new spectroscopic techniques to probe and 
quantify polymorphism and crystallinity. 
• To further assess the applicability of multivariate analysis in combination with 
spectroscopy to quantify polymorphism and crystallinity. 
Specifically the study aimed to: 
• Investigate the ability of multivariate analysis in combination with near-
infrared FT-Raman spectroscopy to quantify polymorphism and crystallinity. 
• Explore the potential of terahertz pulsed spectroscopy (TPS) to investigate and 
quantify pharmaceutical polymorphism and crystallinity. 
• Investigate the use of second harmonic generation to quantify pharmaceutical 







This chapter covers the sourcing of pharmaceutical materials and how different solid 
state forms were created. All other chemicals were used as received ( except for 
sieving (Endecotts Ltd, London, UK) and ball milling of Si02 (Chapter 5)) and were 
of reagent or analytical grade. 
2.1 Carbamazepine 
CBZ (5H-dibenz[b,j]azepine-5-carboxamide, purity> 99%) CBZ was supplied from 
Salutas Pharma GmbH (Barleben, Germany) as form III (P-monoclinic ), and this form 
was used without further purification. Form I (triclinic) was obtained by heating form 
III to 170 °C for two hours, as described by Lefebvre et al 118 and McMahon et al 36. 
Form I was stored over silica gel at 4 °C. 
2.2 Enalapril maleate 
EM (N-N-[(S)-1-ethoxycarbonyl-3-phenyl-propyl]-L-alanyl-L-proline hydrogen 
maleate, purity > 99%) was obtained from Salutas Pharma GmbH (Barleben, 
Germany) as form II and this form was used as received. Form I of EM was prepared 
based on the saturated solution method described by Ip et al 46 . 15 g of form II was 
mixed with 250 ml of ethyl acetate in a round-bottomed flask combined with a 
condenser, and heated until boiling. Further ethyl acetate was added gradually in 100 
ml aliquots, allowing the solution to boil for approximately 30 min between additions. 
EM that had precipitated on the sides of the flask was scraped off during boiling. If a 
clear solution was not obtained once the solution reached approximately 550 ml and 
left to boil gently for 2 h, further aliquots of 50 ml of ethyl acetate were added until 
the EM was completely dissolved. Once the EM was dissolved, the solution was 
removed from the heat, and 3.5% w/w methanol added. The solution was then cooled 
to room temperature and the sides of the flask scratched with a glass rod. The flask 
was placed in a fridge at 4 °C overnight, or up to 48 h if necessary, for the formation 
of crystals. The crystals were scraped off the sides of the flask, and the solution was 
filtered under vacuum using nitrate filter paper (pore size 4 µm). The filtered crystals 
were then dried for three hours in a vacuum oven at room temperature, and stored at 
4 °Cover silica gel. 
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2.3 Indomethacin 
IM (1-5-methoxy-2-methylindole-3-acetic acid) was purchased from Sigma Chemical 
Co. (St Louis, MO, USA). y-Crystalline IM was used as supplied. Amorphous 
samples were produced by the method outlined by Taylor and Zografi 119. IM was 
melted on a stainless steel plate at 165°C in an oven for 5 min and quench-cooled 
using liquid nitrogen. The amorphous material was warmed to room temperature 
under vacuum to prevent atmospheric moisture condensation on the sample. The 
amorphous material was then ground in a mortar and pestle, and stored at 4 °C over 
silica gel. 
2.4 Lactose 
Lactose was obtained as aLMH (4-0-~-D-galactosepyranosyl-a-D-glucose) and ~L 
(~-D-galactopyranosyl-~-D-glucose) from Lactose New Zealand (Hawera, New 
Zealand). The lactose forms were used without further modification. aLMH and ~L 
were used as supplied and aLs was prepared by dehydration with methanol as 
specified by Lerk et al 120,121 . aLMH was suspended in methanol to form a slurry, and 
left to stand for 1 h. The slurry was then dried at room temperature using a vacuum 
oven. 
2.5 Fenoprofen calcium 
Fenoprofen calcium (FC) ((±)-2-(3-phenoxyphenyl)propionic acid) dihydrate was 
purchased from Spectrum Chemical Manufacturing Corp. (New Jersey, USA) and 
Sigma Aldrich Chemie, GmbH (Steinheim, Germany). Crystalline FC dihydrate was 
used as received. The supercooled thermotropic liquid crystalline form of FC was 
prepared by heating the crystalline powder in beakers open to air in a preheated oven 
for 45 min at 125 °C to remove the water of crystallization 122• The samples were then 
brought back to room temperature over silica gel. 
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2.6 Sulphathiazole 
Sulphathiazole (STZ) (4-amino-N-2-thiazolylbenzenesulphonamide) forms I, II, III, 
IV and V were supplied by Terry Threlfall (Department of Chemistry, University of 
Southhampton, UK) and used as received. 
2. 7 Ranitidine hydrochloride 
Ranitidine hydrochloride (RN) (N-[2-[[[5-[(dimethylamino)methyl]-2-
furanyl]methyl]-thio ]ethyl]-N' -methyl-2-nitro-l, 1-ethenediamine, hydrochloride) 
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3 .1 Introduction 
3 .1.1 Raman spectroscopy 
The theory of Raman spectroscopy and its use in characterising pharmaceutical 
polymorphism and crystallinity was introduced in Section 1.1.2. The advantages of 
Raman spectroscopy in investigating polymorphism and crystallinity include minimal 
sample preparation, and a very weak water signal. In the pharmaceutical sciences 
near-IR excitation of the sample is most commonly used because it is less likely than 
visible excitation to induce fluorescence in organic molecules. The most commonly 
used near-IR excitation wavelength is 1064 nm. FT-Raman spectroscopy 
measurements are faster than those obtained using dispersion Raman spectroscopy 
and the SNR ratio is improved especially when the Raman scattering is weak 75 . 
3 .1.2 Partial least squares regression 
As introduced in Section 1.5.2.2, PLS is one of the most commonly used ILS methods 
used to quantify components in a mixture. Another ILS method commonly used is 
PCR. Both methods decompose X and reduce the dimensionality of the spectral data 
hence stabilising xt (Equation 1.9). 
(1.9) 
PLS and PCR differ in the way X is decomposed, and hence how xt is calculated. In 
PCR the largest spectral variation is used to construct xt. In PLS the largest 
covariance between the spectral data and the concentration data is used to construct 
xt. Therefore PLS has a theoretical advantage because it is more likely to use only 
the spectral variation that results from the changing component concentration. 
Because of this theoretical advantage, PLS is more widely used than PCR to 
determine component concentrations in mixtures. However PCR is also frequently 
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used successfully for the same purpose 123 • In this thesis PLS is the only multivariate 
analysis method used to determine component concentrations, although the author has 
found that PCR can also be successfully used for the same purpose 124• 
The mathematical derivation of PLS will not be explained in detail in this thesis and 
there are several algorithms that can be used for PLS analysis. The reader is referred 
to other sources for a detailed theoretical explanation 125,126 . Briefly, in PLS, it can be 
shown that X is decomposed and the newly formed pseudoinverse matrix, xt, goes as 
(3.1) 
where W is the weights matrix, PT is the transposed loadings matrix, and T is known 
as the scores matrix. If each frequency in the spectra is considered a dimension, then 
pT defines a new set of dimensions that are linear combinations of the old frequency 
dimensions. T defines each spectrum in terms of the new dimensions, and the 
columns of T correspond to the new dimensions and are known as factors or latent 
variables. W maximises the covariance or relationship between the spectral variation 
and the component concentration and also makes the factors orthogonal (preventing 
each factor from describing the same information) 127• 
Usually only a few factors are required to adequately describe the correlation between 
the spectral variance and the component concentration. The factors are ordered such 
that the first factor represents the most spectral variation correlated to y, the second 
factor represents the second most spectral variation correlated to y, and so on. In 
PLS, only factors that contribute significantly to the correlation between the spectra 
and component are required, and the rest can be rejected as they are likely to model 
noise or other unwanted spectral variation. The reduced number of factors means that 
xt is much more stable (contains smaller errors), making the model more robust. 
Once xt has been obtained, the regression coefficients b are calculated, and then the 
model can used to predict the component concentration in unknown samples. By 
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slight adjustments in the algorithm, simultaneous quantitation of several components 
is possible 125 . 
The spectral variation related to the concentration of one component theoretically can 
be described in one dimension, that is, only one latent factor is required to describe 
the spectral variation due to the component concentration 128. However, sometimes 
other sources of variation require that more than one latent variable extract the 
spectral variation due to the component of interest. 
For more information on PLS, Chemometrics in Environmental Analysis by Einax et 
al (1997) 129 and Multivariate Analysis Part 2: Classification, Covariance Structures 
and Repeated Measurements by Krzanowski and Marriot (1995) 126 are 
recommended. An excellent article by Wold et al also explains the theory and use of 
PLS 125. 
3 .1.3 Model performance and optimisation 
The model produced after PLS analysis is assessed and then adjusted and optimised if 
appropriate. Criteria commonly used for model assessment and methods for 
optimisation are outlined below. 
3.1.3.1 Model performance 
Once a PLS model has been constructed, a calibration curve is plotted, and a 
validation curve is also constructed. A calibration curve measures the model output 
of the concentration versus the actual concentration. One measure of the quality of 




L)c i,caz - c i,caz f 
i=l 
(3.2) 
where ci,cal is the actual concentration of the ith sample, c i,cal is the fitted 
concentration of the ith sample, nsamp is the number of samples and nsel is the number 
of factors used in the model. 
A validation curve is constructed by using the model to predict the concentration of 
"unknown samples". A validation curve can be obtained one of two ways, either 
through a test set validation or cross validation. Test set validation uses a new set of 
samples which are entered into the model. Although test set validation is the most 
robust approach, the method is time and resource consuming, because extra samples 
are required for the test set. A frequently used alternative is cross validation which 
uses the same set of samples to construct and test the model. During cross validation, 
one ( or more) samples are removed during model construction, and the sample left out 
is used to test the model. The process is repeated for all samples 115,1 25 ' 129. The 
goodness of fit of a validation curve can be assessed based on the root-mean-square 
error of prediction (RMSEP). 
RMSEP= 
~ 
L(ci,vaz - ci,vaz f 
i=l (3.3) 
where ci,val is the actual concentration of the ith sample, C;,val is the predicted 
concentration of the ith sample using nsel variables, nsamp is the number of samples in 
the validation set. If cross validation is used, then the RMSEP is known as the root-
mean-square error of cross validation (RMSECV). The RMSEP, or RMSECV in the 
case of cross validation, is a more important measure of the model quality than the 
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RMSEC because the validation is a better predictor of the future performance of the 
model with unknown samples 115 . 
Limits of detection (LOD) and quantitation (LOQ) can also be calculated using the 









where (j is the standard deviation of either the three lowest constituent concentrations 
of each constituent or of all the predicted concentrations about the validation curve, 
and S is the slope of the validation curve. 
In a formal validation many other measures of performance are used such as accuracy, 
precision and inter-operator and intra- and inter-day variation 130, however the 
RMSEP ( or RMSECV), LOD and LOQ are commonly used as judges of model 
performance prior to a formal validation. 
3.1.3.2 Model optimisation 
3 .1.3 .2.1. Data preprocessing 
PLS analysis can be improved by performing data preprocessing as an initial step to 
remove variation in the spectra not due to concentration changes. There are many 
types of data preprocessing. If chosen carefully, data preprocessing is able to 
significantly improve models constructed using multivariate analysis. Care must be 
taken, however, not to remove useful data during preprocessing. Preprocessing may 
involve spectral or variable preprocessing methods, and the most common methods of 
preprocessing and their specific purposes are listed in Table 3.1. 
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Mean centering of the spectra is routinely performed prior to PLS. Mean centering 
removes the intercept from the model at each frequency, allowing the factors to more 
accurately model the variation in the data due to concentration changes. Spectral 
region selection is another commonly used preprocessing technique, and is used to 
choose regions that will contribute concentration related information to the model. 
There are several methods that may be used to select the appropriate spectral regions. 
One method is to choose the regions where the spectra visibly vary with changing 
component concentration. Alternatively, regions that have the largest loadings for 
each factor or contribute the most to the regression equation may be chosen 115 . 
Two other very frequently used preprocessmg techniques are first derivative 
calculation and multiplicative scatter correction (MSC). First derivative calculation 
removes absolute baseline differences. MSC attempts to remove spectral differences 
resulting from sample preparation effects such as packing and particle shape 128. An 




Table 3.1 Some data preprocessing options prior to multivariate analysis (adapted 
from Beebe et al (1998) 115). 
Tool Specific method Purpose Source of error 
Spectral Normalisation Minimum-maximum Removes Sample volume or 
preprocessing normalisation, vector differences in total thickness 
normalisation spectral intensity differences, laser 
intensity 
Smoothing Mean, running mean, Reduces random Noise from emission, 
and running median noise over entire detection, and 
smother, running spectrum or sample effects (e.g., 




Baseline First and second Removes Low frequency 
correction derivatives (running systematic sources of variation 
simple and mean differences in not related to 
differences, Savtizky- spectral intensity parameters being 






Variable Mean Subtraction of mean of Removes intercepts Some features 
preprocessing centering the variable values at each present in all 
from all variables wavenumber and samples 
therefore overall 
spectral features 
common to all 
samples 
Variable Spectral region Removes redundant Some variables more 
weighting selection or weighting data or emphasises related to 
some variables instrumentation, 
known to be helpful sample, environment 
over others effects 
* Etaloning is explained in Section 4.3.1.2.2.1. 
3.1.3.2.2. Number of factors 
One of the main problems of using PLS (and PCR) is deciding how many factors to 
incorporate into the calibration model. As described previously, the factors are 
ordered such that the first factor describes the most variation related to the 
concentration of the component, with the following factors progressively describing 
less and less variation related to the component concentration. When choosing the 
number of factors, it is important to include enough factors to include sufficient 
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variation in the data related to component concentration, however if too many factors 
are used, noise will be incorporated into the model. The number of factors to use can 
be decided based on the number of factors associated with the lowest RMSEP ( or 
RMSECV). The contribution of spectral regions to each factor (loadings) can be used 
to determine whether the data incorporated into the model is correlated to spectral 
changes associated with the changing component concentration. 
3 .1.3 .2.3. Detection of outliers 
Outliers can be divided into concentration and spectral outliers. Concentration 
outliers can be detected using prediction intervals on the validation curve. Spectral 
outliers can be detected by calculating the spectral residuals and Mahalanobis 
distance ii for the calibration and validation curves. If the model is improved after the 
outlier is removed then the outlier(s) is/are excluded. Performance of the model 
before and after removal of the outlier(s) is assessed using the RMSEP (or 
RMSECV) 115 • 
3 .1.4 Applications of partial least squares analysis 
PLS was developed in the 1970s by Herman Wold to model complex data sets based 
on a so-called path models approach to data analysis 125 . It was initially used in the 
social sciences, but has been adapted to quantify systems in science and technology 
applications including those in analytical chemistry 115, biochemistry 125, materials 
science 132 and bioprocess engineering 133 . 
In the pharmaceutical sciences PLS is being increasingly combined with spectroscopy 
for quantitative analysis. Rantanen et al (2005) analysed mixing, spraying and wet 
massing during high shear granulation. Information on chemical homogeneity, water 
ii The Mahalanobis distance is the multivariate counterpart of the univariate distance measured in 
standard deviations 131 • 
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content and particle size was extracted and endpoints of the three subprocesses were 
able to be determined for automated endpoint control 134. Frake et al (2003) used 
near-IR spectroscopy and PLS along with PCR and MLR to determine the particle 
size of lactose monohydrate powders 123 . Svensson et al (2000) used Raman 
spectroscopy in combination with PLS to monitor the synthesis of metoprolol 135 . 
PLS has been used with spectroscopy to quantify pharmaceutical polymorphism and 
crystallinity by several researchers. Lee et al (2000) used PLS in combination with 
FTIR spectroscopy to quantify the polymorphism of a drug in binary mixtures 136. 
Aboul-Enein et al (2002) used PLS and FTIR spectroscopy to quantify polymorphs of 
mebendazole in formulation 137. In a study by Jalsovszky et al (1995) polymorphic 
mixtures of cimetidine were quantified using FT-Raman spectroscopy and various 
mathematical techniques, of which PLS was found to be the best 138. 
The aim of this chapter is to investigate the use of PLS combined with FT-Raman 
spectroscopy to quantify polymorphism and crystallinity of CBZ, EM and IM. 
Polymorphs of CBZ and EM and y-crystalline and amorphous IM were prepared and 
their solid state form and purity confirmed by XRPD and DRIFTS. Binary mixtures 
of the solid state forms of each drug were prepared with concentration ranges of one 
form from O - 100% and O - 10%. 
3 .2 Materials and methods 
3.2.1 Sample preparation 
CBZ forms I and III, EM forms I and II, and y-crystalline and amorphous IM were 
supplied and prepared as specified in Sections 2.1, 2.2 and 2.3 respectively. Samples 
were gently ground in a pestle and mortar, and were sieved to a particle size of< 63 
µmor< 75 µm. 
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3.2.2 Measurements 
3.2.2.1 X-ray powder diffraction 
XRPD of the prepared solid state forms of each compound was performed to ensure 
the correct forms were obtained free from contamination by other solid state forms. 
XRPD was performed with a PANalytical X'Pert PRO MPD system (PW3040/60) 
(Holland) using CuKa radiation with A=l.542 A (30 kV and 40 mA) and a divergence 
slit of 1 °. Samples were scanned between 3 and 40 ° (28) using a step size of 0.008 ° 
and a count time of 2 s. Data was collected using X'Pert Data Collector and viewed 
using X'Pert Data Viewer (Holland). 
3.2.2.2 Infrared spectroscopy 
DRIFTS of the prepared solid state forms was performed as a complementary 
technique to Raman spectroscopy, and to further assess the purity of the prepared 
solid state forms. DRIFTS was performed using an FTIR spectrometer (FTS 175C, 
BioRad Laboratories, Massachusetts, USA) with a diffuse reflectance accessory 
attached (Pike Technology Easidiff, Madison, WI, USA). A background scan was 
performed prior to analysis. A reference sample of anhydrous KBr (250 mg) was 
ground gently for 2 min in a pestle and mortar, and placed in the DRIFTS reference 
sample holder. Samples (5%) were ground gently with KBr for 2 min using geometric 
dilution and otherwise prepared in the same manner as the reference sample. They 
were placed in the test sample holder. Spectra were recorded after Kubelka-Munk 
transformation. The final spectrum was the mean of 32 scans. 
3.2.2.3 Raman spectroscopy 
The FT-Raman instrument consisted of a Bruker IFS 55 FT-Raman interferometer 
fitted with a Bruker FRA 106 S FT-Raman accessory. The instrument used a D 425 
Ge diode detector and a Compass 1064-500 laser. Analysis was carried out at room 




power set at approximately 105 mW. Samples were packed in an aluminium sample 
holder and spectra were collected at a resolution of 4 cm-1, with the z position set at 
90 or 88 °. The number of scans obtained per spectrum was 195 for CBZ, 155 for EM 
and 150 for IM. Sulphur was used as reference standard to monitor wavenumber 
accuracy. Data was collected using OPUS™ software (Bruker Optics, Germany). 
3.2.2.4 Quantitative analysis of polymorphism and crystallinity using Raman 
spectroscopy 
Binary mixtures were prepared containing two forms of the drugs CBZ, EM and IM 
from 0% to 100% w/w in 20% intervals. Mixtures containing O - 10% CBZ form I in 
form III and EM form I in form II were prepared at 1 % intervals. Mixtures were 
prepared by geometric dilution with a pestle and mortar and minimal grinding. 
Quantitative analysis was performed using the Quant2 package that accompanies 
OPUS™ software (Bruker Optics, Germany). Spectra were mean centred and MSC 
was applied to remove spectral differences due to sample packing inconsistencies. 
The selection of spectral regions for calibration was based on two criteria: (1) the 
largest spectral differences between the pure forms in the preprocessed data and (2) 
the wavenumber regions that provided the greatest contribution to the linear 
regression equation for the component and had the highest loadings for each factor. 
The calibration models were calculated using the PLS algorithm with the concept of 
cross-validation ( one sample removed per cycle). The RMSECV was determined for 
each factor. The number of factors used to construct the models was based on the 
lowest RMSECV without exceeding three factors, thus ensuring an acceptable 
complexity of the resulting model. LODs and LOQs were calculated using the 
standard deviation of the three lowest constituent concentrations of each component 
and standard deviation of the regression fit, as specified in Section 3.1.3.1. 
Constituent outliers (> 99% based on the cross validation) and spectral outliers (> 
99% based on the Mahalanobis distance) were identified and considered for removal 




3.3 Results and discussion 
3 .3 .1 Carbamazepine 
3.3.1.1 X-ray powder diffraction of carbamazepine forms I and III 
The x-ray powder diffractograms of CBZ forms I and III are shown in Figure 3.1. 
The peak positions of each form agree with those previously reported, however the 
relative peak intensities differ, which is presumably due to preferred orientation of the 
particles 35'38. Form III exhibits peaks at 15.3, 19.5 and 24.9 and 27.4 ° (28), while 
form I shows six medium to weak peaks between 5 and 10 ° (28), and also peaks at 
7.9, 9.4, 12.3 and 19.9 ° (28). Although it is possible form I contains a small amount 
of form III 38, this is unlikely due to the absence of peaks between 5 and 10 ° (28) and 
at 27.4 ° (28) and the well defined peaks specific to forms I and III obtained using 
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Figure 3.1 X-ray powder diffractograms of CBZ forms I and III. Form III is offset 
for clarity. 
3.3.1.2 Fourier transform infrared spectroscopy of carbamazepine forms I and 
III 
The DRIFTS spectra of CBZ forms I and III show the same peak positions (within 4 
cm-1 resolution) as those reported elsewhere 35'38 . Consistent with previous reports, 
peak shifts are observed from 1386, 1679 and 3463 cm-1 for form III to 1396, 1689 
and 3483 cm-1 respectively for form I 35'38 . These modes at 1386 and 1679 cm-1 have 
been identified by ab initio calculations iii, and the vibration at 1386 cm-1 is 
characterised by stretching of the bond between the N in the central ring and the 
carboxyl C (Figure 1.4), and the mode at 1679 cm-1 involves C-0 stretching 140. The 
iii Ab initio calculations are calculations based on approximations of quantum mechanics theory. They 
can be used to refine molecular structures and predict vibrational spectra of molecules 139• 
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mode at 3463 cm-1 is characterised by an N - H vibration 38. The vibrational changes 
between form I and III are therefore associated with structural and/or environmental 
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The results from XRPD and DRIFTS suggest that forms I and III are both pure, and 
therefore the created forms are suitable for qualitative and quantitative analysis by 
FT-Raman spectroscopy. 
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3.3.1.3 Raman spectroscopy of carbamazepine forms I and III 
The Raman spectra of CBZ forms I and III do not show such large spectral shifts as 
the IR spectra, however peak position and intensity differences are evident in the 
difference spectrum (Figure 3.3). 
Form I - form Ill 
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Figure 3.3 FT-Raman spectra of CBZ forms I and III and the spectral differences 
between the two forms (form I- form III). 
Inspection of the fingerprint region reveals that there are several peak position shifts 
of 4 cm-1 or greater (Figure 3.4), and relative peak intensity differences between forms 
III and I are present, especially at around 1025, 1040 and 1601 cm-1. These modes 
principally involve the aromatic rings, though almost half of the potential energy 
associated with the mode at 1025 cm-1 is centred about the CONH2 moiety 
140
. The C 
- H bonding region of form III exhibits a weak, broad peak at 2967 cm-1 and three 
similarly intense peaks at 3021, 3044 and 3071 cm-1. In the form I spectrum, the two 
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highest frequency peaks appear to have merged into one, broad band centred about 
3062 cm-1, with another band present at 3025 cm-1 (Figure 3.7). The band at 
3025 cm -l is due to an aliphatic C - H vibration, whilst the others are all aromatic C -
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Figure 3.4 FT-Raman spectra of CBZ forms I and III between 650 and 1750 cm-1• 
3.3.1.4 Quantitation of binary mixtures of carbamazepine forms I and III 
CBZ forms III and I were quantified with binary mixtures of O - 100% form I in form 
III (20% intervals) and also with binary mixtures of O - 10% form I in form III (1 % 
intervals). The Raman spectra of mixtures containing O - 100% form I show the 
largest intensity changes occurring at approximately 1025, 1040, 1600 and in the 
3000 cm-1 region as form I concentration increases and form III concentration 




- H bonding region (Figure 3.7) reveals many other gradual changes with changing 
form I and III concentration. 
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Figure 3.5 FT-Raman spectra of binary mixtures of CBZ forms I and III (20% 
intervals, 0 - 100% form I). The arrows indicate the most obvious spectral changes as 
form I concentration increases and form III concentration decreases. 
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Figure 3.6 FT-Raman spectra of binary mixtures of CBZ forms I and III between 650 
and 1700 cm-1 (20% intervals, 0 - 100% form I). The arrows indicate regions of 
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Figure 3. 7 FT-Raman spectra of binary mixtures of CBZ forms I and III between 
2970 and 3100 cm·1 (20% intervals, 0 - 100% form I). 
PLS analysis was performed on various spectral regions. The best quantitative model 
(lowest RMSECV) of the CBZ O - 100% form I in form III mixtures was obtained 
using the spectral regions 1244 - 1738 cm·1 and 2917 - 3169 cm·1. A RMSECV of 
1.3% was obtained using two factors (Table 3.2). 
62 
( 
Table 3.2 Parameters used in the generation of the quantitative models of mixtures of 
solid state forms of CBZ and EM (region, preprocessing and number of factors used) 
and model assessment (RMSECV, R2 (coefficient of determination), LOD and 
LOQ).* 
Mixture CBZ 0-100% CBZ 0-10% EM0-100% EM0-10% 
form I form I form I form I 
Region (cm-1) 1244- 1738 669- 1649 735-1746 604-1761 
2917-3169 2986-3104 2849-3113 2893- 3104 
Factors used 2 3 2 2 
RMSECV(%) 1.3 0.514 1.76 1.14 
R2 0.999 0.988 0.997 0.890 
LOD(%t 1.24 1.41 6.95 3.04 
LOD(%l 0.665 1.01 4.73 1.64 
LOD(%)° 4.55 2.31 6.08 2.87 
LOQ(%t 3.77 4.27 21.17 9.21 
LOQ(%l 2.02 3.05 14.39 4.98 
LOQ(%)° 13.8 7.01 18.50 8.70 
* All spectra were preprocessed using mean centering and MSC. 
a LOD and LOQ calculated using the standard deviation of the three samples with the lowest 
constituent concentration as defined in the table. 
b LOD and LOQ calculated using the standard deviation of the three samples with the highest 
constituent concentration as defined in the table. 
c LOD and LOQ calculated using the residual standard deviation of the fitted regression line. 
The difference spectrum of forms I and III after MSC preprocessing in these regions, 
along with the loadings for each factor and the total contribution of spectral regions to 
the regression vector, are shown in Figure 3.8. The spectral differences are mirrored 
in the contribution of spectral regions to the factor loadings and regression 
coefficients. The largest spectral difference occurs between 1550 to 1650 cm-1, and 
this region makes the largest contribution to the loadings for the first factor. The 
second factor mainly incorporates spectral differences around 3000 cm-1. It is this 
higher frequency region that contributes the most to the regression coefficients, 
perhaps because the changes here are less affected by unrelated spectral variation. 
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Figure 3.8 Spectral differences between CBZ forms I and III (form I- form III) in the 
spectral regions selected after MSC, and the contributions of each spectral region to 
the regression coefficients and first and second factors (loadings) for the mixtures 
containing O - 100% form I in form III. The region with a straight line was not 
included in the model. 
LODs of between 0.665 and 4.55% were obtained depending on whether the standard 
deviation of the lowest (0%) or highest form I (100%, corresponding to 0% form III) 
concentration or the standard deviation of the fitted regression line was used (Figure 
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Figure 3.9 Predicted versus actual concentration of CBZ form I in form III from (a) 0 
- 100% form I and (b) 0 - 10% form I with 95% confidence bands (dots) and 
prediction bands (dashes). 
The PLS analysis of CBZ O - 10% form I in form III obtained a RMSECV of 0.514% 
with three factors using the spectral regions 669- 1649 and 2986 - 3104 cm-1 (Table 
3 .2). The difference spectrum (Figure 3 .10) of 10% form I and 100% form III after 
MSC preprocessing mirrors the differences observed between pure forms I and III 
(Figure 3.4). The largest differences are again between 1550 and 1650 cm-1 and this 
region has the largest loadings for the first and second factors. The loadings for the 
third factor mainly incorporate spectral differences below 800 cm-1. The largest 
contribution to the regression vector is provided from 1550 and 1650 cm-1, and in 
contrast to the O - 100% form I in form III binary mixtures, the region 3 000 - 3100 
cm-1 is the second most important contributor to the regression vector. The predicted 
concentrations from the model generated using the O - 10% form I in form III binary 
mixtures are shown in Figure 3.9(b). LODs of between 0.74 and 1.74% were 
achieved (Table 3.2). 
The loadings plots for each factor and the regression vector show that PLS is able to 
select spectral variation that varies in response to concentration changes of form I. 
The RMSECVs and mean LODs suggest that FT-Raman spectroscopy combined with 




that the O - 10% range is better than the O - 100% range for detecting low levels of 
CBZ form I, with a detection limit of about 1 %. 
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Figure 3.10 Spectral differences between CBZ forms 10% form I in form III and 
100% form III (10% form I- form III) in the spectral regions selected after MSC, and 
the contributions of each spectral region to the regression coefficients and first, 
second and third factors (loadings) for the mixtures containing O - 10% form I in form 
III. The region with a straight line was not included in the model. 
Although these results are promising this quantitation study is not a formal validation, 
and as such has not assessed several figures of merit such as selectivity, signal to 
noise ratio, sensitivity, accuracy and precision, as well as intra- and inter-day 
variation. Nevertheless the results suggest that FT-Raman spectroscopy combined 
with PLS is a promising method for the quantitation of CBZ polymorphs. A 
comparison of this approach for quantifying CBZ polymorphs with published 





3 .3 .2 Enalapril maleate 
3.3.2.1 X-ray powder diffraction of enalapril maleate forms I and II 
Forms I and II of EM have similar x-ray powder diffractograms (Figure 3.11) with 
many peaks in the same or similar positions. This is due to the two forms having very 
similar conformational and packing arrangements 47• Peaks specific to form I were 
found at 10.7, 14.7, and 22.7 ° (28), and peaks specific to form II were found at 13.0, 
18.7, and 22.0 ° (28). The peaks at 14.7 ° (28) (form I) and 13.0 ° (28) (form II), have 
previously been found by spinning techniques not to be an artefact of preferred 
orientation 46. The x-ray powder diffraction data presented here therefore suggests 
that the EM forms I and II samples are pure polymorphic forms 47• 
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Figure 3.11 X-ray powder diffractograms of EM forms I and II. Form II is offset for 
clarity. 
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3.3.2.2 Infrared spectroscopy of enalapril maleate forms I and II 
The DRIFTS spectra of EM forms I and II are very similar over the entire mid-IR 
spectrum (Figure 3.12). The most notable difference is a peak unique to form I 
present at 952 cm-1 (Figure 3.13). There are also some small peak shifts, with peaks 
present at 756, 851, 1179 and 1232 cm-1 for form I present at 751, 845 and 1173 and 
1226 cm-1 respectively. Two previous studies have reported that the only notable 
difference between the spectra of the two forms is the band at 756 for form I shifting 
to 751 cm-1 for form II 46'47 . This band has been identified as out-of-plane hydrogen 
bending, associated with adjacent aromatic hydrogen atoms. Unfortunately the rest of 
the mid-IR spectra were not presented in these studies. It is surprising that other 
differences were not reported, considering that structural studies of forms I and II 
have revealed the main conformational differences between the two forms is in a 
dihedral angle associated with the esterified carboxylate group (Figure 1.5). 
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Figure 3.13 DRIFTS spectra of EM forms I and II between 400 and 1300 cm-1• 
3.3.2.3 Raman spectroscopy of enalapril maleate forms I and II 
Although the Raman spectra of the two forms were also similar there were more 
differences than in the IR spectra. Interestingly, EM form II was a better Raman 
scatterer than form I. This is reflected in the difference spectrum ( form I minus form 
11) where the differences are almost all negative (Figure 3.14). Peaks present for form 
I at 801, 865, 1029, 1057, 1232 and 1605 cm-1, appeared for form II at 805, 861, 1025, 
1063, 1226 and 1609 cm-1 respectively (Figure 3.15). Two small peaks at 956 and 
1119 cm-1 appear in form I only, and a small peak at 469 cm-1 is specific to form II. 
Unlike in the IR spectra, in the C - H bonding region there are several relatively large 
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Figure 3.14 FT-Raman spectra of EM forms I and II the the difference between the 
spectra (form I - form II). 
Lower wavenumber regions were not investigated due to the limitations of the FT-
Raman spectrometer, however Ip et al (1986) probed this region using Raman 
spectroscopy and an intense band at about 24 cm-1 was present for form I, but not for 
form II which was most likely due to a crystalline phonon vibration 46,47 iv. 
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Figure 3.15 FT-Raman spectra of EM forms I and II between 200 and 1650 cm-1• 
3.3.2.4 Quantitation of binary mixtures of enalapril maleate forms I and II 
Binary mixtures of EM forms I and II combined with Raman spectroscopy and PLS 
analysis were used to build models for quantifying O - 100% form I in form II and O -
10% form I in form IL The spectral changes associated with the mixtures containing 
0 - 100% form I in 20% intervals are shown in the regions 2800 - 3150 cm-1 (Figure 
3.16) and 450 - 1650 cm-1 (Figure 3.17). Form II exhibits a peak at 2940 cm-1 which 
decreases as the proportion of form I increases. A peak at 3064 cm-1 for form II also 
decreases, and a peak at 3060 -I increases as the concentration of form I increases. In 
the fingerprint region, there are several subtle changes (indicated by arrows) as form I 
concentration increases and form II concentration decreases (Figure 3 .17). 
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Figure 3.16 FT-Raman spectra of binary mixtures of EM forms I and II between 2800 
and 3150 cm-1 (20% intervals, 0 - 100% form I). 
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Figure 3.17 FT-Raman spectra of binary mixtures of EM forms I and II between 450 
and 1650 cm-1 (20% intervals, 0 - 100% form I). Regions of spectral change with 
increasing form I concentration are shown with arrows. 
Quantitative analysis of the O - 100% form I in form II mixtures using PLS analysis 
yielded a RMSECV of 1.75% with two factors and using the spectral regions 735 -
1746 cm-1 and 2849 - 3113 cm-1• The difference spectrum of forms I and II after 
MSC preprocessing shows differences throughout the spectral regions used, however 
the largest differences are between 2900 and 3080 cm-1 (Figure 3.18). The loadings 
for the first factor are very similar to the difference spectrum, with the largest spectral 
contribution to the first factor in the same region. The loadings for the second factor 
appear to contain much less meaningful information, suggesting that almost all of the 
useful information is contained in the first loading. The regression vector closely 
resembles the loadings for the first factor, and the higher frequency region which had 
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Figure 3.18 Spectral differences between EM forms I and II (form I-form II) in the 
spectral regions selected after MSC, and the contributions of each spectral region to 
the regression coefficients and first and second factors (loadings) for the mixtures 
containing O - 100% form I in form II. The region with a straight line was not 
included in the model. 
PLS analysis resulted in LODs of between 4.73 and 6.95%, depending on the method 
of LOD calculation (Figure 3.19(a) and Table 3.2). Considering the modest changes 
in the Raman spectra between the two forms this is an encouraging result, and 
suggests that PLS is able to extract useful quantitative information from spectra to 
determine polymorph concentrations even when spectral changes are subtle. 
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Figure 3.19 Predicted versus actual concentration of EM form I in form II from (a) 0 
- 100% form I and (b) 0 - 10% form I with 95% confidence bands (dots) and 
prediction bands (dashes). 
The difference spectrum between the MSC preprocessed spectra of EM containing 
10% form I and 100% form II (Figure 3 .20) is dominated by noise in the lower 
frequency region between 604 -1761 cm-1• Between 2893 - 3104 cm-1, differences 
resemble those exhibited by the pure forms of EM (Figure 3.18) albeit with more 
noise. In response, the loadings for the first factor are concentrated in the higher 
frequency region, but the loadings for the second factor incorporate the spectral 
difference at 1000 cm-1. The regression coefficients show that the higher frequency 
region is largest contributor to the quantitative model. 
The large amount of noise is reflected in the larger variation in the validation curve 
compared to the corresponding curve for CBZ. Nevertheless a RMSECV of 1.14 with 
two factors was obtained, and the LODs were between 1.64 and 3.04%. This suggests 
that FT-Raman spectroscopy combined with PLS analysis can detect low levels of 
form I in form II. Quantitation of EM polymorphs by other techniques will be 
discussed in Chapter 6. 
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Figure 3.20 Spectral differences between EM 10% form I in form II and 100% form 
II (10% form I - form II) in the spectral regions selected after MSC, and the 
contributions of each spectral region to the regression coefficients and first and 
second factors (loadings) for the mixtures containing O - 10% form I in form IL The 
region with a straight line was not included in the model. 
From the CBZ and EM results, it is evident that as low as 1 or 2% of one polymorph 
may be detected in the presence of the other polymorph if O - 10% of the contaminant 
polymorph is used. Considering the similarity of the spectra, especially of the two 
forms of EM, this is an impressive result and suggests that PLS is a powerful 
technique to analyse FT-Raman spectra to quantify pharmaceutical polymorphism. 
For the true determination of the model robustness a formal validation would need to 
be performed including an investigation of batch-to-batch variation. However that is 
outside the scope of this thesis. 
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3 .3 .3 Indomethacin 
Amorphous and y-crystalline IM were chosen to quantify crystallinity using FT-
Raman spectroscopy and PLS analysis. Amorphous IM can be created easily by 
quench cooling the melt, and IM is commonly used in crystallinity and amorphous 
property studies (Section 1.3.3). 
3.3.3.1 X-ray powder diffraction of y-crystalline and amorphous indomethacin 
The x-ray powder diffractogram of y-crystalline IM shows peaks at 10.2, 11.6, 12.8, 
16.8, 17.0, 19.7, 21.9 and 26.7 ° (28) which have been previously reported as 
characteristic of the y-crystalline form 142,143 . Peaks at 7 .0, 8.4, 12.0, 14.0 and 
14.4 ° (28), characteristic of the a-crystalline form, and at 3.9 ° (28), characteristic of 
a ~-crystalline form, are absent in the diffractogram suggesting that no other 
polymorphic forms are present 142' 143 . The baseline of the diffractogram is flat above 
7 ° (28), indicating the absence of amorphous material. Therefore, the y-crystalline 
form of IM has negligible contamination by other solid state forms. The 
diffractogram of amorphous IM shows no features except for a halo between 15 and 
25 ° (28), which is characteristic of amorphous materials. The absence of peaks 
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Figure 3.21 X-ray powder diffractograms of y-crystalline and amorphous IM. 
Amorphous IM is offset for clarity. 
3.3.3.2 Infrared spectroscopy of y-crystalline and amorphous indomethacin 
In the DRIFTS spectra of IM, the peaks from the amorphous form are less intense and 
broader than those associated with the y-crystalline form (Figure 3.22). The peak 
broadening is due to slight variations in molecular conformation and the disordered or 
poorly ordered intermolecular bonding of the amorphous form. As well as decreased 
intensity, the peak broadening leads to increased peak overlap. There are also many 
frequency changes in the peaks associated with the y-crystalline and amorphous 
forms, some of which are identified in Figure 3 .23. Differences are also visible 
between 2500 and 3500 cm-1 (Figure 3.22). In the higher frequency region for 
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Figure 3.22 DRIFTS spectra of y-crystalline and amorphous IM. 
y-Crystalline IM is known to exist as dimers with cyclic hydrogen bonding between 
carboxylic acid moieties (Figure 1.6) 49 . The mode at 1716 cm-1 has previously been 
attributed to an asymmetrical carbonyl stretch of the cyclic dimer 119. By 
investigating the bonding of amorphous IM to polyvinylpyrrolidone the mode at 1710 
cm-1 for amorphous IM has also been attributed to the same vibration, and therefore 
the amorphous form is also thought to exist with the same dimer formation 49 . This 
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Figure 3.23 DRIFTS spectra of y-crystalline and amorphous IM between 550 and 
1750 cm-1. 
3.3.3.3 FT-Raman spectroscopy of y-crystalline and amorphous indomethacin 
As with the IR spectra, the Raman spectrum of amorphous IM has broader, less 
intense peaks than its y-crystalline counterpart and the peak broadening has led to 
fewer peaks being discernable. There are many peak position differences, which are 
evident by the positive and negative differences in the difference spectrum of y-
crystalline and amorphous IM (Figure 3.24). In addition the spectrum of the 
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Figure 3.24 FT-Raman spectra of y-crystalline and amorphous IM and the difference 
spectrum (y-crystalline - amorphous). 
Between 250 and 1750 cm-1 there are many peak shifts, some of which are shown in 
Figure 3.25. The largest shift involves the mode at 1698 cm-1 in the y-crystalline 
form, and at 1681 cm-1 in the amorphous form. This mode has been attributed by 
Taylor and Zografi (1997) to a benzoyl vibration (Figure 1.6) 119, which has been 
confirmed by ab initio calculations by the author of this thesis ( data not shown). The 
higher frequency of this mode in the y-crystalline form has been attributed to 
coplanarity differences of the carbonyl ring with the indole ring. Clarification of this 
and the reasons for other peak shifts between y-crystalline and amorphous IM are 
being sought by analysis of the lowest energy molecular conformation of IM v_ 
v Lowest energy molecular conformations can be obtained by optimisation of the molecule(s) using ab 
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Figure 3.25 FT-Raman spectra of y-crystalline and amorphous IM between 250 and 
1750 cm-1. 
Between 2700 cm-1 and 3300 cm-1 there are more peaks discemable for the y-
crystalline form than the amorphous form. Peaks that are not visible in the spectrum 
of the amorphous form appear at 3023 and 3084 cm-1, and there is also a shoulder at 
2916 cm-1. All the peaks visible for the amorphous form are in the same position for 
the y-crystalline form. The broader peaks associated with the amorphous form are 
likely to be due to variations in C - H and O - H vibrations as a result of the 
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Figure 3.26 FT-Raman spectra of y-crystalline and amorphous IM between 2700 and 
3300 cm-1. 
3.3.3.4 Quantitation of binary mixtures of y-crystalline and amorphous 
indomethacin 
The Raman spectra of the y-crystalline IM and the amorphous IM prepared for 
quantitative analysis are shown in Figure 3.27. The spectra are not baseline corrected 
and there is a high baseline intensity for the amorphous form - higher than in the 
Raman spectrum of amorphous IM in Figure 3.24. This large baseline response is 
probably due to fluorescence, and it was necessary to use a laser power of 75 mW 
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Figure 3.27 FT-Raman spectra of y-crystalline and amorphous IM prepared for 
quantitative analysis. Both spectra have the same intensity scales. 
The fluorescence is probably two photon fluorescence resulting from an impurity. As 
the crystalline sample does not fluoresce it is likely that an impurity was created 
during the amorphous form preparation. The impurity may have come from a 
degradation product from molten IM or introduction of material, for example from the 
stainless steel container in which the IM was melted. Carstensen and Morris (1993) 
studied the chemical stability of IM in the molten and amorphous phases and found 
that degradation followed first order kinetics for both phases 50. According to their 
results, molten IM held at a temperature of 165 °C for 5 min, should produce less than 
1 % degradation. This method was followed as closely as possible. However, even if 
the sample was held for 15 min at 175 °C, 98% of the IM should remain intact. 
Although spectral preprocessing can be used in an attempt to remove the fluorescence 
in the binary mixtures, quantitative analysis was not attempted. The magnitude of the 






batch suggest that Raman spectroscopy should not be used to quantify mixtures of 
amorphous IM prepared by quench cooling the melt. This is in contrast to the 
findings of Taylor and Zografi (1998), where, in a study of IM crystallinity using FT-
Raman spectroscopy and 1064 nm excitation, amorphous IM (prepared by quench 
cooling) did not fluoresce 88. Quantitation by using peak ratios yielded an LOD of 1 % 
amorphous or y-crystalline IM. However, this study did not assess batch-to-batch 
variation of amorphous IM, and it may be suspected that this would be a significant 
source of spectral variation of the mixtures containing amorphous IM prepared by 
quench cooling the melt. 
In another study the crystallinity of polylactide was quantified using FT-Raman 
. h IR . . 144 spectroscopy wit near- exc1tat10n . PLS was successfully employed to 
accurately quantify the crystallinity of the compound, with PLS being superior to 
univariate analysis. With this result it would be interesting to investigate the ability of 
FT-Raman spectroscopy and PLS to quantify the crystallinity of pharmaceutical 
materials other than IM. It would also be interesting to investigate using FTIR 
spectroscopy to investigate the crystallinity of IM, as well as other compounds. 
3 .4 Chapter summary 
Raman spectroscopy is a spectroscopic technique that detects the change in 
polarisability of molecular vibrations. Advantages of Raman spectroscopy in the 
pharmaceutical setting include the lack of sample preparation and minimal water 
interference. In addition pharmaceutical materials often contain molecules which are 
strong Raman scatterers. Raman spectroscopy with an excitation wavelength of 
1064 nm is popular in the pharmaceutical setting due to a lower likelihood of 
fluorescence and sample degradation compared with shorter wavelength excitation, 






PLS analysis is a multivariate analysis technique that correlates spectral variation over 
large spectral regions to changes in component concentration. In this chapter, FT-
Raman spectroscopy has been used in combination with PLS analysis to quantify 
binary polymorphic mixtures of forms I and III of CBZ, and forms I and II of EM. 
For CBZ LODs as low as 1% were obtained with O - 10% form I in form III. The 
Raman spectra of EM forms I and II were very similar. Nevertheless, LODs of as low 
as 2% were obtained when detecting O - 10% form I in form II. Using the O - 10% 
concentration range of form I for both CBZ and EM achieved lower LODs than using 
the O - 100% form I concentration range, suggesting that using a smaller range around 
the concentration of interest is best. For amorphous IM, an impurity which appeared 
to vary from batch-to-batch fluoresced which prevented the use of FT-Raman 
spectroscopy for the quantitative analysis of IM crystallinity when amorphous IM was 
prepared by quench cooling the melt. 
In conclusion, in the absence of fluorescence, FT-Raman spectroscopy combined with 
PLS analysis can quantify mixtures of different solid state phases of the same 




Using terahertz pulsed spectroscopy to investigate 













4.1.1 Definition of the terahertz region 
Terahertz radiation, also known as far infrared (far-IR) radiation, lies between the IR 
and microwave regions of the electromagnetic spectrum (Figure 4.1 ). It can be 
defined as having a frequency of between 0.05 and 4 THz, corresponding to 1.67 to 
133 cm-1. 













Figure 4.1 Terahertz radiation shown as a function of wavelength, spatial frequency 
(wavenumber) and temporal frequency. 
4.1.2 Material responses to terahertz radiation 
In materials, terahertz radiation can induce rotational transitions, low frequency bond 
vibrations, crystalline phonon vibrations, hydrogen-bonding stretches and torsion 
vibrations (Figure 4.2) 145,1 46. The response of a material to terahertz radiation 
depends on both the frequency of the radiation and on the material. In gases 
rotational transitions predominate, in liquids some hydrogen bonding and other low 
energy bonding vibrations occur, and in solids the response is composed mainly of 
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Figure 4.2 Vibrational and rotational modes of materials induced by terahertz 
radiation (courtesy Tera View Ltd) . 
4.1.2.1 Crystalline phonon vibrations 
Crystalline phonon vibrations, also known as lattice vibrations, deserve special 
attention because they are important vibrations in terahertz spectroscopy of solid 
materials. Comprehensive physical accounts of crystalline phonon vibrations are 
given in Vibrational spectroscopy of solids by Sherwood (1972) 147, Far-infrared 
spectroscopy by Moller and Rotschild (1971) 146 and Submillimetre spectroscopy: a 











Crystalline phonon vibrations can be thought of as collective vibrations constructed 
from the interaction of many intramolecular vibrations. Molecules in solids are in 
close proximity to each other and therefore a vibration of one molecule affects the 
vibrations of neighbouring molecules. The interaction of the intramolecular modes 
leads to the formation of a collective mode that propagates through the material. The 
existence and nature of crystalline phonon vibrations depend on the bulk material 
structure. The material must have a periodic structure to sustain phonon vibrations. 
Crystalline materials have periodic structures and therefore are capable of sustaining 
crystalline phonon modes. If a material is amorphous, the lack of long range order 
prevents propagation of the phonon vibration and the energy associated with the 
vibration is diffusely dissipated within the material. 
Crystalline phonon vibrations are quantised into discrete energy levels and can be 
characterised by quantum mechanics. Analogous to the photon of electromagnetic 
radiation, the quantum of a crystalline phonon vibration is a phonon. The crystalline 
phonon vibrations that may result in molecular crystals are complex, and may consist 
of transverse or longitudinal waves depending on whether the molecules move 
perpendicular or parallel to the direction of propagation of the wave. In addition, 
these waves may be acoustic, where nearest neighbouring molecules move in the 
same direction, or optical, where the nearest neighbour molecules move in opposite 
directions 148. 
The same selection rules that exist for absorption of IR radiation apply to absorption 
of terahertz radiation. Thus, in the terahertz regime crystalline phonon vibrations that 
involve a large dipole moment change are strongly absorbed. In addition, crystalline 
phonon vibrations that exhibit a large polarisability are highly Raman active. 
Therefore, terahertz spectroscopy and Raman spectroscopy in the terahertz regime are 





4.1.3 Far infrared spectroscopy 
Terahertz radiation has wavelengths that fall between the wavelengths of radiation 
generated by electronic sources, which generate microwaves and radio waves, and 
optical sources, which generate IR radiation and radiation with shorter wavelengths. 
This has made generation of useable amounts of terahertz radiation comparatively 
difficult. 
The first account of terahertz radiation production was provided in Berlin in 1892 by 
H. Rubens and B. W. Snow, who produced quasi-monochromatic rays of terahertz 
radiation using the method of residual rays 145 . In fact Rubens was responsible for 
providing the data at these long wavelengths that allowed the development of 
quantum mechanics by Max Planck in 1900. In 1911 Rubens and O. Baeyer produced 
terahertz radiation using a quartz envelope mercury lamp, a source that is still used 
today in conventional far-IR spectroscopy. The first example of spectroscopy in the 
terahertz regime, generally known as far-IR spectroscopy, was a rotational spectrum 
ofHCl produced by Czerny in 1925 145 • 
Improvements in the production and detection of terahertz radiation occurred 
throughout the twentieth century. The development of computers for Fourier 
transform analysis and more convenient bolometers in the 1950s improved access and 
the ability to use the far-IR spectrum. In addition, the advent of the laser in the 1960s 
allowed much more powerful sources ofterahertz radiation 145 . 
From the 1960s onward, most far-IR spectroscopy has involved a continuous wave 
incoherent blackbody source of radiation, usually a quartz envelope mercury lamp. 
The emitted radiation passes through a chopper to create pulses, and is split into two 
beams, the pump and probe beams. The pump beam is focused onto the sample, and 
the reflected or transmitted radiation is recombined with the probe beam which has 
been subject to an optical delay system. The interference of the pump and probe 





pyrodetector, and an interferogram in the temporal domain is produced. Through 
Fourier transformation, the interferogram is converted into a spectrum in the 
frequency domain 145' 146,149. 
Despite the knowledge and availability of such setups, the terahertz regime has been 
one of the least utilised regions of the electromagnetic spectrum, and research using 
this region has remained mainly in the hands of physicists and physical chemists. The 
main problems have been associated with weak blackbody sources and hindered 
detection of the weak signal by background thermal radiation 150,151 . The use of 
synchrotrons has allowed very powerful sources of far-IR radiation. However the 
scale and expense of a synchrotron preclude any commonplace use. For these reasons 
the terahertz regime has been popularly termed the "terahertz gap". 
4 .1.4 Terahertz pulsed spectroscopy 
Accessibility to the terahertz regime has been improved with time-domain 
spectroscopy, developed in the last twenty years. Time domain spectroscopy in the 
terahertz regime is known as terahertz pulsed spectroscopy (TPS). Although used to 
probe the same region of the electromagnetic spectrum as far-IR spectroscopy, TPS 
involves a very different setup. In TPS, terahertz radiation is generated using ultra 
short laser pulses in the femtosecond (10-15 s) time scale 151-153 . A typical set up for 






















Figure 4.3 Schematic illustration of the transmission mode configuration of a TPS 
system ( courtesy Tera View Ltd). 
Initially a laser generates ultra-short pulses of either visible or near-IR radiation on the 
femtosecond time scale. The short pulses are necessary for a sufficiently wide 
bandwidth to produce a spectrum with a large enough frequency range. These pulses 
pass through a beam splitter and form the pump and probe beams. The pump beam is 
directed onto a terahertz emitter, which most commonly produces terahertz radiation 
by one of two methods, optical rectification or photoconduction. Optical rectification 
is a nonlinear optical phenomenon where a constant bias voltage is generated in the 
material irradiated when the material becomes saturated with high laser powers. This 
constant bias voltage leads to terahertz radiation emission. In optical rectification, the 
most efficient terahertz radiation is generated when a material with a high nonlinear 
susceptibility and phase-matching ability (between the incident radiation and the 
terahertz radiation) is used. Materials used to generate terahertz radiation by optical 
rectification include LiNb03, semiconductors such as GaAs and ZnTe, and organic 
crystals. In optical rectification, the power from the laser is used to generate the 
terahertz radiation 152' 153 . 
Photoconduction, as the name suggests, uses a material that conducts when it is 
irradiated by the laser beam. Such materials are known as semiconductors. When a 
semiconductor such as GaAs or ZnTe is irradiated, electrons are excited from the 






the conducting orbital allows electrons to be delocalised across the crystal, thus 
allowing the electrons, and hence a current, to flow. In the valence orbitals "holes" 
are created, and these can also act as conductors. The "electron-hole" pairs created by 
the laser pulses are then accelerated across an antenna with a bias voltage. This 
acceleration produces terahertz radiation, which is emitted with the aid of a silicon 
lens. With these photoconductive antennae, the pulses from the laser act as a switch, 
and it is the bias voltage on the antenna which provides the power to generate 
terahertz radiation. Of the two terahertz generation techniques, the photoconduction 
method is slightly more efficient. The terahertz radiation produced by both 
techniques is coherent and therefore time-gated detection is possible 151-153 . 
Once the terahertz radiation is generated, the beam is focused onto the sample using 
off-axis parabolic mirrors. Measurements can be made either using transmission or 
reflection. In either sampling arrangement, once the beam has interacted with the 
sample it is refocused onto the detector. Detection involves interaction of the 
terahertz beam with the probe beam. Like terahertz generation, there are two main 
techniques for detection in TPS. One method involves electro-optic sampling, and the 
other involves photoconductive antennae. Electro-optic sampling relies on coupling 
between the low frequency electric field induced by the terahertz pulse, and the 
optical pulse from the laser in a sensor crystal. When photoconduction is used, 
photoconductive antennae identical to those used in generation can be used. 
However, the detection antenna does not have a bias voltage applied across it. The 
terahertz signal is recorded as a time domain waveform, which is converted into a 
spectrum in the frequency domain using Fourier transformation 152' 153 . 
4.1.5 Previous applications ofterahertz pulsed spectroscopy 
As outlined earlier, TPS operates in the frequency range of the electromagnetic 
spectrum where molecular rotations and hydrogen bond, low frequency bond and 
lattice vibrations predominate. TPS has previously been applied in the fields of 
semiconductors, medicine 154, security 155' 156, and space research 151 ' 153 . TPS has also 







frequency vibrational modes of amino acids, proteins and DNA 157-159, and to 
differentiate isomeric configurations of retinal chromophores 160. Benzoic acid and 
some monosubstituted derivatives, including salicylic acid and acetylsalicylic acid 
( aspirin), have also been differentiated using TPS 161 . 
Crystalline phonon vibrations and low-energy hydrogen bonding vibrations are 
directly affected by changes in intermolecular bonding. Thus, changes in crystallinity 
and polymorphism will change these modes and these changes should be manifest in 
TPS spectra. These changes may be more pronounced in the terahertz regime than in 
the IR or NIR region where most of the vibrations are due to intramolecular modes. 
With this in mind, TPS has been used to probe intermolecular changes in 
polycrystalline and amorphous saccharides 162. In a recent study by Taday et al 163, 
two polymorphs of RN gave distinct terahertz spectra. 
In this chapter, a method for measuring solid state spectra of pharmaceutical materials 
was optimised, the ability of TPS to differentiate different solid state forms of 
pharmaceutical compounds was investigated, and, for the first time, different solid 
state forms of the compounds were quantified using TPS . 
4.2 Materials and Methods 
4.2.1 Sample preparation 
CBZ forms I and III, EM forms I and II, y-crystalline and amorphous IM, crystalline 
FC dihydrate and supercooled liquid crystalline FC, lactose in the forms aLMH, ~L 
and aLs and sulphathiazole (STZ) forms I, II, III, IV and V were received and 
prepared as specified in Chapter 2. All metastable forms of the compounds were 
stored at 4 °C over silica gel. Polyethylene (PE) powder with particle sizes < 80, 50 -










Samples were gently ground using a pestle and mortar to reduce particle size. The 
solid state forms of the samples were confirmed by XRPD (Section 3.2.2.1). Sample 
discs were prepared by mixing the pharmaceutical powder and PE with a pestle and 
mortar using geometric dilution. PE acted as a binder and diluent in the sample 
preparation although it is not generally used in pharmaceutical tablet formulations. 
PE was chosen because it exhibits negligible absorption in the terahertz regime thus 
allowing the spectra of the drugs to be observed without signals from other materials. 
Circular 13 mm diameter discs of mass 300 mg or 400 mg were prepared with a 
hydraulic press (Specac Ltd, UK) and 1 ton compression. The thickness of the discs 
was approximately 2.1 - 2.5 mm for the 300 mg discs, and 3.2 - 3.6 mm for the 400 
mg discs. All samples were prepared in triplicate. The concentration of the 
pharmaceutical materials in PE was varied according to the absorption of the drug. 
For qualitative studies CBZ was used at 50%, EM at 25%, IM and FC at 75%, and aL 
at 12.5% w/w in PE in the 300 mg discs. aLMH and PL were prepared at 15% and 
STZ at 20% in PE with a total disc mass of 400 mg. Samples of each solid state form 
of the compounds were also compressed into discs using 2 and 5 tons (with the 
exceptions of aL and STZ due to lack of material). Binary mixtures were prepared 
containing two forms of the drugs CBZ, EM, IM and FC from 0% to 100% w/w in 
20% intervals. Mixtures containing 0%, 0.5%, 1 %, 2.5%, 5%, 7.5% and 10% of CBZ 
form I in form III, EM form I in form II, amorphous IM in y-crystalline IM, 
crystalline FC in liquid crystalline FC and aLMH in PL were also prepared. The 
concentrations of the pharmaceutical compounds in PE and the masses of the discs 
used in the quantitative studies are shown in Table 4.1. 
Table 4.1 The concentration of the pharmaceutical compound (including both forms) 
and PE in the discs and their masses used in the quantitative experiments. 
CBZ CBZ EM EM IM IM FC FC Lactose 
Mixture 0-100% 0-10% 0-100% 0-10% 0-100% 90-100% 0-100% 0-10% 0-10% 
form I form I form I form I crystalline crystalline crystalline crystalline aLMH 
Concentration 
of 




50 50 75 75 25 50 25 50 85 of PE(% w/w) 
Total mass of 







The powders used in the O - 10% quantification studies were sieved to a particle size 
of< 75 µm (with the exception of CBZ). In addition, EM forms I and II were sieved 
to< 75 µm size range for O - 100% form I in II quantification. Spectra from sieved 
and unsieved samples were compared, and no differences due to particle size were 
observed (Appendix 1 ). 
4.2.2 Measurements 
Transmission measurements were made on samples usmg a TPI™ spectra 1000 
spectrometer (Tera View Limited, Cambridge, UK). A schematic illustration of the 
experimental setup is shown in Figure 4.3. Samples were measured from 2 to 75 cm-
1, or 2 to 90 cm-1 if there was sufficient signal at the higher wavenumber range. The 
resolution was between 1 and 1.5 cm-1. Spectra were the average of 1800 scans 
(approximately one minute measuring time). Data was acquired using OPUS™ 
software (Bruker Optics, Germany). 
Ultra-short (75 fs) pulses of 800 nm radiation were emitted from a bandwidth-limited 
titanium-sapphire laser (Vitesse, Coherent, US) with a repetition rate of 80 MHz, and 
focused onto a GaAs photoconductive switch (the terahertz emitter). The generation 
of photocarriers within the switch leads to a transient current flow across a dipole 
antenna and a short burst of broadband terahertz radiation is emitted. A hemispherical 
silicon lens couples the radiation out of the GaAs substrate into free-space 164. 
Parabolic mirrors focus the terahertz radiation onto the sample. Detection of the 
terahertz radiation is achieved using an optically-gated semiconductor receiver 
antenna similar to the emitter. The near-infrared laser pulses (probe) optically gate 
the switch and the pulses repeatedly sample the longer terahertz pulses. Fourier-
transformation of the resulting temporal-domain waveform leads to the frequency-
domain spectrum. The technique can measure transmission spectra of samples 
(transmission mode) 150,162,163 or observe the reflected terahertz signature from the 




4.2.2.1 Method optimisation for pharmaceutical sample analysis 
The TPI™ spectra 1000 was a newly developed instrument. Therefore before 
measurements on pharmaceutical materials were carried out, the method was 
optimised by investigation and minimisation of the effects of water vapour, particle 
size and sample thickness on the spectra. 
4.2.2.2 Quantitative analysis of polymorphism and crystallinity 
Quantitative analysis was performed using the Quant2 package that accompanies 
OPUS™ software (Bruker Optics, Germany). Spectra were mean centered and 
converted to their first derivatives. Quantitative models were constructed using PLS, 
and optimised and assessed using methods defined in Section 3.2.2.4. As in Chapter 
3, loadings plots for each factor and regression coefficients were assessed. However, 





4.3 Results and discussion 
4.3 .1 Method optimisation for pharmaceutical sample analysis 
4.3.1.1 Minimisation of water vapour absorbance 
Figure 4.4 depicts the terahertz spectrum obtained without any sample disc and at 
atmospheric conditions (no N2 purge) within the sample chamber. It can be seen that 
unpurged atmospheric conditions produce intense absorbance signals. This spectrum 
can be predominantly attributed to gaseous water, which is known to be a strong 
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Figure 4.4 Terahertz pulsed spectra of water vapour in the sample chamber after 
purging with N2 gas at 10 Lmin-
1 and 1.5 bar for various times. Each spectrum was 
taken starting at the time specified, and took approximately 1 min to collect. 
Figure 4.4 also shows spectra as a function of purge time with dry N2 gas. At a flow 






baseline of the < 80 µm particle size range response begins to increase at 
approximately 110 cm-1, corresponding to 90 µm, suggesting that the change m 
baseline is indeed due to Mie scattering. The low SNR of the 200 - 400 µm sized 
particles above 60 cm-1 is due to the sensitivity of the absorbance above 1 combined 
with decreased terahertz radiation output from the emitter at higher wavenumbers. 
The discs made from< 80 µm sized PE exhibit a broad, low intensity band that peaks 
at 72 cm-1• This band has previously been observed in PE using far-IR spectroscopy 
174 It appears that by using particles with a size range of less than < 80 µm, 
significant particle size induced scattering will not occur. The pharmaceutical 
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Figure 4.5 Terahertz pulsed spectra of PE discs made from different particle size 
ranges. Discs were made using 300 mg PE with 1 ton compression. The arrows 
indicate the spectra of the discs using the size ranges< 80 µm (2.77 ± 0.02 mm thick), 
50-200 µm (mean 3.01 ± 0.01 mm thick) and 200-400 µm (mean 3.06 ± 0.03 mm 









4.3 .1.2.2. Disc thickness 
4. 3.1. 2. 2.1. Effect of polyethylene disc thickness on spectra 
The thickness of discs prepared using different masses of PE is shown in Table 4.2. 
The standard deviations are less than 3 % of the total disc thickness. Pronounced 
regular fluctuations were observed in the signal (Figure 4.6) for all but the thickest 
discs, with an average thickness of 2. 77 mm, corresponding to a sample weight of 300 
mg. For other samples this signal fluctuation exhibited a shorter periodic frequency in 
the THz spectrum. These fluctuations are due to etaloning. Etaloning occurs when 
radiation reflects internally at interfaces, in this case corresponding to the two faces of 
the discs. Etaloning depends on the wavelength of the light, and the thickness and 
absorbance of the discs. Constructive and destructive interference leads to 
fluctuations in the spectra. Fringes, rather than spikes appear in the spectra because 
the two surfaces of the discs are not perfectly flat and parallel. As the disc thickness 
increases the interference fringes merge, and etaloning becomes less evident. In 
addition, increased disc thickness leads to increased path length of the internally 
reflected light, increasing absorption and thus reducing the effect of etaloning 175 . To 
minimise etaloning in the pharmaceutical samples, all 13 mm discs were prepared 
with a sample mass of 300 mg or 400 mg, with a resulting disc thickness of at least 
2.2 mm. The resulting disc thickness is lower for pharmaceutical samples than for the 
pure PE 300 mg discs because of the compressibility and density differences between 
the pharmaceutical materials and PE. 
Table 4.2 Average thickness of 13 mm diameter discs prepared from different masses 
of PE with a size range of< 80 µm and 1 ton compression. 
Mass of PE (mg) 75 150 
Average thickness (mm) 0.73 1.38 
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Figure 4.6 Terahertz pulsed spectra of discs of different average thicknesses made 
from PE with particle size < 80 µm and 1 ton compression. The spectra of each 
different average disc thickness are offset for clarity. Samples were prepared in 
triplicate. 
4.3.1.2.2.2. Polyethylene disc thickness after compression 
The thickness of the PE discs was measured over time after compression (Figure 4.7). 
and the discs expanded about 4% in the first 15 min after compression, with little 
expansion thereafter. Therefore spectra of discs were taken at least 15 min after 
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Figure 4.7 Thickness of three 300 mg 13 mm PE(< 80 µm particle size) discs as a 
function of time after 1 ton compression. 
4.3 .2 Terahertz pulsed spectra of pharmaceutical materials 
4.3.2.1 Carbamazepine 
All peaks in the TPS spectra of CBZ forms I and III are polymorph specific (Figure 
4.8). Form III exhibits major peaks at 41, 60 and 68 cm-1, and smaller peaks at 28 and 
47 cm-1 while the form I spectrum has prominent peaks at 31, 44, 52 and 70 cm-1, with 
a low intensity peak at 23 cm-1• Both forms exhibit dimer formation with H-bonding 
between the CONH2 groups. Differences in the crystal structure associated with this 
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Figure 4.8 Terahertz pulsed spectra of CBZ forms I and III 50% in PE 300 mg discs. 
Each spectrum is the average of three spectra (from three independent samples) that 
were smoothed using the Savitzky-Golay algorithm to remove etaloning artefacts (13 
smoothing points). 
To ensure that compression during disc preparation did not affect the polymorphic 
form present, spectra were collected of samples prepared using 2 and 5 ton 
compression in addition to 1 ton compression. Figure 4.9 shows that the absorbance 
spectra are almost the same for different compression strengths for both forms I and 
III. The first derivatives of these spectra indicate that almost all differences are 
attributable to baseline difference except for a small but noticeable difference of form 
III at 48 cm-1 in the spectral derivative vi_ 
vi The first derivative of the spectrum is a measure of the slope of the signal at any given wavelength, 
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Figure 4.9 Terahertz pulsed spectra of CBZ forms I and III 50% in PE (a) and their 
first derivatives using 13 smoothing points (b) with 1, 2 and 5 ton compression during 
disc preparation . 
The spectra of mixtures of CBZ forms I and III show features attributable to both 
forms I and III (Figure 4.10). As the proportions of form I and form III decrease and 
increase respectively, the spectral features show a corresponding change that is both 
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Figure 4.10 Terahertz pulsed spectra of binary mixtures of CBZ forms I and III (20% 
intervals, 0 to 100% form I). The arrows indicate spectral changes as form III 
concentration decreases and form I concentration increases. Each spectrum is the 
average of three spectra (from three independent samples) that were smoothed using 
the Savitzky-Golay algorithm to remove etaloning artefacts (13 smoothing points). 
PLS analysis was performed on CBZ mixtures of forms I and III with an increasing 
proportion of form I from O - 100% and O - 10% in form III (Figure 4.11 and Table 
4.3). For the mixtures containing O - 100% form I in form III and using one factor, a 
RMSECV of 2.00% was obtained (Table 4.3). LODs between 4.00% and 7.03% were 
achieved depending on whether the LOD was calculated using the standard deviation 
of the fitted regression line (RMSECV) or the standard deviation of the lowest 
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Table 4.3 Parameters used in the generation of the quantitative models of mixtures of solid state forms of CBZ, EM, IM and FC (region, 
preprocessing and number of factors used) and model assessment (RMSECV, R2 (coefficient of determination), LOO and LOQ).* 
CBZ 0-100% CBZ 0 - 10% EM0-100% EM0-10% IM 0-100% IM 90 - 100% FC 0 - 100% FC 0-10% 
Lactose 
Mixture 0 - 10% form I form I form I form I crystalline crystalline crystalline crystalline 
aLMH 
15.6-20.7 
Region 27.9- 35.2 26.1-34.7 25.8-29.8 
9.98 - 60.1 
35.7 - 46.5 
36.4-45.0 14.1-47.0 11.4 - 33.4 
33.2-40.2 
(cm-1) 42.9 - 57.0 43.7-50.5 35.9-44.0 61.3 - 70.6 40.9-49.2 
52.9- 72.2 
Factors used 1 2 1 3 2 I 2 2 3 
RMSECV (%) 2.00 0.349 0.897 0.610 1.42 1.69 2.35 1.12 0.404 
R2 0.996 0.991 0.999 0.986 0.999 0.783 0.995 0.900 0.986 
L0D(%)° 4.00 1.23 1.80 0.692 1.05 6.64 2.69 4.51 0.785 
L0D(%)6 6.64 0.356 4.74 2.27 3.84 3.72 9.41 0.863 1.33 
LOD (%)" 7 03 1.17 3.12 2.13 5.00 6.64 8.25 4.10 1.39 
LOQ (%)" 12.1 3.73 5.47 2.10 3.18 20.1 8.16 13.7 2.38 
LOQ(%)6 20.1 1.08 14.4 6.87 11.6 l l.3 28.6 2.62 4.03 
LOQ(%)" 21.3 3.56 9.45 6.45 15.2 20.1 25.0 12.4 4.23 
* All spectra were preprocessed using mean centering and first derivative conversion (Savitzky-Golay algorithm, 13 points). 
a LOO and LOQ calculated using the standard deviation of the three samples with the lowest constituent concentration as defined in the table. 
h LOO and LOQ calculated using the standard deviation of the three samples with the highest constituent concentration as defined in the table. 
c LOO and LOQ calculated using the residual standard deviation of the fitted regression line . 
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Figure 4.11 Predicted versus actual concentration of CBZ form I in form III from (a) 
0- 100% form I and (b) 0-10% form I with 95% confidence bands (dots) and 
prediction bands (dashes). 
The model generated using O - 10% form I in form III gave a RMSECV of 0.349%. 
LODs of 0.356% to 1.23% (depending on the method of LOD calculation) suggest 
that very low LODs can be obtained using TPS when quantifying CBZ polymorphs in 
a limited concentration range. 
4.3.2.2 Enalapril maleate 
The spectra of EM forms I and II (Figure 4.12) show several differences, with form I 
exhibiting peaks at 23, 40 and 69 cm-1 and form II showing peaks at 20, 27, and 57 
cm-1. A common peak is observed at approximately 44 cm-1. Forms I and II of EM 
exhibit very similar mid-IR and Raman spectra (Section 3.3.2). This has been 
attributed to very similar crystal packing, hydrogen-bonding patterns and 
conformations 47 . However, differences have been observed between the two forms 
of EM in the low wavenumber Raman spectra of forms I and II between 25 and 
100 cm-1 46 . The TPS results suggest that the terahertz regime is better suited than the 
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Figure 4.12 Absorbance spectra of EM forms I and II 25% in PE 300 mg discs. Each 
spectrum is the average of three spectra (from three independent samples) that were 
smoothed using the Savitzky-Golay algorithm to remove etaloning artefacts (13 
smoothing points). 
Spectra of EM discs made using 1, 2 and 5 ton compression are depicted in Figure 
4.13. There is a small frequency and intensity shift between the spectra of the disc 
compressed using 1 ton and the discs made with 2 and 5 ton compression. For 
example, the peak of form I at 40 cm-1 corresponding to 1 ton compression shifted to 
41 cm-1 and decreased in intensity for the 2 and 5 ton discs. These changes are due to 
calibration of the spectrometer. The spectral shifts are 1 cm-1 or less which is less 
than the resolution. If these changes are ignored no absorbance or first derivative 
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Figure 4.13 Terahertz pulsed spectra of EM forms I and II 25% in PE (a) and their 
first derivatives using 13 smoothing points (b) with 1, 2 and 5 ton compression during 
disc preparation . 
The binary mixtures of the polymorphs, show that the spectra (Figure 4.14) gradually 
change as the proportion of forms I and II decrease and increase respectively, 
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Figure 4.14 Terahertz pulsed spectra of binary mixtures of EM forms I and II (20% 
intervals, 0 to 100% form I) . The arrows indicate spectral changes as form II 
concentration decreases and form I concentration increases. Each spectrum is the 
average of three spectra (from three independent samples) that were smoothed using 
the Savitzky-Golay algorithm to remove etaloning artefacts (13 smoothing points). 
EM was modelled from O - 100% form I in form II (Figure 4.15(a)) and LODs 
between 1.80% and 4.74% were achieved (Table 4.3). EM mixtures were also 
quantified using O - 10% form I in form II (Figure 4.15(a)) with LODs of between 
0.692% and 2.27% being obtained (Table 4.3). The low LODs for O - 10%, together 
with the low RMSECVs of 0.897% and 0.610% for the O - 100% and O - 10% form I 
concentration ranges respectively, suggest that TPS is a very good technique to 
quantify polymorphism in EM. 
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Figure 4.15 Predicted versus actual concentration of EM form I in form II from 
(a) 0 - 100% form I and (b) 0 - 10% form I with 95% confidence bands (dots) and 
prediction bands (dashes). 
As was the case with FT-Raman spectroscopy (Chapter 3), the quantitative analysis of 
CBZ and EM polymorphs both give lower RMSECV s and LODs for mixtures over 
the concentration range O - 10% compared with the O - 100% concentration range. 
Therefore, a more precise model is created using a narrower concentration range of 
the polymorph of interest. 
4.3.2.3 Indomethacin 
IM was used to compare and quantify the terahertz spectra of amorphous and 
crystalline forms of a pharmaceutical compound (Figure 4.16). The y-crystalline form 
of IM shows peaks at 41, 50 and 66 cm-1, although IM is a comparatively weak 
terahertz absorber with 75% IM in PE being used. There are no distinct peaks in the 
spectrum of the amorphous form. With no peaks in the amorphous form, the observed 
signals in y-crystalline IM are almost certainly due to crystalline phonon vibrations. 
Short range vibrations of intermolecular 0-H bonds between carboxylic acid groups 
on the IM molecule can also be ruled out as contributing to the peaks in the y-
crystalline form spectrum, because both the y-crystalline and amorphous forms consist 










The higher overall absorbance profile for amorphous indomethacin compared with the 
y-crystalline form was initially attributed to Mie scattering as the amorphous form 
appeared to have a slightly larger particle size than they-crystalline form. However 
spectra of both amorphous and crystalline IM samples where sieving was performed 
to ensure particle sizes of less than 80 µm in both forms (Figure A, in appendix), 
showed the same baseline differences as observed in Figure 4.16. Previous results 
(Section 4.3 .1.2.1) have suggested that scattering of terahertz radiation is negligible 
for PE powders with particle sizes below 80 µm, and these findings of the higher 
baseline of amorphous IM are therefore inconsistent with Mie scattering. Therefore 
independent of particle size, amorphous IM absorbs more strongly than y-crystalline 
IM in the terahertz regime, especially at higher wavenumbers. This observation 
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Figure 4.16 Absorbance spectra of y-crystalline and amorphous IM 75% in PE 300 
mg discs. Each spectrum is the average of three spectra (from three independent 
samples) that were smoothed using the Savitzky-Golay algorithm to remove etaloning 




There are no systematic visible differences in the absorbance spectrum, or its first 
derivative, of amorphous IM after compression of the discs with 1, 2 or 5 tons (Figure 
4.17). While there are no visible changes in the corresponding crystalline absorbance 
spectra, small decreases in the peak at 41 cm- 1 with increasing compression are 
present in the first derivatives of the spectra of the y-crystalline form. This suggests a 
slight loss of crystallinity. A slight yellowing of the disc compressed using 5 tons was 
also observed, which suggests amorphous IM formation. There were no colour 
changes from the white colour of y-crystalline IM powder of discs compressed using 1 
and 2 tons. It is therefore possible that some y-crystalline IM in the discs prepared 
using 1 ton compression converts to amorphous IM, however any change is most 
likely minimal. In addition, no peaks suggesting the formation of a new polymorph, 
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Figure 4.17 Terahertz pulsed spectra of y-crystalline and amorphous IM 75% in PE 
(a) and their first derivatives using 13 smoothing points (b) with 1, 2 and 5 ton 






In the mixtures, as the crystallinity of the samples increases, one observes the 
appearance and gradual accentuation of the peaks defining the y-crystalline form 
(Figure 4.18). There is also a steady decrease in the intensity and slope of the 
baseline with increasing crystallinity. 
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Figure 4.18 Terahertz pulsed spectra of binary mixtures ofIM amorphous and y-
crystalline forms (20% intervals, 0 to 100% y-crystalline form). The arrows indicate 
spectral changes as the amorphous form concentration decreases and the y-crystalline 
form concentration increases. Each spectrum is the average of three spectra (from 
three independent samples) that were smoothed using the Savitzky-Golay algorithm to 
remove etaloning artefacts (13 smoothing points). 
Quantitation from O - 100% y-crystalline IM resulted in a RMSECV of 1.42 and 
LODs from 1.05% to 5.00% (Figure 4.19(a) and Table 4.3). These results were 
obtained using two factors, and the wavenumber ranges 35.7 - 46.5 and 61.3 - 70.6 
cm·1, the regions in which the two main peaks occur in the spectra of y-crystalline IM. 
However mixtures with 90 - 100% y-crystalline IM in amorphous IM, corresponding 
to O - 10% amorphous IM were less quantifiable. Using one factor and the region 
116 
36.4 - 45.0 cm-1, a RMSECV of 1.69% and LODs of between 3.74% and 6.64% were 
obtained. Incorporating the higher wavenumber region (61.3 - 70.6 cm-1) used in the 
0 - 100% model increased the RMSECV which was probably due to a decreased 
SNR. Using XRPD, another technique that probes at the lattice level, it has been 
found that it is considerably more difficult to quantify low levels of amorphousness in 
otherwise crystalline systems compared with quantifying low levels of crystallinity in 




. The reason for the poorer quantitation of O - 10% compared to the O - 100% 
amorphous IM mixtures should be investigated. Quantifying low levels of y-
crystalline IM in amorphous IM using TPS would also be worthwhile. Investigating 
quantitation of other crystalline and amorphous mixtures using TPS may shed more 
light on whether TPS is capable of detecting and quantifying low levels of amorphous 
forms. 
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Figure 4.19 Predicted versus actual concentration of y-crystalline IM in amorphous 
IM from (a) 0- 100% y-crystalline IM and (b) 90- 100% y-crystalline IM with 95% 
confidence bands (dots) and prediction bands (dashes). 
4.3.2.4 Fenoprofen calcium 
Fenoprofen calcium (FC) is a propionic acid derivative (Figure 4.20). It is classified 
as a nonsteroidal anti-inflammatory agent, and is used for the same analgesic and anti-









Figure 4.20 Molecular structure of FC. 
The stable form of FC is a dihydrate, which is slightly soluble in water. Although FC 
has been studied since the 1970s, its crystal structure was only published by Zhu et al 
in 2001 178. The crystal lattice was defined as monoclinic, with space group P21/n. 
Zhu et al also described a less ordered state that formed when water was evaporated 
from the sample to form a mono- or anhydrate. This less ordered state has previously 
been investigated and characterised by Rades and co-workers 122,1 79,lSo. It was 
identified as a supercooled thermotropic liquid crystalline phase, specifically reverse 
hexagonal. FC was the first drug to be discovered that can exist in this supercooled 
thermotropic mesophase, and the liquid crystalline form has been found to have 
significantly higher solubility than its crystalline counterpart 122' 179. Thus, one can 
conclude that forming liquid crystalline compounds is an additional approach to 
increasing the solubility of poorly water soluble compounds. 
Thermotropic liquid crystalline systems are potentially particularly useful to elucidate 
the degree of order required to sustain to phonon modes. Although organic systems 
simpler than FC are likely be more beneficial when eliciting such information, the 
pharmaceutical example of thermotropic liquid crystalline FC provides an opportunity 
to see whether the degree of order of liquid crystalline FC is sufficient to sustain 
phonon modes in the region probed by TPS. 
The x-ray diffractogram of the crystalline FC dihydrate exhibits many peaks the 
largest of which are a double peak at 6.5 and 6.7 and another peak at 20.6 ° (28) 
(Figure 4.21). There are many smaller peaks between 12 and 30 ° (28) which is 
typical of organic crystalline materials. The liquid crystalline form shows x-ray 
118 
intereferences only in the small angle range. These interferences are consistent with a 
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Figure 4.21 X-ray powder diffractograms ofliquid crystalline and crystalline FC. 
The spectrum of FC dihydrate exhibits peaks at 17, 27, 52 and approximately 66 cm-1 
(Figure 4.22). Like y-crystalline IM, the high proportion of FC in the discs shows that 
the crystalline hydrate form of FC is a poor absorber of terahertz radiation compared 
with CBZ and EM. The liquid crystalline form lacks any distinct peaks in the spectral 
region studied, which shows that there is insufficient order in the liquid crystalline 
form to sustain phonon modes in the spectral region studied. However, the elevated 
spectral baseline of the liquid crystalline form suggests that diffuse absorption is 
occurrmg. It is possible that the modes observed in the crystalline form are a 
consequence of interactions with the water molecules in the crystal as no solvent 
molecules are present in the thermotropic mesophase, though such interactions, 
especially hydrogen bonding, tend to occur at higher frequencies. Unlike IM, the 
baselines of the two forms are relatively similar, suggesting that overall absorption is 












containing crystalline FC compared with other pharmaceutical systems, though the 
thickness of the discs was very similar. 
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Figure 4.22 Absorbance spectra of crystalline and thermotropic liquid crystalline FC 
75% in PE 300 mg discs. Each spectrum is the average of three spectra (from three 
independent samples) that were smoothed using the Savitzky-Golay algorithm to 
remove etaloning artefacts (13 smoothing points) . 
There were no differences due to different compressions in either the absorbance 
spectrum or first derivative spectrum of liquid crystalline FC (Figure 4.23). A small 
decrease in peak intensity in the first derivative spectrum of the crystalline hydrate at 
17 and 27 cm-1 with increased compression is probably due to decreased crystallinity. 
Since the changes are small, the sample compressed using 1 ton compression is likely 





3.0 a b 
- Crystalline form 1 ton 
- Crystalline form 2 ton 
2.5 
- Crystalline form 5 ton 
(.) 
- Liquid crystalline form 1 ton 
~ - Liquid crystalline form 2 ton 
0.10 




















O.O ~...----.---,--..-----,---r--,..........--,,-----r--~--.-~-,----.-~ -0.10 
10 20 30 40 50 60 70 10 20 30 40 50 60 70 
Wavenumber/ cm-1 
Figure 4.23 Terahertz pulsed spectra of FC crystalline hydrate and thermotropic 
liquid crystalline FC 75% in PE (a) and their first derivatives using 13 smoothing 
points (b) with 1, 2 and 5 ton compression during disc preparation_ 
The mixtures of liquid crystalline FC and the crystalline hydrate show that as the 
proportion of the crystalline form increased, the intensity of the peaks due to the 
crystal form also increased (Figure 4_24). There were some baseline inconsistencies 
between samples, which disappeared with first derivatisation. The SNR above 50 cm-
1 decreased with increasing crystallinity, which is at least partly due to the higher 
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Figure 4.24 Terahertz pulsed spectra of binary mixtures of FC liquid crystalline and 
crystalline forms (20% intervals, 0 to 100% crystalline form). The arrows indicate 
spectral changes as the liquid crystalline form concentration decreases and the 
crystalline form concentration increases. Each spectrum is the average of three 
spectra (from three independent samples) that were smoothed using the Savitzky-
Golay algorithm to remove etaloning artefacts (13 smoothing points). 
Previous work quantifying the crystalline dihydrate form in binary mixtures with the 
super-cooled liquid crystalline FC resulted in a LOD of 4.06% (from O - 10% liquid 
crystalline in crystalline FC) using FT-Raman spectroscopy indicating a difficulty in 
quantifying the solid state forms of this drug 90. Using TPS, a RMSECV of 2.35% 
and LODs of between 2.69% and 9.41% were achieved for O - 100% crystalline FC 
with two factors (Figure 4.25 and Table 4.3). With the narrower concentration range 
of O - 10% crystalline FC, a RMSECV of 1.12 and LODs of between 0.863% and 
4.51 % were obtained. With such results, TPS appears to be equal or better than other 
spectroscopic techniques to quantify crystallinity and liquid crystallinity of FC. In 
light of the IM results with low levels of amorphous IM, the ability of TPS to detect 
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liquid crystalline FC using a model generated with low concentrations of this form is 
worth investigating. 
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Figure 4.25 Predicted versus actual concentration of crystalline FC dihydrate in 
thermotropic liquid crystalline FC from (a) 0- 100% crystalline FC and (b) 0- 10% 
crystalline FC with 95% confidence bands (dots) and prediction bands (dashes). 
4.3.2.5 Lactose 
X-ray powder diffractograms confirmed the crystal forms of aL5, ~L and aLMH 
(Figure 4.26) 121 . aL5 specific peaks occur at 12.3 and 19.4 ° (20), a peak unique to 
~Lis present at 10.5 ° (28) and an aLMH specific peak is present at 12.6 ° (20). The 
absence of these peaks in other forms suggests that each form is without 
contamination from other forms 68' 121 . The terahertz pulsed spectra of ~L, aL5 and 
aLMH show pronounced differences up to 90 cm-1 (Figure 4.27). ~L exhibits modes 
at 41, 46, 50, 74 and 80 cm-1, and an especially intense mode at 63 cm-1. aLMH 
exhibits a much more intense mode at 46 cm-1. aLMH also absorbs strongly at 
86 cm-1, and other peaks occurr at 18, 40 and 61 cm-1. aL5 shows peaks at 28, 36, 45, 
54, 77 and 86 cm-1, and a much stronger signal at 61 cm-1. The aL5 samples were 
prepared using only 62.5% of the total lactose used for the other samples, and 
therefore the overall absorption of aL is lower than for the other samples. The peaks 
of aLMH are narrower than those of all the other pharmaceutical materials 
investigated, which may be due to aLMH having the highest order and the fewest 
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crystal defects. The x-ray powder diffractogram of aLMH also contains narrower, 
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Figure 4.27 Absorbance spectra of ~L, aL5 and aLMH in PE discs (15% ~L and 
aLMH in PE 400 mg discs and 12.5% aL in PE 300 mg discs). Each spectrum is the 
average of three spectra (from three independent samples) that were smoothed using 
the Savitzky-Golay algorithm to remove etaloning artefacts (13 smoothing points). 
The spectra are offset for clarity. 
Although there are several peaks common to the three forms, no spectrum contains all 
peaks present in the spectrum of another form. Spectra of aLMH and ~L prepared 
with higher compressions suggest no crystallinity changes at any compression (Figure 
4.28). There was not enough aLs to prepare samples using higher compressions. 
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Figure 4.28 Terahertz pulsed spectra of ~Land aLMH 15% in PE (400 mg total) (a) 
and their first derivatives using 13 smoothing points (b) with 1, 2 and 5 ton 
compression during disc preparation. 
Quantitation of low levels (0 - 10%) of aLMH in ~L was performed using the 
spectral region where strong absorption occurs for either aLMH or ~L and three 
factors. A RMSECV of 0.404% and LODs from 0.75 to 1.39% suggest that TPS is 
potentially a valuable technique to quantify changes in lactose crystallinity (Figure 
4.29 and Table 4.3). These low LODs reflect the large differences in the spectra of 
the two forms, the comparatively high useable spectral range and a low SNR. 
A further model made with ternary mixtures of all three forms of lactose would allow 
the quantification of all three forms simultaneously. It would also be interesting to 
carry out experiments using mixtures with O - 100% component concentrations, to 
assess quantitation abilities over the complete concentration ranges. Due to the 
ubiquitous use of lactose in the pharmaceutical industry, the different 
physicochemical characteristics of the forms and the speed of TPS measurements, 
quantitative analysis of lactose forms using TPS has potentially widespread 
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application. Other techniques that have been used to quantify lactose forms are 
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Figure 4.29 Predicted versus actual concentration of O - 10% aLMH in ~L with 95% 
confidence bands (dots) and prediction bands (dashes). 
4.3.2.6 Sulphathiazole 
Sulphathiazole (STZ) is a sulphonamide antibiotic that has been around for almost 70 
years (Figure 4.30). It has been used to treat urinary tract infections, however its 
systemic use is limited due to toxicity and hypersensitivity related adverse reactions. 
More commonly, it is used topically for skin, eye and vaginal infections 31 . STZ 
exists in several published polymorphic forms, and has been named the "classic" 
polymorphic compound 181 . Five polymorphic forms have been identified, and the 
crystal structures of these have now been published 182-185. However, due to similar 
conformational and crystal structures, variable stability and difficulty in preparing 
pure forms, there has been much confusion in the literature over the number and 
nomenclature of the different forms. Apperley et al (1999) have helped to clarify the 
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STZ polymorphism nomenclature and have suggested a numbering system which is 
used in this thesis 186. 
Figure 4.30 Structural formula of STZ. 
Forms I and II of STZ have quite different conformations and crystal packing, while 
forms III, IV and V have similar solid state structures. Forms IV and V have almost 
the same molecular conformations and crystal packing. However, there is a 
difference in the intermolecular bonding of their ring systems. Form III incorporates 
the ring systems of both forms IV and V 186. The physicochemical properties and 
spectra of forms III, IV and V are all very similar, and the properties of form III are 
intermediate to those of forms IV and V 186. The IR, Raman and NMR spectra of 
form III are identical to the spectra obtained from a 50/50 mixture of forms IV and V 
182,187 
The terahertz pulsed spectra of all five forms are shown in Figure 4.31, and all five 
forms show distinct peaks. Form I was relatively glassy in appearance, and this, 
combined with the low intensity peaks in the terahertz pulsed spectrum, suggests that 
significant amounts of amorphous material may have been present. However, several 
extremely broad modes are observable in the spectrum, and a strong absorption is 
present at 66 cm-1. The spectra of the other forms all contain abundant peaks. Form 
II exhibits peaks at 22, 28, 35, 40, 59, 67 and 83 cm-1. Form III shows well defined 
peaks at 30, 38, 45 and 50 cm-1, with an intense absorption at 69 cm-1 and other modes 
at 55, 62 and 83 cm-1. Form IV shows several peaks at slightly lower frequencies than 
those observed in form III, namely at 28, 36, 44 and 83 cm-1• Broad relatively ill 
defined modes are also evident at 61 and 68 cm-1. Form V is host to fewer peaks, 
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Figure 4.31 Terahertz pulsed spectra of STZ forms I, II, III, IV and V 20% in PE 
discs ( 400 mg total). The spectra are offset for clarity. 
No form exhibits peaks that are entirely present in another form, which suggests that 
all forms are indeed independent polymorphs, and not mixtures of polymorphs. The 
spectrum of form III contains peaks at 30, 50, 55 and 69 cm-1 that do not appear in the 
spectra of forms IV or V, providing strong support that form III is a separate crystal 
structure and not a 50/50 mixture of forms IV and V. Thus, on this occasion, TPS has 
clarified a structure that could not be resolved using mid-IR or NMR techniques. In 
fact, the spectrum of form III has several modes that are at an intermediate frequency 
to those of forms IV and V, supporting the findings that form III combines the 
molecular conformations of forms IV and V. 
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4.4 Chapter summary 
TPS is a spectroscopic technique developed in the last twenty years that shows an 
improved ease and ability to obtain spectra in the terahertz regime compared with 
conventional far-IR spectroscopy. Crystalline phonon or lattice vibrations are modes 
present in solids that predominantly occur in the terahertz region of the 
electromagnetic spectrum. These modes are collective modes that occur in solids, and 
are determined by crystal structure. The appearance of such modes makes TPS 
potentially an ideal spectroscopic technique to differentiate polymorphs of a 
compound. 
The application of TPS to differentiate and quantify different solid state forms of 
pharmaceutical compounds has been investigated here for the first time. After the 
effects of water vapour, particle size and sample thickness on spectra obtained by TPS 
were investigated and minimised, different forms of CBZ, EM, IM, FC, lactose and 
STZ were studied and gave rise to very different spectra. The modes cannot yet be 
attributed to specific vibrations. However evidence of the modes being due to 
crystalline phonon vibrations is provided by the lack of distinct modes in the spectra 
of amorphous and liquid crystalline examples. 
The large differences in the spectra of the different solid state forms of the compounds 
were exploited for quantitative analysis using the multivariate analysis technique, 
PLS. The examples investigated in this study suggest that TPS is at least as good as 
other physico-chemical techniques to detect and quantify solid state forms. It should 
be stressed that the quantitative data presented in this chapter serves as proof-of-
concept and not validation data, such as that presented for example in a paper by 
Laasonen et al where caffeine content was quantified in tablets using near-IR 
spectroscopy 188. Further investigations, including formal validations will provide 
further insight into the ability of TPS to quantify pharmaceutical polymorphism and 
crystallini ty. 
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In conclusion, TPS is a new spectroscopic tool capable of characterising the solid 
state of pharmaceuticals, and its full potential for quantitative analysis, including that 




Using second harmonic generation to quantify 




5 .1 Introduction 
Second harmonic generation (SHG) is a nonlinear optical phenomenon that has not 
previously been used in pharmaceutics. Therefore, the following sections introduce 
the theoretical basis of SHG with an emphasis on material characterisation. Due to the 
complexity of this area of research, this introduction cannot be comprehensive and 
some approximations are made in order to aid understanding. For a comprehensive 
text on the field of nonlinear optics, The Principles of Nonlinear Optics by Shen 189 
and Nonlinear Optics by Boyd 190 are recommended. Optics by Hecht 173 and Insight 
into Optics by Heavens 191 are two textbooks that provide an introduction into 
nonlinear optics and second harmonic generation. 
5.1.1 Nonlinear optics and second harmonic generation 
When light irradiates a medium, the medium responds to the force that the 
electromagnetic field of the light exerts on the medium. The loosely bound outer 
electrons within the medium polarise in response to the electric field of the light, thus 
creating their own electric field. In everyday situations, when the light is not too 
intense, the electron movement and hence the polarisation or electric field of the 
electrons, P, is directly proportional to the electric field of the light, E. This 
relationship is defined as 
(5.1) 
where Bo is the electric permittivity of free space and x is the linear susceptibility of 
the medium. A plot of P versus E will be linear 173' 191 . Following polarisation, the 
light is reradiated from the medium. When the medium polarises linearly, the 
reradiated light is at the same frequency, phase and wavelength as the incident light 
(which irradiated the medium). This is known as elastic scattering and the behaviour 
described obeys the classical model of light 173 . 
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With the advent of lasers, light with much higher electric field intensities could be 
generated. When laser generated light with sufficiently high E irradiates a medium, 
the electrons within the medium can no longer polarise in proportion to E. In this 
situation, the response of the system consists of both a linear and nonlinear 
component, and the polarisation of the medium can be defined as 
(5.2) 
where / 2) and / 3) are the second and third order susceptibilities of the material 
respectively 189. In general, the linear susceptibility of the material, X, is much greater 
than / 2) and / 3), and therefore these nonlinear susceptibilities only contribute 
significantly at high values of E (approximately 106 vm-1). The polarisation of the 
medium is no longer proportional to the electromagnetic field of the light wave, and 
thus the material is said to respond nonlinearly 173,1 91 . 
The polarisation response, P, of the material will only be the same upon irradiation 
from any direction if the material is isotropic. Most crystalline materials are 
anisotropic, and therefore by definition have different linear and nonlinear 
susceptibilities in some or all of the three dimensions of the crystal lattice. 
5 .1.2 Introduction to second harmonic generation 
If the incident light consists of a harmonic wave of frequency, w, then the light wave 
can be can be expressed as 
E = E 0 exp(i(kz - wt)) (5.3) 
where E0 is the electric field amplitude, i denotes a complex quantity, k is the wave 
vector of the electric field, z is the direction of wave propagation, OJ is the angular 
frequency and t is time. The term wt is the variation of the electric field in time, and 
kz is the phase change of the wave during propagation 189. 
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Consider the situation of two electric fields propagating through a material in the z 
direction at time t with amplitudes Eo and E1, then the total electric field, E, is given 
by 
(5.4) 
The two fields sum together, and if we consider only the second order nonlinear 
component of the resulting polarisation response (P), then the response of the material 
is proportional to the square of the electric field (Equation 5.2) and goes as 
P (X E5 exp( -i(2w0t)) + EJ exp( -i( - 2wi)) + 
E 0E1 exp(i(L1kz- (w0 - w1)t)) + E 0E1 exp(i(L1kz - (w0 + wJt)) 
(5.5) 
By considering the time dependent terms in Equation 5.5, it is evident that the 
polarisation responds with frequencies that are related to the input frequencies. The 
resulting electric field contains frequencies at twice the fundamental frequency of 
each of the waves. This is known as second harmonic generation (SHG). Difference 
(wo - w1) and sum frequency (wo + w1) generation are also possible 189. 
In terms of photons, SHG can be thought of as the combining of two photons of 
frequency OJ to form one photon of frequency 2w, with energy and momentum being 
d d · · 173 189 conserve urmg conversion ' . 
5 .1.3 Dependence of second harmonic generation on crystal symmetry 
The high intensity of the electric field of the laser is a necessary but not sufficient 
condition for SHG. The symmetry of the material is also critical to SHG. A second 
harmonic response of a material is only possible in the absence of inversion 
symmetry, or if the structure of the material in the dimensions xyz is not equal to the 
structure -xyz 2' 189' 190. Depending on the crystal structure, SHG may be possible in 
some directions but not others. Directions that allow second harmonic generation are 
termed non-vanishing elements. These elements do not exhibit planar symmetry. The 
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crystal classes capable of SHG are summarised in Table 5.1 189' 190. Within a crystal 
class SHG is dependent on the polarity or dipole moment of the unit cell. One can 
thus conclude that crystals will be capable of different amounts of SHG or may not 
exhibit SHG depending on their symmetry and the dipole moment of the unit cell. 
Table 5.1 Independent elements of / 2) for some common crystal symmetry classes, 








































All elements are independent and nonzero 
Each element vanishes 
xyz, xzy, xxy, xyx,yxx,Y,Y.Y,yzz,yzx,yxz, zyz, zzy, zxy, zyx(tv,ro 
fold axis parallel toy) 
xxx, xyy, xzz, xzx, xxz,yyz,yzy,yxy,yyx, zxx, zyy, zzz, zzx, zxz 
(mirror plane perpendicular toy ) 
Each element vanishes 
xyz, xzy,yzx,yxz, zxy, zyx 
xzx, xxz,yyz,yzy, zxx, zyy, zzz 
Each element vanishes 
xyz = -yxz, xzy = -yzx, xzx = yzy, xxz = yyz, zxx = zyy, zzz, zxy = -
zyx 
xyz = yxz, xzy = yzx, xzx = -yzy, xxz = -yyz, zxx = -zyy, zzz, zxy = 
zyx 
xyz = -yxz, xzy = -yzx, zxy = -zyx 
xzx = yzy, xxz = yyz, zxx = zyy, zzz 
xyz = yxz, xzy = yzx, zxy = zyx 
Each element vanishes 
xyz = -xzy = yzx = -yxz = zxy = -zyx 
xyz = xzy = yzx = yxz = zxy = zyx 
xyz = yzx = zxy, xzy = yxz = zyx 
Each element vanishes 
xxx = -xyy = -yyz = -yxy, xyz = -yxz, xzy = -yzx, xzx = yzy, xxz = 
yyz, Y.Y.Y = -yxx = -xxy = -xyx, zxx = zyy, zzz, zxy = -zyx 
xxx = -xyy = -yyx = -yxy, xyz = -yxz, xzy = -yzx, zxy = -zyx 
xzx = yzy, xxz = yyz, zxx = zyy, zzz, Y.Y.Y = -yxx = -xxy = -xyx (mirror 
plane perpendicular to x) 
Each element vanishes 
xyz = -yxz, xzy = -yzx, xzx = yxy, xxz = yyz, zxx = zyy, zzz, zxy = -
zyx 
xxx = -xyy = -yxy = -yyx, Y.Y.Y = -yxx = -xyx = -xxy 
xyz = -yxz, xzy = -yxz, zxy = -zyx 
xzx = yxy, xxz = yyz, zxx = zyy, zzz 
Y.Y.Y = -yxx = -xxy = -xyx 




5.1.4 Influence of phase-matching on second harmonic generation 
The previous sections established that a sufficiently intense laser beam and a crystal 
without inversion symmetry and a unit cell with sufficient polarity are required for 
SHG. However, even if these requirements are fulfilled SHG may be negligible. This 
is because destructive interference between the original light and the second harmonic 
light within the crystal may prevent SHG. The refractive index, n, and therefore the 
speed of light within a crystal are frequency dependent. Thus the cv-wave and the 2cv-
wave will have different phase velocities within the crystal. 
Initially, when the cv-wave generates the 2cv-wave within the crystal the two waves 
are in phase. At this time they are said to be coherent, and the peaks of the cv-wave 
line up with the peaks of the 2cv-wave, and the waves combine constructively. When 
the peaks of the cv-wave and the 2cv-wave combine constructively power flows from 
the cv-wave to the 2cv-wave. However, due to different refractive indices, as the two 
waves propagate through the crystal the peaks do not stay lined up. When the peaks 
of the cv and the 2cv waves no longer line up they are said to be out-of-phase. At this 
point the waves combine destructively and little second harmonic light is preserved. 
The distance for which the peaks can stay lined up is known as the coherence length, 
L 173,189,190,192 C • 
The refractive index of the light within the crystal depends on the direction of 
propagation and polarisation of the electric field through the crystal. In some crystals 
it happens that the refractive indices of the incident light, nw, and the second harmonic 
light, n2w, are the same for a particular direction of propagation and polarisation 
within the crystal. In this situation, the waves travel at the same velocity. Thus, the 
second harmonic light remains in phase with the incident light This leads to power 
flow from the incident wave to the second harmonic wave, leading to increased SHG. 
This is known as birefringent phase-matching 192. Thus, if some crystals are oriented 
in a particular direction, they may be efficient second harmonic generators. Other 
kinds of phase-matching can occur 189' 190, but are not considered here. 
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5 .1.5 Influence of particle size on second harmonic generation 
Particle size will influence SHG because this is important in determining the path 
length over which SHG will be generated and propagated. Kurz and Perry developed 
a method for the measurement of SHG from powders (known as the Kurz powder 
method) and explained the effect of particle size on SHG theoretically 193 • The 
response, hro, of a single spherical particle goes as 
(5.6) 
where d is Yz x<2) and r is the particle radius 193 . This response can be adjusted to 
predict SHG from a powder where many particles are involved. In a powder, it is 
assumed that particle orientation is random. The second harmonic response depends 
on average particle size, (r), and whether the material can be phase-matched 192,1 93 . 
For nonphase-matchable materials, the response depends on whether (r) is less than or 
greater than Le. If (r) is less than or equal to Le, each particle will emit some second 
harmonic which is partly correlated with the second harmonic generated by the other 
particles. In this situation, the larger the particles, the more opportunity there is for 
generation of second harmonic from the laser light frequency. Thus, the intensity of 
the second harmonic response increases proportional to the average size of the 
particles, (r). The response goes as 
/ "' (d) 2 L(r) 




where <~ is the average of d tensor elements vll and L is the path length of the 
sample. The largest response is obtained when (r) is equal to Le (Figure 5.1) 192,193 . 
vii The tensor elements describe the nonlinearity of the second harmonic contributing elements as 
defined in Table 5.1. 
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Once (r) becomes much greater than Le, the response from each individual particle has 
no phase coherence to any other particle. Thus, one can sum the intensities of the 
response of all the individual particles that are in-adiated. The response goes as 
(5.8) 
where \Le; is the average coherence length for the crystal type. Overall this leads to 
a decrease in the second harmonic response with increasing particle size, due to 
destructive interference (Figure 5.1) 192,193 . 
For phase-matchable materials, the response depends on whether the particle size is 
larger or smaller than the distance over which effective SHG can occur, LApm (the 
distance before the co-wave and the 2co-wave become spatially separated). Apm is a 
constant depending on the beam parameters of the laser and the birefringence of the 
crystalline material 192. If (r) is much larger than LApm, then the phase-matched 
response will dominate the total response. The intensity of the second harmonic 
response goes as 
(5.9) 
where de/ is the combination of d tensor elements in the phase-matching direction. 
Once (r) is much larger than LApm, this equation shows that particle size does not 
influence SHG. This is shown by the flat profile of the dashed line in Figure 5.1. 
Instead, the distance that the laser beam can interact with the second harmonic 
determines the intensity of the SHG. When (r) is less than or equal to LApm, the 
response becomes proportional to the particle size, and the response is defined by 
Equation 5.7. 
Therefore the intensity of SHG increases with increasing particle size until a plateau is 
reached when (r) is larger than the distance over which the laser and second harmonic 




Figure 5.1, which shows the theoretical SHG from phase-matchable and nonphase-
matchable powdered systems as a function of r, the average particle size, is 
normalised. The phase-matched response can be much larger than the nonphase-
matched response. Also, the model assumes all particles have an identical particle 
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Figure 5.1 Theoretical response of different phase-matched and nonphase-matched 
particles as a function of particle size 193 . 
Equations 5.7 to 5.9 contain several assumptions. These are that the gaps between the 
particles are much smaller than Le, that the particles are in a fluid with a matching 
refractive index, and that all the particles are of the same polymorph. These 
requirements will almost certainly not be met in pharmaceutical experimental 
conditions however, and it can be assumed that in practice SHG will deviate from the 
theoretical response 192' 193 . 
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5 .1.6 Applications of second harmonic generation 
Soon after the development of the first working laser in 1960 by Maiman, Franken et 
al published the first account of SHG in 1961 194. In just over forty years SHG has 
been investigated and utilised in diverse areas. Initially research focused on the 
generation of materials that are able to efficiently produce a second harmonic 
response. These are useful in the generation of previously unobtainable 
electromagnetic frequencies with lasers, useful for optical signal processing and 
optical communications 189. There has also been growing interest in the use of SHG 
to investigate and monitor material properties. In particular the possibility of using 
SHG to characterise surfaces has been investigated 195' 196. This is possible because 
surfaces are noncentrosymmetric. In particular, SHG has been used successfully to 
investigate the adsorption of molecules onto surfaces with submonolayer specificity. 
This includes but is certainly not limited to the study of orientation of substrates on a 
surface and adsorption kinetics 195, adsorption of ionic surfactants at solid-liquid 
interfaces 197 and the interaction of dyes with surfactants at the air-water interface 198. 
More recently SHG from interfaces has been investigated in biological systems. Such 
applications of SHG include determining the orientation of dye molecules adsorbed 
onto supported phospholipid bilayers 199, and imaging of proteins and cells in tissues 
200-202 
The application of SHG as a tool to probe polymorphism and crystallinity has 
received less attention. LeCaptain and Bergland (1999) used SHG to monitor the 
crystallisation of noncentrosymmetric crystals from supersaturated solutions 203 . An 
attempt to quantify crystallinity was made by Henson et al in 1999, where the 
polymorphic state of octahydro 1,2,3 ,5, 7-tetranitro-1,3 ,5, 7-tetrazocine was quantified 
by monitoring the intensity of the generated second harmonic 204. This appears to be 
the only account where polymorphism or crystallinity has been quantified using SHG. 
This chapter focuses on using SHG as a tool to quantify polymorphism and 
crystallinity in powdered pharmaceutical mixtures based on the Kurtz powder method 
of measuring second order optical nonlinearity 193 . This method was developed 
initially to estimate SHG from materials for screening before producing large single 
crystals for use in lasers as frequency converters, for example. However in the 
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pharmaceutical setting, drugs and excipients in the solid state are usually present 
either in powdered form or in tablet form, which in the context of SHG can be 
regarded as similar to powders. Thus the Kurtz powder method is ideal for starting to 
look at the ability of SHG to monitor polymorphism and crystallinity of solid state 
materials and dosage forms in the pharmaceutical setting. The Kurtz powder method 
did not look at quantitation of crystallinity of materials. The aim of this chapter is to 
develop a method to quantify polymorphism and crystallinity using SHG, firstly with 
quartz and glass mixtures as proof-of-principle, followed by pharmaceutical 




5 .2 Materials and methods 
5.2.1 Materials 
Quartz, fine granular, washed and calcined was purchased from BDH Laboratory 
Supplies (Poole, UK). Pyrex® was supplied by the Glass Blowing Unit (University of 
Otago, Dunedin, NZ). Polyvinylpyrrolidone (PVP) USP (poly[l-(2-oxo-l-
pyrrolidinyl) ethylene]) was purchased from BASF Aktiengesellschaft 
(Ludwigshafen, Germany). EM forms I and II, aLMH and ~L, CBZ forms I and III 
and y-crystalline and amorphous IM were supplied and prepared as specified in 
Sections 2.2, 2.4, 2.1 and 2.3 respectively. RN forms I and II were supplied as 
specified in Section 2. 7. 
5 .2.2 Methods 
5.2.2.1 Sample preparation 
Quartz and Pyrex® were ball milled (Pascall Engineering Co. Ltd, Gatwick Rd, 
Crawley, Sussex, UK) with a motor speed rotator (Berco HSR) to reduce particle size, 
and sieved (Endecotts Ltd, London, UK) by vibration and subsequent sluicing with 
distilled water. The size fractions were dried at 80 °C for approximately 24 h. All 
other materials used were sieved by vibration without the addition of water. The 
polymorphs and amorphous forms of all compounds were confirmed by XRPD 
(Section 3 .2.2.1 ). All metastable forms were stored over silica gel at 4 °C. 
Particle size fractions were confirmed by SEM. This was performed using a scanning 
electron microscope (Cambridge Stereoscan S-360, UK), with powders mounted on 
aluminium stubs with double-sided carbon tape and sputter coated (Biorad Coating 
System, UK) under argon vacuum with gold-palladium (80 nm coating). Samples 
were viewed under an acceleration voltage of 10 kV and a probe current of 100 pA. 
5.2.2.2 Experimental set up and measurements 
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The experimental setup is shown in Figures 5.2 and 5.3. The samples were carefully 
placed in round sample holders 12.5 mm in diameter and 2 mm long, enclosed by 
fused silica windows (Edmund Optics, Singapore). Fused silica is pure and 
amorphous, and therefore does not emit any bulk second harmonic or fluoresce due to 
the presence of other elements. The samples were irradiated by a modified 
Continuum Powerlite 700 Nd: YAG laser. The Q-switched laser emitted 60 mJ 
pulses, 10 ns in duration with a repetition rate of 10 Hz. The energy incident on the 
sample was controlled by passing the beam through a half-wave plate and thin film 
polariser. Residual second harmonic generated by the laser and beam steering optics 
was removed by passing the beam through a dichroic filter. The samples were 
irradiated at pulse energies of between 5 and 30 mJ ( except for IM where it was 
necessary to use a higher pulse energy) depending on the sensitivity of the material 
and its optical nonlinearity. The unfocused laser beam had a radius of 2 mm giving 
energy densities of up to 0.25 Jcm-2, which is well below the damage threshold for 
most materials 205 . 
The reflected light was imaged at the slit of a grating spectrometer (Jarrell Ash, with 
adjustable entrance and exit slits fitted) using a 25 mm diameter lens of focal length 
50.2 mm. The angle between the spectrometer and fundamental was as close to 
normal as allowed by the geometry of the physical devices. The amount of light 
gathered by the lens was further increased by placing the sample at a slight angle to 
the beam. The angle of the sample holder was chosen such that the reflection of the 
fundamental from the front face of the sample holder just missed the entrance slit of 
the spectrometer. A 10 nm pass band filter centred on 532 nm was placed between 
the lens and the spectrometer. The filter helped reduce fluorescence signals and also 
provided some protection to the grating spectrometer from the higher energy 
fundamental. The entrance slit was set to< 0.5 mm while the exit slit was left open at 
a width estimated to be 1.5 mm. 
The signal was detected by a photomultiplier tube (PMT) (Philips 56UVP, Holland) 
and filtered using a box car integrator (Stanford Research Systems, SR250). This was 
possible because the fundamental and second harmonic are simultaneous while the 
fluorescence is usually delayed by a time of 1 ns or more 7. The box car integrator 
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was set to gate in signals that were simultaneous with the fundamental and the output 
was the rolling average of 100 such pulses. Thus only the second harmonic and fast 
fluorescence could contribute to the output signal, and measurements took just over 
10 s. To remove the influence of the fluorescence signal and simultaneously allow for 
the drift of the box car integrator three measurements were taken: one at 530 nm, one 
at 532 nm, and a third at 536 or 536.5 nm. The 6.0 or 6.5 nm spread of measurements 
is much wider than the bandwidth of the second harmonic radiation but most 
fluorescence signals have a considerably broader bandwidth 7. The average value of 
the low and high measurements was removed from the measurement of the second 
harmonic intensity. The PMT bias voltage was set to between -1500 and -2100 V 
depending on the second harmonic response of the sample. Measurements were taken 
after irradiation for 30 s if the output was initially changing due to sample bleaching. 
Since the laser energy and PMT bias voltage varied between experiments, responses 
were normalised to the largest response in each experiment. Where the sample 
response was recorded as a function of time a digital sampling oscilloscope with a 200 






















5 .3 Results and discussion 
5.3.1 Quartz and Pyrex® 
Quartz and glass are both primarily composed of silicon dioxide, Si02. Quartz 
consists almost exclusively of Si02 and exists in several polymorphic forms, but the 
most common crystalline form, stable at room temperature and atmospheric pressure, 
is a-quartz 206. a-Quartz is a non-centrosymmetric trigonal crystalline material, 
belonging to space group, P3 121. This form of Si02 is thus capable of exhibiting 
SHG. Glass is amorphous and principally derived from Si02. Window or plate glass 
contains about 10% w/w sodium and calcium. Pyrex® is a trademarked form of 
glass. It differs from typical window glass, inter alia, by containing about 4% boron, 
which is present in a higher proportion than sodium, and, the absence of calcium 207. 
Hereafter Pyrex® glass will be referred to as Pyrex. Since all forms of glass are 
amorphous, they are not capable of bulk SHG though surface induced SHG is 
possible. 
Quartz has been subjected to second harmonic measurements, and its nonlinear 
optical properties are well characterised 208,209. Quartz and glass have high laser 
damage thresholds. Since the Kurtz powder technique has not been used to quantify 
powder mixtures, quartz and Pyrex were used as proof-of-principle before 
pharmaceutical samples were investigated and quantified. 
5.3.1.1 X-ray powder diffraction of quartz and Pyrex 
After milling quartz remained crystalline, with no signs of conversion to the 
amorphous form in its diffractogram (Figure 5.4). Pyrex showed no signs of 
crystallinity, and a "halo" featured in its diffractogram at around 20 - 25 °28, which is 
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Figure 5.4 X-ray powder diffractograms of quartz and Pyrex after milling. 
5.3.1.2 Scanning electron microscopy of quartz and Pyrex 
SEM confirmed that the sieved particles of Pyrex and quartz were of uniform size 
range, with very little adsorption of smaller particles (Figure 5.5). 
Figure 5.5 Scanning electron micrographs of quartz (left) and Pyrex (right) sieved to 




5.3.1.3 Second harmonic response of quartz and Pyrex 
5.3.1.3.1. Response of quartz and Pyrex at different wavelengths 
With 1064 run irradiation, SHG will be specific to 532 run. The responses of quartz 
and Pyrex between 392 and 692 run were recorded (Figure 5.6). The quartz spectrum 
shows a sharp peak at 532 run and a minimal baseline response at other wavelengths. 
There was a constant response of Pyrex over all wavelengths, with no peak at 532 run 
indicating no SHG. After a single pulse the Pyrex response was higher than the 
baseline quartz response, however the response decreased to quartz baseline levels 
after pulsed irradiation for 30 s. This suggests that Pyrex shows some fluorescence, 
which is probably due to sodium and can be easily quenched with repeated irradiation. 
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Figure 5.6 Response spectrum of quartz and Pyrex after a single pulse and after 













5.3.1.3.2. Time resolved response of quartz and Pyrex 
SHG is close to instantaneous while fluorescence usually occurs over a longer period 
and has a later onset (greater than 1 ns delay). Thus, in addition to recording the 
response as a function of wavelength, the time profile of the response should indicate 
whether any fluorescence is present. Figure 5.7 shows the time-resolved response of 
pure quartz and quartz-Pyrex binary mixtures. All samples exhibit a symmetrical 
peak at 5.8 x 10 -s s that decreases in intensity with decreasing quartz concentration . 
The short response indicates that no fluorescence was recorded. 
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Figure 5.7 Time-resolved response of quartz and Pyrex binary mixtures. An output 
was recorded every 5 x 10-10 s and particle size was 90 - 125 µm. 
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5.3.1.3.3. Influence of particle size on the response of quartz and Pyrex 
Figure 5.8 shows the second harmonic response of quartz and Pyrex divided into 
various particle size fractions. Quartz is a nonphase-matchable material, and can be 
compared to the theoretical model presented in Section 5.1.4. 
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Figure 5.8 Second harmonic response of different particle size ranges of quartz and 
Pyrex (mean± SD (y-axis), n = 3). X-axis error bars represent particle size ranges. 
The response of quartz was not size dependent over the size ranges investigated 
(Figure 5.8). This may be because all particle sizes are much larger than Le, where the 
particle size influence on the response becomes negligible according to the theoretical 
model for nonphase-matchable materials (Section 5.1.4 and Figure 5.1). It is also 
possible that the particle size is in the range of Le, but the response does not match the 
theoretical model. This may be because several conditions of the theoretical model 
are not adhered to in the experimental setup. In contrast to the theoretical model, the 
powder is not in an index-matching fluid and the gaps between the particles may be 




was used. For quantitative analysis of pharmaceutical polymorphism or crystallinity 
however, it is an advantage if the response is not dependent on particle size. As 
expected the SHG by amorphous Pyrex was negligible for all size ranges. 
5.3.1.3.4. Response of quartz and Pyrex binary mixtures 
The second harmonic response from binary mixtures of quartz and Pyrex was 
investigated by two methods. First, the response with a constant PMT bias voltage, 
and then the PMT bias voltage required to obtain a 5 m V response was measured. 
The responses are shown in Figures 5.9 and 5.10 respectively. 
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Figure 5.9 Second harmonic response of binary mixtures of quartz and Pyrex as a 
function of increasing quartz concentration (n = 1). Particle size was 90-125 µm and 
samples were irradiated for 30 s prior to measurement. 
With a constant PMT bias voltage, SHG increased linearly with increasing quartz 
concentration (Figure 5.9). Since quartz is a nonphase-matchable material and the 
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particle size is greater than Le, the second harmonic response can be modelled 
according to Equation 5.8: 
\Le) 
(r) (5.8) 
According to this equation, the only variable which changes in the binary mixtures is 
L, the path length of the sample. In this experiment, L is proportional to the 
concentration of quartz (the second harmonic active species). Therefore, one can 
expect a linear increase in the response as a function of increasing quartz 
concentration, which is what was observed. At low quartz concentrations the 
response appears to be highly linear. However, for samples with quartz concentrations 
above 50% the standard deviation of the response increases. The reasons for this 
require further investigation, but it may be related to the amount of the sample 
contributing to the second harmonic response or multiple scattering. 
The PMT bias voltage required to elicit a 5 m V response decreased with increasing 
quartz concentration (Figure 5.10). The response was nonlinear with respect to quartz 
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Figure 5.10 PMT bias voltage required to obtain a 5 m V response from binary 
mixtures of quartz and Pyrex (n = 1 ). Each sample was measured ten times. The 
particle size was 125 - 180 µm. 
The results indicate that both methods are possible for measuring quartz concentration 
in binary mixtures with Pyrex. Furthermore, the results suggest that using SHG to 
measure the crystallinity and polymorphism of powdered pharmaceutical mixtures 
may be possible. Given that the first method produced a linear second harmonic 
response and that experimentally it is easier to measure the response using a constant 




5 .3 .2 Pharmaceutical materials 
5.3.2.1 Enalapril maleate forms I and II and polyvinylpyrrolidone 
The ability of SHG to distinguish EM forms I and II and PVP and then quantify 
binary mixtures of EM forms I and II followed by EM form II and PVP (amorphous) 
was investigated. 
5.3.2.1.1. X-ray powder diffraction ofpolyvinylpyrrolidone 
The amorphous form of PVP was confirmed by the absence of peaks in its 
diffractogram (Figure 5.11). The x-ray powder diffractograms of EM forms I and II 
are shown in Section 3.3.2. 
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Figure 5.11 X-ray powder diffractogram of PVP. 
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The particle size dependency of the second harmonic response of EM forms I and II 
and PVP is shown in Figure 5.12. EM form I gave the most intense response 
followed by form II and then PVP. The effect of particle size on the responses of EM 
forms I and II and PVP was analysed using a one-way analysis of variance (ANOVA) 
combined with the Tuk:ey method (95% confidence level) of mean comparisons. 
The second harmonic response of EM form I was dependent upon particle size (P = 
0.002). Particles sized between 63 and 180 µm had a significantly higher second 
harmonic response compared with particles larger than 250 µm. Particles in the size 
range 90 - 125 µm, with the largest mean second harmonic response, had a 
significantly larger response than particles in the range 180 - 250 µm, and particles 
with sizes between 125 and 180 µm produced a greater response than particles larger 
than 250 µm. Overall, SHG is greatest from EM form I particles smaller than 180 
µm. The response suggests that EM form I is not phase-matchable. 
The response of EM form II was also dependent on particle size (P = 0.040). Particles 
between 90 and 125 µm had a significantly larger response than particles between 125 
and 180 µm and particles larger than 250 µm. However, these differences were 
possibly due to chance because the responses of particles between 90 and 125 µm and 
180 and 250 µm are not significantly different. Therefore the second harmonic 
response of EM form II was not particle size dependent. 
The response of PVP was much smaller than that of EM forms I and II. However, the 
particles of < 63 and 63 - 250 µm in size both produced significant responses (P = 
0.003 and 0.046 respectively). As the amorphous nature of PVP precludes bulk SHG, 
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Figure 5.12 Second harmonic response of different particles size ranges of EM forms 
I and II and PVP (mean± SD (y-axis), n = 3). X-axis error bars represent particle size 
ranges. 
5.3.2.1.3. Response of enalapril maleate form I and II binary mixtures 
SHG from binary mixtures of EM forms I and II steadily increased with increasing 
form I concentration (Figure 5 .13 ). Regression analysis showed a significant 
relationship between form I concentration and response (P < 0.0001). The non-zero 
intercept means that form II also had significant SHG in the model (P = 0.012). At 
low form I concentrations the standard deviations of the responses were small; 
however as the proportion of form I increased the standard deviation of measurements 
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Figure 5.13 SHG from binary mixtures of EM forms I and II with 95% confidence 
bands (dots) and prediction bands (dashes) (mean± SD, n = 3). The particle size 
range was < 63 µm. 
Table 5.2 Quantitative analysis from a straight line fit of response versus EM form I 
concentration in binary mixtures with form II (also see Figure 5.13). 
Equation 




LOO based on SD of 
slope 
23.5% 
LOD based on SD of0% form I 
5.1% 
The response of the mixtures over the entire concentration range is close to linear, and 
this suggests that neither EM forms I or II phase-match. Depending on the coherence 
length of forms I and II, the response of the binary mixtures could be modelled using 
Equations 5.7 and 5.8. If (r) >> Lc1 ;::::; Lc2, where Lc1 and Lc2 are the coherence lengths 
of forms I and II respectively, then there is no coherence between the light emitted by 





where Ns1 and Ns2 are the numbers of particles of forms I and II respectively, and N is 
the total number of particles available to produce SHG. 
If (r) :S Lc1 ;::::; Le2, then there is some coherence between the individual particles and 
the total response is larger than the result obtained by summing the responses of forms 
I and II (Equation 5.7). 
Calculation of the LOD (Table 5.2) based on the standard deviation of the slope 
resulted in an LOD of 23.5%. However, if the LOD is calculated based on the 
standard deviation of the three 0% form I values, the LOD becomes 5.1%. This 
decrease in LOD is probably due to the large standard deviations of the responses at 
high form I concentrations. Although the LODs are too high for most practical uses, 
these results suggest that with experimental improvement, for example incorporating 
multiple angle measurements, the technique may provide acceptable LODs for in-line 
process control. 
5 .3 .2.1.4. Response of enalapril maleate form II and polyvinylpyrrolidone binary 
mixtures 
EM form II and PVP mixtures are an example of mixtures of crystalline and 
amorphous materials. From Figure 5.14, one can see that the second harmonic 
response increased with increasing EM form I concentration (P < 0.001). In addition, 
there is no evidence of a non-zero intercept (P = 0.534). 
Since EM form I cannot be phase-matched, the theoretical response is best explained 
by adaptations of Equations 5.7 or 5.8 depending on the Le of EM form I. If (r) >> Le, 




where N51 is the number of EM form I particles 
192
. If <r) :S Lc1 :::::: Lc2, then the 
response becomes 
(5.12) 
where (L) is the average path length of the light through the sample 192. At low 
concentrations of EM form II, the data is highly linear with low standard deviations. 
Consistent with the previous mixtures, the standard deviation of the response 
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Figure 5.14 SHG from binary mixtures of EM form II and PVP with 95% confidence 
bands (dots) and prediction bands (dashes) (mean± SD, n = 3). The particle size 
range was < 63 µm. 
The LODs are 23.0 and 0.13%, based on the standard deviation of the slope and three 








suggests that use of SHG is an excellent technique to detect small amounts of 
crystalline EM form II in an otherwise amorphous PVP medium. However, at higher 
levels of crystallinity the technique loses much of its sensitivity. 
The LOD of 0.13% is substantially lower than levels obtained using most other 
techniques, such as near-IR spectroscopy and XRPD 84·85•110•210,rn. Although further 
investigations are required, the sensitivity in this example and the speed of the 
technique suggests great potential for the use of SHG to detect very low levels of 
crystalline material in an otherwise amorphous medium. 
Table 5.3 Quantitative analysis from a straight line fit of response versus 
concentration of form II in binary mixtures with PVP (also see Figure 5.14). 
Equation 




LOD based on SD of 
slope 
23.0% 
LOD based on SD of 0% 
form II 
0.13% 
5.3.2.2 Alpha-lactose monohydrate and beta-lactose anhydrate 
The second harmonic response of binary mixtures of ~L and aLMH is shown in 
Figure 5.15. There was a linear increase in SHG as the ~L concentration increased 
from O to 90%. There was disproportionate increase in SHG at 100% ~L which may 
be due to ~L being a phase-matchable material. If Le is much larger than r the 
introduction of the nonphase-matchable aLMH may have disturbed the coherent 
phase-matched response of ~L leading to a sharp drop in SHG. Up to 90% ~L it is 
likely that no phase-matching occurred and the response could be treated in the same 
way that EM forms I and II mixtures were modelled. A linear fit in the O - 90% ~L 
concentration range revealed a significant relationship between ~L concentration and 
response (P < 0.001). There was a non-zero intercept (P < 0.001), which confirms 
that pure aLMH produces a significant second harmonic response . 
Quantitative analysis of the data yielded LODs of 24.9 and 12.7% based on the 
standard deviation of the slope (0 to 90% ~L) and 0% ~L sample measurements 
respectively. Though too high for practical use, with improvement of the apparatus 
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(Section 5.4), it may be possible to lower these values to acceptable levels for in-
process control. 
In future investigations samples with between 90 and 100% ~L should be measured to 
characterise the SHG response in the concentration range where phase-matching of ~L 
appears to be occurring. If the sharp change can be well quantified, a lower LOD for 
~L than aLMH may be obtained in binary mixtures of the two forms. 
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Figure 5.15 SHG from binary mixtures of ~L in aLMH with 95% confidence bands 
(dots) and prediction bands (dashes) (mean± SD n = 3). Particle size range was 63 to 
125 µm. The linear fit was calculated using the second harmonic response from O to 









Table 5.4 Quantitative analysis from a straight line fit of response versus proportion 
of ~L in binary mixtures with aLMH using responses from mixtures containing O to 
90% ~L (also see Figure 5.15) . 
R2 (COD) 
LOD based on SD of LOD based on SD of 0% 
Equation 
slope ~L 
Response= 0.00297 (% ~L) + 
0.966 24.9% 12.7% 
0.231 
5.3.2.3 Qualitative studies 
5.3.2.3.1. Ranitidine hydrochloride forms I and II 
A significantly higher (P = 0.001) second harmonic response was observed for RN 
form II compared with form I (Figure 5.16 and Table 5.5). The responses were 
localised at 532 nm and therefore the different response profiles of the two 
polymorphic forms can be attributed to SHG differences. No sample damage was 
visible after irradiation. The samples were unsieved, so it is possible that some of the 
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Figure 5.16 Response from pure RN forms I and II at 529, 532 and 536 nm (mean± 
SD, n = 3). Particles were unsieved. 
Table 5.5 SHG from pure RN forms I and II with PMT bias voltage at -2100 V and 














Much larger outputs were recorded for form I than form III of CBZ at 529, 532 and 
536 nm (Figure 5.17). However, once the scaled second harmonic outputs of the two 
forms were calculated (by subtracting the average of the responses at 529 and 536 nm 
from the response at 532 nm) the results of the two forms were not significantly 
different (P = 0.053) (Table 5.6). In fact, the form I output was negative. The 
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minimal SHG from both forms of CBZ may be due to molecular dimer formation in 
both crystal forms, and subsequent increased crystal symmetry and decreased unit cell 
dipole moment. This hypothesis needs further investigation by unit cell analysis. 
Bleaching and some discolouration occurred with form III, which may have affected 
the results. 
The scaled second harmonic outputs of the two forms show that SHG was negligible 
for both forms, which would prevent the use of SHG to differentiate and quantify 
forms I and III of CBZ. The larger response of form I than form III at all wavelengths 
indicates that form I exhibits broad fast fluorescence. Brittain 212 found that although 
CBZ does not fluoresce in solution, in the solid state both form III and the dihydrate 
forms fluoresce. After irradiation with 34 7 nm radiation, the fluorescence from the 
dihydrate was found to be about three times as intense as the fluorescence from form 
III. This difference was used to model the kinetics of the form III to dihydrate 
transition in suspension. Although the fluorescence of form I was not investigated by 
Brittain, the findings in this section suggest that it may be possible to differentiate and 
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Figure 5.17 Response from pure CBZ forms I and III at 529, 532 and 536 nm (mean 
± SD, n = 3). Particle size range was< 63 µm. 
Table 5.6 SHG from pure CBZ forms I and III with PMT bias voltage at -1760 V and 














The responses of y-crystalline and amorphous IM at different wavelengths are shown 
in Figure 5.18. A pulse energy of 41 mJ was used as lower pulse energies did not 
register signals in the crystalline sample. Crystalline IM exhibited only a weak 
response at 532 nm. A second peak, of almost equal intensity, was also observed at 
502 nm. A peak at the second harmonic frequency also appears in the amorphous IM 
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spectrum. These results suggest that y-crystalline IM exhibits very poor SHG, and 
quantitation of binary mixtures of y-crystalline and amorphous IM was not possible 
(data not shown). As was hypothesised for CBZ, the minimal SHG from y-crystalline 
IM may be due to molecular dimer formation in the crystal, therefore increasing 
symmetry and minimising the unit cell dipole moment. This hypothesis needs further 
investigation, by unit unit cell analysis. Samples were also measured with different 
size fractions, and no relationship between particle size and response was observed 
(data not shown). 
II Crystalline IM 
1.0 - • • Amorphous IM • 
::J 0.9 -
ro - 0.8 -Q) • en II 
C 
0.7 -· Ill 0 II 






1111 s.... 0.3 - Ill 0 z II 
0.2 - I 
I 
0.1 -
I I I I I 
500 520 540 560 580 
Wavelength / nm 
Figure 5.18 Response of y-crystalline and amorphous IM at different wavelengths 
after a single pulse. Each point is the average of ten measurements. The amorphous 
particle size was 90 - 125 µm and they-crystalline sample was< 63 µm. 
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5.4 Apparatus development 
The work presented in this chapter involved binary mixtures. In binary systems a 
single output can be used to quantify both components. However, a single output can 
not quantify analyte concentrations if more than two components are present. In 
contrast, a multivariable output allows the concentration of components in multi-
component systems to be determined, especially if multivariate analysis is used. In 
addition, multivariate analysis results in better models than univariate analysis as 
outlined in Section 1.5.2. Two possible approaches to achieve multivariate outputs in 
SHG measurements are the use of second harmonic detection at different angles 
relative to the sample (angle resolved measurements) and also using variable 
wavelength excitation of the sample with a tuneable laser to obtain resonant second 
harmonic generation. 
Angle resolved measurements of SHG may be useful because the second harmonic 
response is a function of a scattering pattern. Variable wavelength excitation offers 
potential because the second order susceptibility of materials varies as a function of 
wavelength. Resonant second harmonic generation occurs when the second harmonic 
becomes resonant with a dipole transition of one of the components. If the second 
harmonic is resonant with a dipole transition then the dipole moment increases and the 
optical nonlinearity is also increased 213 . Initial experiments have been carried out, 
and SHG measurements involving angle resolved and variable wavelength 
measurements are the subject of a provisional patent 214 • 
More generally, the LODs in most quantitative experiments were too high for 
practical use. The SHG experiments in this thesis were conducted using a prototype 
optical bench instrument. It is very likely that, with engineering input into apparatus 
design, much of the variation related to apparatus will be eliminated. This may 
substantially reduce the LODs. Measurement automation is also likely to reduce 
significantly the measurement time, potentially down to milliseconds for each output. 
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5 .5 Chapter summary 
The potential of SHG to monitor and quantify polymorphism and crystallinity in 
binary mixtures of pharmaceutical powders has been investigated. Since SHG has not 
previously been used to quantify polymorphism or crystallinity in powders, proof-of-
principle was first established by using an adaptation of the Kurtz powder method in 
combination with quartz and Pyrex mixtures. SHG was found to be dependent on 
quartz concentration, and independent of particle size. Measurements took less than 
10 s. 
Binary mixtures of EM forms I and II, EM form II and PVP (amorphous), ~L and 
aLMH could be quantified using SHG. With the exception of lactose, LODs were 
consistently better when calculated for the component with lower SHG using the three 
0% samples, compared with those calculated using the standard deviation of the linear 
regression fit. 
Qualitative investigations revealed that RN forms I and II could be differentiated 
using SHG. CBZ forms I and III did not produce measurable second harmonic 
responses; however there were significant fluorescence differences. y-Crystalline IM 
exhibited negligible SHG, and could not be differentiated from amorphous IM using 
SHG. 
In conclusion, SHG has been used for the first time to investigate and quantify 
pharmaceutical polymorphism and crystallinity. In most cases a significantly 
different second harmonic response was obtained for either two solid state forms of 
the same compound or mixtures of two different compounds, one crystalline and the 
other amorphous. These results were in general agreement with the theory of SHG by 
particulate solids. Quantitation of the solid state components was demonstrated, and 
with improvement of the apparatus, combined with the advantage of the 
measurements being inherently rapid, this technique may be a useful tool for in-line 
quantitation of polymorphism and crystallinity in the pharmaceutical setting. In 
addition, angle resolved and resonant SHG measurements combined with multivariate 


















Many analytical techniques are currently used to characterise and quantify 
polymorphism and crystallinity of pharmaceutical materials. Whilst analysis using 
available techniques such as IR spectroscopy, XRPD, and thermal analysis often 
allows considerable insight into solid state forms of pharmaceutical materials, and 
quantitation of polymorphism and crystallinity to acceptable limits is often possible, 
no technique is ideal and different materials and forms of materials are investigated 
and quantified better by some techniques than by others. 
This project used the spectroscopic techniques FT-Raman spectroscopy, TPS and 
SHG to investigate and quantify pharmaceutical polymorphism and crystallinity. 
Quantitative analysis of the FT-Raman and terahertz pulsed spectra was performed 
using the multivariate analysis method PLS. Four materials: CBZ, EM, IM and 
lactose were investigated with at least two of the spectroscopic techniques for each 
material. Additionally FC, STZ and RN were investigated using one technique for 
each material. The following discussion will consider the advantages and 
disadvantages of each of the techniques used, and then the characterisation and 
quantitation of each material will be discussed and compared to other studies 
involving the same materials. 
FT-Raman spectroscopy detects polarisability changes during vibrations, which are 
mainly intramolecular between 400 cm-1 and 4000 cm-1. Advantages of FT-Raman 
spectroscopy include minimal or no sample preparation, its insensitivity to 
atmospheric water and water within the sample, and a broad spectral range. 
Disadvantages of the technique include a small sample area and possible laser induced 
chemical/and or physical degradation. In addition FT-Raman spectroscopy is 
presently slower than the other techniques (measuring time of about five to fifteen 
minutes for quantitative analysis of solid-solid mixtures) used in this thesis and 
spectral differences between solid state forms may be small, since it mainly probes 
intramolecular vibrations. Whilst FT-Raman spectroscopy has been used to 
investigate and quantify pharmaceutical polymorphism and crystallinity, quantitative 
analysis of pharmaceutical polymorphism and crystallinity using multivariate analysis 
has not been widely published. In this thesis, FT-Raman spectroscopy combined with 
PLS was successfully used to quantify the polymorphism of pharmaceutical materials, 
even when spectral differences were small. 
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TPS is a recently developed technique which operates in the terahertz domain and 
predominantly probes phonon vibrations in crystalline solids. Advantages of TPS 
include large spectral differences between solid state forms because the crystal 
structure is directly probed, the energy impinged onto the sample is small, the 
sampling area is large and the technique is currently much faster than FT-Raman 
spectroscopy. At this stage, the nature of spectral features in the terahertz domain is 
still poorly understood, although current research into phonon modes should reveal 
more information about what produces the observed spectral features. Measurements 
were made in transmission mode, and hence some sample preparation was involved. 
Recently, reflection mode measurements have been developed which reduce the 
requirement for sample preparation. A disadvantage of TPS is its sensitivity to 
atmospheric water. Prior to this thesis, TPS had only been used once to qualitatively 
investigate an example of polymorphism 163 . Amorphous and liquid crystalline 
materials had not been investigated using this technique. Furthermore, TPS had never 
been used to quantify polymorphism or crystallinity. In this thesis, TPS has been 
successfully used to investigate and quantify polymorphism and crystallinity for the 
first time. 
SHG is a nonlinear optical phenomenon which depends on the symmetry and dipole 
moment of the crystal. SHG is the fastest measurement technique used in this study 
with measurements taking a few seconds. SHG does not occur in water or other 
amorphous materials. At present, disadvantages of the method include its 
nonspecificity, higher variability compared with the other techniques and potential for 
physical and chemical degradation of the sample. Unlike the instruments used for FT-
Raman spectroscopy and TPS, the apparatus used for SHG in this thesis was a 
prototype which was built during this project. Ongoing development of the apparatus 
should remove many of the disadvantages. For example, its nonspecificity may be 
countered by variable angle and resonant wavelength measurements, and variability is 
likely to decrease if the apparatus is refined using adequate engineering. In addition 
automation and higher pulse repetition rates may reduce the sampling time to 
milliseconds. SHG has never been used to investigate or quantify pharmaceutical 
polymorphism or crystallinity. In this study, SHG measurements were successfully 




Multivariate analysis usually quantifies systems better than univariate analysis, and 
therefore PLS was used for the quantitative analysis of the FT-Raman and terahertz 
pulsed spectra 115 . SHG analysis was univariate since the output was a single intensity 
value. Future variable angle and resonant wavelength measurements with SHG will 
permit the use of multivariate analysis. 
6.1 Carbamazepine 
Forms I and III of CBZ were investigated by FT-Raman spectroscopy, TPS and SHG 
measurements. Although the FT-Raman spectra of the two forms contained smaller 
differences than the IR spectra, there were several peak position and intensity 
differences in the fingerprint and high C - H bonding regions between 3000 cm-I and 
3100 cm-I. These differences allowed quantitation of binary mixtures of CBZ forms I 
and III using FT-Raman spectroscopy combined with PLS. Mixtures containing O -
100% and O - 10% form I mixed with form III could be quantified with LODs of 
about 3% and 1 % respectively. The terahertz pulsed spectra of fo1ms I and III were 
very different between 3 cm-I and 70 cm-1 with no peaks in common between the two 
forms. These differences were used in combination with PLS to quantify binary 
mixtures of form I and form III. Using TPS, mixtures containing O - 100% and O -
10% form I in form III resulted in LODs of about 5% and 1 % respectively. The two 
forms of CBZ did not produce a significant second harmonic response, although there 
appeared to be a fluorescence response from form I. The lack of SHG is probably due 
to the formation of molecular dimers in both polymorphs, which in turn minimise the 
dipole moment of the unit cell. Of the three methods investigated FT-Raman 
spectroscopy and TPS combined with PLS analysis are the most suitable methods to 
quantify binary mixtures of CBZ form I in form III with LODs of about 1 %. 
The same FT-Raman spectra have also been analysed usmg PCR and LODs of 
between 0.33 and 2.2% were obtained, though these LODs were calculated from 
calibration data 124. Other researchers have quantified mixtures of CBZ forms I and 
IL Suryanarayanan (1990) quantified binary mixtures of forms I and III by using 
XRPD and integrating a peak unique to form I. An LOD of 2% was obtained 112• 
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However there were strict requirements for sample preparation. The particle size was 
less than 15 µm and a special sample holder was designed to minimise preferred 
orientation of the crystalline particles. Braga and Poppi (2004) used DRIFTS and 
PLS to quantify binary mixtures of forms I and III and assessed the quality of the 
quantitative model using figures of merit such as accuracy, precision and sensitivity 
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. For mixtures containing O - 20% form I in form III a RMSEP of 0.81 % w/w was 
obtained. The RMSEP is similar to the standard deviation of the slope and therefore, 
according to the ICH guidelines, the LOD would be about 2.5% 130. Although this 
LOD is larger than the LODs obtained using FT-Raman spectroscopy and TPS, the 
concentration range used was also larger. If a O - 10% form I concentration range 
were used, the RMSEP and the LOD values may be comparable to those obtained in 
this thesis. 
In another study, McGregor et al (2003) investigated the use of high speed DSC to 
quantify physical mixtures of forms I and III 216 . With a heating rate of 250 °Cmin-1 
the enantiotropic conversion of form III to form I was inhibited, allowing the melting 
enthalpies of both forms to be measured. A melting endotherm corresponding to form 
III was detected in mixtures with as little as 1 % form III in form I. However 
quantitation of mixtures of the two polymorphs was not possible, because the high 
melting form I acted as a seeding crystal in the melt of form III inducing partial 
recrystallisation of the melt into form I during the measurements. 
From the available studies, FT-Raman spectroscopy and TPS in combination with 
PLS are equally as good as or better than other methods used to quantify forms I and 
III of CBZ in binary mixtures. Formal validations would further determine the 
performance of the techniques used in this thesis in quantifying CBZ polymorphic 
mixtures. 
6.2 Enalapril maleate 
Forms I and II of EM are known to have similar molecular conformations and packing 
structures 47 . FT-Raman spectroscopy and TPS combined with PLS in addition to 
SHG measurements were used to investigate and quantify mixtures of forms I and II. 
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The similar conformations were reflected in the similarity of the Raman spectra of 
forms I and II, although there were more differences than in IR spectra. Quantitation 
of binary mixtures with O - 100% and O - 10% form I in form II resulted in LODs of 
about 6% and 2 - 3% respectively. The spectra of the two forms obtained using TPS 
contain many differences, with only one peak appearing in the same position for both 
forms. The large differences in the terahertz pulsed spectra are reflected in the 
improved LODs of about 3% and 1 - 2% for the O - 100% and O - 10% form I in 
form II mixtures respectively. In the SHG measurements form I emitted more second 
harmonic than form II. Depending on how the LOD was calculated a LOD of as low 
as 5% could be obtained. Although this LOD is substantially higher than that 
obtained by FT-Raman spectroscopy and TPS the apparatus used to measure the 
second harmonic was a prototype, and future apparatus refinement may significantly 
reduce this limit. In this thesis TPS was the best technique to quantify mixtures of 
forms I and II. 
An additional study was made using SHG to quantify EM form II in amorphous PVP. 
Although the standard deviations of the response at high EM form II concentrations 
were large, at low EM form II concentrations the response was very reproducible and 
a LOD of as low as 0.13% was obtained. This is an excellent result, and further 
investigation into using SHG to quantify small amounts of crystalline material in an 
amorphous environment is merited. 
There have been no other studies quantifying the two forms of EM. Due to the similar 
crystal structures of forms I and II, physicochemical properties such as melting 
temperature are very similar. Therefore it is likely that TPS, and possibly SHG (with 
further development) may be better than currently available techniques to quantify the 
EM forms I and II. It would be interesting to investigate and quantify other 
polymorphs that exhibit similar crystal and physicochemical properties by the 




The y-crystalline and amorphous forms of IM were studied using all three techniques 
used in this thesis. The FT-Raman spectra of amorphous and y-crystalline IM 
contained many differences, but quantification by FT-Raman spectroscopy and PLS 
using near-IR excitation was not possible due to fluorescence from impurities in the 
amorphous form. In another study FT-Raman spectroscopy was used to quantify IM 
crystallinity using univariate analysis and a LOD of about 1 % was obtained 88 . In this 
study the spectra of the amorphous form did not appear to be hampered by 
fluorescence. However, the potential problem of fluorescence may limit the 
application of FT-Raman spectroscopy to quantify IM crystallinity when multiple 
batches of amorphous IM prepared by melting and quench cooling are analysed. 
Quantitation using SHG was also not possible because the y-crystalline IM did not 
emit a second harmonic response that was measurable. The reason for this needs to 
be investigated, but it is probably due to centrosymmetric symmetry and a small 
dipole moment of the unit cell associated with dimer formation of the IM molecules in 
the y-crystalline form 49. The terahertz pulsed spectra of y-crystalline IM featured 
several peaks, however the amorphous form exhibited diffuse absorption with no 
distinct peaks. When TPS and PLS were used to quantify amorphous IM, RMSECV s 
of 1.42 and 1.69 and LODs of about 3% and 6% were obtained for O - 100% y-
crystalline in amorphous IM and O - 10% amorphous in y-crystalline IM respectively. 
The poorer performance of the O - 10% model compared with the O - 100% model 
merits further investigation, but may be associated with a difficulty in quantifying low 
levels of amorphous material. 
Other methods to quantify the crystallinity of IM have been investigated by several 
researchers. Mixtures of amorphous and y-crystalline IM have been quantified by 
XRPD using a lithium internal standard and the peak intensity of y-crystalline IM at 
11.6 ° (28) 217 . Although no LODs or other model performance parameters were 
provided ( except for a linear plot), these calibration curves have been used to study 
the kinetics and mechanism of crystallisation of amorphous IM at various 
temperatures 54, in the presence of sorbed water 52, and also the crystallisation of IM 
in molecular dispersions with polymers 218 . Crowley and Zografi (2002) also used 
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XRPD to quantify binary mixtures of y-crystalline IM and amorphous IM 55 . Using 
the height of one peak corrected for the diffuse diffraction of the amorphous form, an 
R2 of 0.997 was obtained and a y-form peak at 11.8 ° (28) could be detected with 2% 
of they-form present. This interference peak was used to study the amorphous IM 
conversion from they-form during cryogenic grinding. Mixtures of y-crystalline IM 
and a-crystalline IM have also been quantified. Otsuka et al (2001) compared XRPD 
and near-IR spectroscopy to quantify mixtures of the two polymorphs from O - 100% 
of they-form in the a-form. Using XRPD and the heights of four peaks attributable to 
they-form an R2 of 0.9699 was obtained. The residuals were attributed to fluctuating 
beam intensity and preferred orientation. Near-IR spectroscopy combined with PCR 
was also used for quantitation, resulting in an R2 of 0.992 and a RMSEP of 3.507 
using three factors after normalization. The accuracy was also better than that 
obtained using XRPD and conventional analysis. Although these results suggest NIR 
is a better technique for quantifying binary mixtures of the IM polymorphs, PCR or 
PLS analysis of the diffractograms may improve the quantitative performance of 
XRPD. Murphy et al (2003) investigated the thermal properties of y-crystalline and 
a-crystalline IM particles using microthermal analysis 106. At present however 
microthermal analysis is only semiquantitative because the volume of material heated 
is not controlled and the size of the furnace is very small in comparison to the sample. 
In this project, TPS was found to be the only viable option for quantifying the 
crystallinity of IM, and the results suggest that TPS combined with PLS is at least as 
good as other published methods. 
6.4 Lactose 
The solid state structure of lactose is characterised by two anomeric forms which may 
exist in at least five crystalline states either in pure or mixed anomeric forms. The 
physicochemical properties of the various forms of lactose have been published in 
many chemistry, pharmaceutical and food science journals. In this thesis, mixtures of 
the crystal forms aLMH and ~L were quantified using TPS and SHG. The TPS 
spectra of the two forms of lactose had very little in common, and the quantitative 
model produced , using O - 10% aLMH in ~L, obtained an R2 of 0.986, a RMSECV 
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of 0.404% and an LOD of about 1 %. LODs as low as 12. 7% were obtained with SHG 
measurements. Drapier-Beche et al (1997) used XRPD to quantify binary mixtures of 
0 - 100% aLMH in ~L. Four methods, using the areas of one or two unique peaks in 
the diffractograms of each form, were used to quantify binary mixtures of the two 
forms 68 . All four resulted in an R2 of 0.99%; however the authors stated that less 
than 5% of either form in the mixtures could not be detected. In another study, binary 
mixtures aLMH and ~L were quantified using near-IR spectroscopy 219. Second 
derivative transformation was applied to the spectra, and the ratio of intensity of the 
transformed spectra at two wavelengths was used to quantify the two forms. Mixtures 
containing 0-100% aLMH in ~L resulted in an R2 of 0.9956, and an almost identical 
R2 of 0.9955 was obtained when quantifying O - 100% ~L in aLMH. Although a 
smaller concentration range was used in the TPS measurements and neither of the two 
published papers used multivariate analysis, it appears that TPS is at least as good as 
XRPD and near-IR spectroscopy for quantifying binary mixtures of the two forms. 
Although the LODs obtained for ~L using SHG are too high for practical use, it may 
be that with further developments in the SHG apparatus, such as angle and excitation 
wavelength dependent measurements, it may be possible to lower the limit 
substantially. It would also be interesting to quantify mixtures of aLMH and ~L using 
FT-Raman spectroscopy. 
Binary mixtures of amorphous and crystalline lactose have been quantified using 
several methods. Fix and Steffens (2004) used XRPD and near-IR spectroscopy 
combined with univariate and PLS analysis to detect and quantify low levels of 
aLMH and amorphous lactose 116. Conventional analysis of the XRPD data allowed 
detection of as little as 0.45 and 0.93% aLMH and amorphous lactose respectively. 
Using PLS analysis these LODs were lowered to 0.27% and between 0.27 and 0.57% 
respectively. Such results show that with careful experimental design and data 
analysis, XRPD may be capable of detecting very small amounts of crystalline or 
amorphous material in binary mixtures, especially if multivariate analysis is applied. 
Using near-IR spectroscopy and PLS the LODs for aLMH and amorphous lactose 
were again less than 1 %. Quantitation using DSC resulted in nonlinear results and 
thus LODs were not calculated. 
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6.5 Fenoprofen calcium 
Crystalline FC and supercooled liquid crystalline FC were investigated and quantified 
using TPS. The terahertz pulsed spectrum of crystalline FC contained several peaks 
which are probably due to crystalline phonon vibrations or possibly hydrogen 
bonding. In contrast peaks were absent in the supercooled liquid crystalline FC 
spectrum, suggesting liquid crystalline FC has insufficient order to sustain crystalline 
phonon modes. It is possible that liquid crystals with a higher degree of order may be 
able to sustain some kind of phonon modes in the terahertz region, and studies using 
such materials should be investigated to learn more about the nature of phonon 
modes. Quantitation of binary mixtures of crystalline FC in liquid crystalline FC 
using PLS resulted in RMSECVs of 2.35 and 1.12% and LODs of about 6% and 3% 
for the for the O - 100 and O - 10% mixtures respectively. The LODs are high 
compared to the other materials quantified using TPS. Previous work quantifying 
mixtures using FT-Raman spectroscopy and PCR could not detect less than 4% liquid 
crystalline FC in crystalline FC. Other spectroscopic methods such as near-IR and IR 
spectroscopy may be better at quantifying the solid state mixtures of crystalline and 
liquid crystalline FC. 
6.6 Sulphathiazole 
Five polymorphs of STZ were also probed by TPS and found to have distinct terahertz 
pulsed spectra. Using the terahertz spectra it was possible to clarify the relationship 
between forms III, IV, and V, all with very similar conformational and packing 
structures, which could not be resolved using other techniques 182•186•187. There may 
be other examples in which TPS is able to resolve structures indistinguishable by 
other methods. 
6. 7 Ranitidine hydrochloride 
Forms I and II of RN were distinguished using SHG. The two polymorphs of RN 
were the first polymorphs to be investigated by TPS, and the two forms have different 
terahertz spectra 163 . Neither technique has yet been used to quantify these, although 
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low L0Ds are likely using TPS based on the quantitative results for other materials in 
this thesis. Quantitative SHG experiments are currently under way. In a previous 
study by Pratiwi et al (2002), the two forms were quantified in binary mixtures using 
FT-Raman spectroscopy and PCR giving LODs of about 1% for forms I and II 220 . 
XRPD combined with artificial neural networks has also been used successfully to 
quantify binary mixtures of forms II and I 221 . By combining XRPD and DRIFTS and 
applying artificial neural networks, the same authors could detect 1.5% of form II in 
form I 222 . Therefore, LODs of 1 - 2% form II in form I can be obtained using several 
approaches. 
In conclusion, the spectroscopic methods FT-Raman spectroscopy, TPS, and SHG can 
all be used to investigate and quantify pharmaceutical polymorphism and crystallinity, 
and very low LODs can commonly be obtained by combining either FT-Raman 
spectroscopy or TPS with PLS. TPS may be better than FT-Raman spectroscopy at 
quantifying mixtures of solid state forms with very similar molecular conformations 
and packing. TPS may also be used to learn more about crystalline phonon vibrations 
and so the material structure. The LODs obtained using SHG measurements should 
be markedly reduced through apparatus improvement and multivariate data 
acquisition and analysis. The very rapid SHG measurements have high potential for 
inline monitoring of pharmaceutical materials and products. FT-Raman spectroscopy 
and the novel methods TPS and SHG are likely to lead to improved monitoring, 
analysis and understanding of the physicochemical properties of pharmaceutical 
materials and systems. 
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Figure A Terahertz pulsed spectra of (a) CBZ form III sieved to< 75 µm size range 
(black lines) and form I before (grey thick line) and after sieving to< 75 µm size 
range (grey thin line)*; (b) EM forms II (black line) and I (grey line) after sieving to < 
75 µm size range only\ (c) y-crystalline IM sieved to< 75 µm size range (black lines) 
and amorphous form before (grey thick line) and after sieving to < 7 5 µm size range 
(grey thin linei; and crystalline FC sieved to< 75 µm size range (black lines) and 
liquid crystalline FC before (grey thick line) and after sieving to< 75 µm size range 
(grey thin line) t. 
* A spectral shift between the thick and thin lines for CBZ is due to recalibration of the machine 
t EM form I and II particles sieved to< 75 µm were used in all measurements 
t Intensity of thin lined spectra have been adjusted to represent spectra for 225 mg IM and FC content 
to match those of the thick line spectra. 
200 
